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Abstract 3
Abstract
Background
Currently, musculoskeletal diseases are the most common cause of disability in high-income 
countries. Among them, fragility fractures are a particularly important cause of morbidity and 
mortality in old age, especially among women. Taking a life course approach to chronic dis-
ease, it is accepted that one of the major determinants of fracture risk in adulthood is bone 
quality achieved in the first decades of life, especially during adolescence. In the past decade, 
there has been increasing research dedicated to bone accrual during this life stage. However, 
important issues remain to be clarified, namely regarding the public health relevance of adi-
posity on bone quality in normal and overweight adolescents. In addition, little is known about 
the variation in mediators of the relation between body fat and bone turnover throughout ado-
lescence in healthy individuals. Finally, there is scarce prospective evidence on the long-term 
effects of lifestyles on bone growth in this life stage.
Objectives
In the present work our objectives were:
1. To quantify the potential for an endocrine effect of adiposity on bone mechanical proper-
ties in the general adolescent population (Paper I)
a) To assess if overweight may elicit a harmful effect of fat on bone mineral density medi-
ated by low-grade systemic inflammation (Paper II)
2. To characterize the associations between bone turnover markers (including osteoclast 
regulators) and bone physical properties throughout adolescence (Paper III)
a) To understand if physiological mediators of the fat-bone communication may have 
different effects on bone turnover and physical properties (Paper IV)
The dynamics of adolescent bone: a cohort study in girls4
3. To assess whether early smoking and alcohol drinking are longitudinal predictors of bone 
mineral density and if that association may be mediated by body size (Paper V)
Methods
We used data from girls born in 1990 and evaluated at 13 and 17 years of age as part of the 
EPITeen cohort study. The cohort was assembled during the 2003/2004 school year in public 
and private schools in Porto, Portugal. Out of a total of 51 schools attended by children born 
in 1990, 46 agreed to participate by providing contact details of students and families. Of the 
2787 eligible students identified, 2160 (1116 girls) accepted to participate by providing infor-
mation for at least part of the protocol for the 13-years-old evaluation (78% individual level 
participation at recruitment). Adolescents were reevaluated in the 2007/2008 school year 
(17-years-old evaluation). Losses to follow-up were 20.5%. 
In both evaluations, adolescents and their legal guardians answered two self-administered 
questionnaires. The questionnaire filled in at home included adolescent medical history, di-
etary intake, physical activity, and family characteristics. The other questionnaire was com-
pleted at school by the adolescent alone and included information on sensitive topics, such as 
smoking and drinking habits (life experience and consumption frequency).
Bone mineral density was measured at the non-dominant distal forearm with a GE Lunar 
Peripheral Instant X-ray Imager (PIXI®) device. Anthropometric assessment included mea-
surements of height, weight, body composition by bioelectric impedance, as well as arm cir-
cumference, and tricipital and bicipital skinfolds thickness.
Venous blood was collected after a 12-hour overnight fast. High-sensitivity C-reactive protein 
was quantified using particle enhanced immunonephelometry. Adipokines (leptin and adipo-
nectin), osteoclast regulators and collagenous markers of bone turnover were quantified using 
commercially available enzyme-linked immunosorbent assay kits.
Results
Paper I
In 868 13-year-old girls, crude measures of adiposity were positively associated with forearm 
bone mineral density and standardized menarche age-adjusted linear regression coefficients 
(95% confidence intervals) were 20.7 (17.6, 23.9) for total body fat mass and 17.8 (14.6, 21.0) 
for upper arm skinfold fat area. After standard weight adjustment, the association with adi-
posity decreased (fat mass: -2.30 (-12.0, 7.37); fat area: 1.96 (-2.84, 6.76)), and the effect of 
Abstract 5
residuals was small. In path analysis, direct effects of both measures of adiposity on bone 
mineral density were negligible (-1.57 (-11.9, 8.75) for fat mass and 1.89 (-3.13, 6.91) for fat 
area), and adiposity did not add a significant contribution in addition to body weight to the over-
all model fit. In summary, the association between adiposity and bone mineral density was 
strongly mediated by weight, and estimates were consistent between methods.
Paper II
In 346 girls, an inverse association between serum high-sensitivity C-reactive protein and 
forearm bone mineral density was observed from 13 years old in overweight girls (linear re-
gression coefficient (95% confidence interval): -11.26 (-21.99, -0.52)). Among normal weight 
adolescents, 13-years-old C-reactive protein was negatively associated with prospective bone 
mineral density variation between 13 and 17 years old (-1.90 (-3.35, -0.45)). Overweight girls 
who maintained levels of C-reactive protein above the median throughout adolescence had 
lower 17-years-old bone mineral density (adjusted mean 0.441 vs. 0.483 g/cm2 in those who 
remained in the lower half of the C-reactive protein distribution). At 17 years of age, significant 
inverse associations were found between C-reactive protein and bone mineral density among 
normal weight and overweight girls. Therefore, obesity-related early systemic inflammation 
might be involved in suboptimal bone accrual, particularly in overweight girls.
Paper III
In 300 girls, osteoclast regulating cytokine RANKL was positively correlated with bone re-
sorption (C-terminal telopeptide of type I collagen, CTX) in early and late adolescence and 
RANKL bioactivity (OPG/RANKL ratio) correlated inversely with CTX at 17 (r=-0.24). No sig-
nificant associations were found between RANKL and osteoprotegerin (OPG) and bone forma-
tion (procollagen type I N propeptide, PINP). In early adolescence, there was an inverse and 
significant correlation of BMD with CTX (r=-0.52) but no significant correlations were found 
between osteoclast regulators and BMD. We observed a linear decrease in serum RANKL with 
increasing time relative to menarche, while OPG increased linearly. Summarily, serum RANKL 
and OPG levels varied markedly between early and late adolescence, independently of men-
arche timing. RANKL and OPG/RANKL were not correlated with bone turnover at 13 years of 
age, but became associated with bone resorption in late adolescence. However, serum levels 
of osteoclast regulating cytokines were not associated with forearm bone mineral density.
Paper IV
Using exploratory factor analysis in a subsample of 300 girls, we found that the same two 
factors at 13 and 17 years of age, named “Fat-bone interaction” and “Local bone turnover”, 
accounted for more than 40% of the variability observed in the selected set of variables (leptin, 
adiponectin, RANKL, OPG, CTX and PINP). “Fat-bone interaction” factors were positively asso-
ciated with leptin and negatively with CTX and RANKL at 13 and at 17 years of age. There were 
crude positive associations between those factors and BMD (β=25.1 (18.8, 31.4) at 13 and 
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β=9.6 (3.8, 15.3) at 17 years), that lost significance after adjustment. “Local bone turnover” 
was directly correlated with PINP and inversely with OPG but not associated with BMD. Using 
an exploratory approach, we identified an important pattern linking fat and bone in adolescent 
girls, involving systemic mediation by leptin and local mediation by RANKL, reflecting an ef-
fect on bone resorption. These results support the hypothesis that hormones and cytokines 
involved in the fat-bone axis may interfere mainly with bone turnover rather than with bone 
mineral density.
Paper V
Among 731 adolescent girls, over one quarter had tried smoking by 13, while 59% had drunk 
alcoholic beverages and 20% had experienced both behaviors by that age. Lower mean BMD 
at 17 years of age was observed in girls who had ever smoked by 13, as well as in those who 
reported drinking at that age. There were no significant cross-sectional associations between 
experience and frequency of smoking or drinking and BMD at 13 years of age. However, we 
observed significant associations between BMD z-score<-1 in late adolescence and having 
ever smoked by 13, after adjustment for menarche age and sports practice, (OR=1.92; 95% 
CI: 1.21, 3.05) and with ever smoking and drinking in the same period (OR=2.33; 95% CI: 1.36, 
4.00). Our study adds prospective evidence on the role of early initiation of smoking and alco-
hol drinking as relevant markers of lower bone mineral density in late adolescence.
Conclusions
In the present study we estimated that fat mass has a small weight-independent effect on bone 
mechanical properties in the weight range observed in the general population. Overweight 
might modify the relative importance of the non-mechanical effect of fat on bone physical 
properties, since we found that low-grade systemic inflammation was inversely correlated with 
forearm bone mineral density and the association was stronger for overweight adolescents. 
With regard to bone physiology, we found that dynamic markers of bone turnover may be more 
sensitive indicators of bone status than bone mineral density throughout different stages of 
growth and sexual development in adolescence. These findings emphasize the importance of 
disentangling mechanical and biochemical dimensions of growing bone. At a contextual level, 
considering adolescence as a period of a set of new experiences that may compromise health 
in adulthood, we found that lifestyles such as early initiation of smoking and alcohol drinking 
may be useful red-flags to indicate suboptimal forearm bone mineral density accrual up to late 
adolescence.
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Resumo
Introdução
Actualmente, as doenças musculoesqueléticas são a principal causa de incapacidade nos paí-
ses desenvolvidos. Entre elas, as fracturas de fragilidade são uma causa de morbilidade e mor-
talidade particularmente importante, principalmente no sexo feminino. Numa abordagem de 
ciclo de vida, é hoje aceite que um dos principais determinantes do risco de fractura na idade 
adulta é a qualidade óssea atingida ao longo das primeiras décadas de vida, especialmente 
durante a adolescência. Na última década, a investigação sobre a aquisição óssea neste perío-
do da vida tem vindo a aumentar. No entanto, permanecem por esclarecer algumas questões 
importantes, nomeadamente a do efeito da gordura corporal na qualidade óssea, tanto em 
adolescentes normoponderais como naqueles com excesso de peso. Pouco se sabe também 
sobre a evolução dos mediadores da relação entre a gordura e o metabolismo ósseo ao longo 
da adolescência e há ainda escassa evidência científica sobre o efeito que os estilos de vida 
têm a longo prazo no crescimento ósseo.
Objectivos
Os objectivos do presente trabalho foram:
1. Quantificar o efeito específico da gordura na densidade mineral óssea durante a adoles-
cência na população geral (Artigo I)
a) Avaliar se o excesso de peso pode desencadear um efeito negativo da gordura corporal 
na densidade mineral óssea, mediado pela inflamação sistémica subclínica (Artigo II)
2. Caracterizar as associações entre os marcadores do metabolismo ósseo (incluindo cito-
cinas reguladoras dos osteoclastos) e as suas propriedades mecânicas ao longo da ado-
lescência (Artigo III)
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a) Compreender se os mediadores fisiológicos da comunicação gordura-osso podem ter 
diferentes efeitos no metabolismo ósseo e nas suas propriedades físicas (Artigo IV)
3. Estimar a associação entre hábitos tabágicos e alcoólicos precoces e a qualidade óssea 
durante a adolescência e compreender se esta poderá ser mediada pela corpulência 
(Artigo V)
Métodos
Foram utilizados dados recolhidos numa amostra de adolescentes do sexo feminino nascidas 
em 1990 e avaliadas aos 13 e aos 17 anos de idade, no âmbito do estudo de coorte EPITeen. 
Esta coorte foi recrutada durante o ano escolar de 2003/2004 em escolas públicas e privadas 
da cidade do Porto, Portugal. Do total de 51 escolas frequentadas por adolescentes nascidos 
em 1990, 46 aceitaram participar, fornecendo contactos dos estudantes e respectivas famí-
lias. Dos 2787 estudantes elegíveis, 2160 (1116 raparigas) aceitaram participar, tendo forneci-
do informação para pelo menos parte do protocolo estabelecido para a avaliação dos 13 anos 
(78% de participação ao nível individual). Os adolescentes foram reavaliados no ano lectivo de 
2007/2008 (avaliação dos 17 anos), tendo havido 20.5% de perdas de seguimento.
Nas duas avaliações, os adolescentes e os pais responderam a dois questionários auto-apli-
cados. O questionário preenchido em casa incluía a história clínica do adolescente, consumo 
alimentar, actividade física e características familiares. Na escola, outro questionário era 
preenchido apenas pelos adolescentes e incluía a avaliação de hábitos tabágicos e alcoólicos 
(experimentação e frequência de consumo).
A densidade mineral óssea foi medida no antebraço distal não dominante usando um apare-
lho GE Lunar Peripheral Instant X-ray Imager (PIXI®). A avaliação antropométrica incluiu a 
medição da altura, peso, composição corporal (impedância bioeléctrica), perímetro do braço e 
pregas cutâneas bicipital e tricipital.
Foi colhida uma amostra de sangue venoso após jejum de 12 horas. A concentração sérica de 
proteína C-reactiva de elevada sensibilidade determinada por imunonefelometria. As adipoci-
nas (leptina e adiponectina), as citocinas ósseas e os marcadores do metabolismo ósseo foram 
quantificados no soro usando kits ELISA comerciais.
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Resultados
Artigo I
Em 868 raparigas de 13 anos, as medidas brutas de gordura corporal associaram-se positiva-
mente à densidade mineral óssea no antebraço e os coeficientes de regressão linear (intervalo 
de confiança a 95%) ajustados para a idade da menarca foram 20.7 (17.6, 23.9) para a gordura 
estimada por bioimpedância e 17.8 (14.6; 21.0) para a gordura estimada pelas pregas cutâ-
neas. Após ajuste para o peso, bem como na análise dos resíduos, a magnitude da associação 
diminuiu (bioimpedância: -2.30 (-12.0, 7.37); pregas: 1.96 (-2.84, 6.76)). Na análise de trajec-
tórias, os efeitos directos das duas medidas de gordura foram desprezáveis (bioimpedância: 
-1.57 (-11.9, 8.75); pregas: 1.89 (-3.13, 6.91)) e a contribuição destas para o ajuste do modelo 
final não foi significativa. Em suma, a associação entre a gordura corporal e a densidade mine-
ral óssea foi extensamente mediada pelo peso, tendo-se obtido estimativas consistentes entre 
métodos.
Artigo II
A partir de uma amostra de 346 adolescentes, encontrou-se uma associação inversa entre a 
concentração sérica de proteína C-reactiva de alta sensibilidade e a densidade mineral óssea 
nas raparigas com excesso de peso (coeficiente de regressão linear (intervalo de confiança a 
95%): -11.26 (-21.99, -0.52)). Entre raparigas normoponderais, a proteína C-reactiva aos 13 
anos associou-se negativamente à variação prospectiva da densidade mineral óssea entre os 
13 e os 17 anos (-1.90 (-3.35, 0.45)). As adolescentes com excesso de peso cujas concen-
trações de proteína C-reactiva se mantiveram acima da mediana ao longo da adolescência 
tiveram menor densidade mineral óssea aos 17 anos (média ajustada: 0.441 vs. 0.483 g/cm2 
naquelas que permaneceram abaixo da mediana). Aos 17 anos de idade, encontraram-se as-
sociações inversas entre a proteína C-reactiva e a densidade mineral óssea na totalidade da 
amostra. Assim, a inflamação crónica sistémica poderá estar envolvida na aquisição sub-ópti-
ma de massa óssea, em particular em adolescentes com excesso de peso.
Artigo III
Em 300 adolescentes, a citocina reguladora da actividade osteoclástica RANKL (ligando do re-
ceptor activador do factor nuclear kB) correlacionou-se directamente com a reabsorção óssea 
(C-terminal do colagénio tipo I, CTX) aos 13 e aos 17 anos e a bioactividade do RANKL (razão 
osteoprotegerina (OPG)/RANKL) associou-se inversamente ao CTX aos 17 anos (r=-0.24). Não 
se econtraram associações significativas entre o RANKL ou a OPG e a formação óssea (pro-
peptídeo N do procolagénio tipo I, PINP). No início da adolescência observou-se uma asso-
ciação inversa e significativa entre o CTX e a densidade mineral óssea (r=-0.52), mas não se 
encontraram associações entre as citocinas OPG ou RANKL e a aquela propriedade mecânica. 
Foi quantificada uma diminuição linear do nível sérico de RANKL, bem como um aumento do 
nível de OPG, com o aumento do tempo decorrido em relação à menarca. Em suma, os níveis 
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séricos de RANKL e OPG variaram marcadamente durante a adolescência, independentemente 
do desenvolvimento sexual. RANKL e OPG/RANKL não se associaram ao turnover ósseo aos 
13 anos, mas foi observada uma associação significativa destes parâmetros com a reabsorção 
óssea aos 17 anos. No entanto, os níveis séricos das citocinas reguladoras da actividade osteo-
clástica não se associaram à densidade mineral óssea.
Artigo IV
Utilizando análise factorial exploratória numa amostra de 300 adolescentes, observou-se 
que os mesmos dois factores aos 13 e aos 17 anos, intitulados “Interacção gordura-osso” 
e “Turnover ósseo”, explicavam mais de 40% da variância observada nas variáveis analisa-
das (leptina, adiponectina, RANKL, OPG, CTX e PINP). Os factores “Interação gordura-osso” 
associaram-se directamente com a leptina e inversamente com o RANKL e o CTX aos 13 e aos 
17 anos. Observaram-se associações brutas significativas entre estes factores e a densidade 
mineral óssea (β=25.1 (18.8, 31.4) aos 13 e β=9.6 (3.8, 15.3) aos 17 anos), cujo significado 
estatístico se perdeu após ajuste para o peso, a altura e a idade da menarca. O factor “Turnover 
ósseo” correlacionou-se directamente com o PINP e inversamente com a OPG, mas não se as-
sociou à densidade mineral óssea. Usando esta abordagem exploratória, foi possível identificar 
um padrão estatístico de associação entre potenciais mediadores da comunicação gordura-
-osso, envolvendo a acção sistémica da leptina e a mediação local do RANKL, que se reflectiu 
na reabsorção óssea. Estes resultados apoiam a hipótese de que as hormonas e citocinas en-
volvidas na relação gordura-osso interferem primariamente com o metabolismo ósseo, antes 
de se reflectirem nas propriedades mecânicas do osso.
Artigo V
Em 731 adolescentes, mais de um quarto tinha já experimentado fumar aos 13 anos, enquanto 
59% tinham bebido bebidas alcoólicas e 20% tinham experimentado ambos os comportamen-
tos nessa idade. Nas raparigas que aos 13 anos tinham experimentado fumar observou-se 
menor densidade mineral óssea aos 17, bem como naquelas que declararam beber na mesma 
idade. Não se encontraram associações transversais significativas entre a experimentação ou 
a frequência de hábitos tabágicos ou alcoólicos e a densidade mineral óssea aos 13 anos. No 
entanto, independentemente da idade da menarca e da prática desportiva, a experimentação 
tabágica aos 13 anos associou-se a baixos valores z de densidade mineral óssea aos 17 anos 
(OR=1.92 (intervalo de confiança a 95%: 1.21, 3.05)), bem como ter experimentado fumar e 
beber precocemente (OR=2.33 (1.36, 4.00)). Em resumo, a experimentação precoce de tabaco 
e álcool foi preditora de menor densidade mineral óssea aos 17 anos de idade.
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Conclusões
No presente estudo foi possível estimar que o efeito da gordura na densidade mineral óssea é 
fortemente dependente do peso corporal na população geral. O excesso de peso poderá modi-
ficar esta relação, visto que se verificou uma associação inversa entre a inflamação sistémica 
e a densidade mineral óssea de maior magnitude em adolescentes com sobrepeso.
Relativamente à fisiologia do osso, os marcadores dinâmicos de metabolismo ósseo foram 
indicadores mais sensíveis da qualidade óssea do que a densidade mineral óssea ao longo dos 
diferentes estádios de crescimento e de desenvolvimento sexual durante a adolescência. Estes 
resultados sublinham a importância de distinguir as dimensões mecânica e bioquímica no que 
respeita ao crescimento ósseo.
No contexto inerente à vivência da adolescência, os estilos de vida relacionados com o tabagis-
mo e consumo de álcool precoces constituíram-se como preditores do atingimento de um nível 
sub-óptimo de densidade mineral óssea no final da adolescência.

1. Introduction
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Musculoskeletal conditions are currently recognized as the most frequent cause of pain and 
disability in high-income countries [1]. However, for a long time this group of diseases had 
been relatively neglected. Indeed, because of their strong relation with increasing age and 
comparatively low case fatality rates, musculoskeletal conditions were considered an irre-
versible and unavoidable consequence of the ageing process. The dramatic overall improve-
ment of population health in the last centuries and the subsequent increase in life expectancy, 
which were attained through a decrease in the burden of competing causes, have resulted in an 
enhanced population burden and awareness of musculoskeletal diseases. As a consequence, 
this group of diseases moved upwards as a public health priority and the United Nations estab-
lished the 2000-2010 period as the Bone and Joint Decade [2]. This initiative aimed at reducing 
the burden of musculoskeletal conditions through raising awareness, implementing preventive 
strategies, improving diagnosis and treatment, and promoting research on this group of dis-
eases. The musculoskeletal conditions specifically targeted were rheumatoid arthritis, osteo-
arthritis, spinal disorders, severe limb trauma and osteoporosis. Among those, osteoporosis 
was selected because of its association with fragility fractures, which have high impact on 
individuals and societies due to their high frequency and associated disability. 
The ultimate goal of establishing effective fracture prevention strategies brought increased 
attention to the study of bone health as a public health issue. Within but also beyond the Bone 
and Joint Decade, an increasing interest was seen in accurately quantifying the burden of fra-
gility fractures, as well as in understanding their etiology more deeply. This trend has allowed 
for the integration of knowledge produced by clinical medicine, population studies and basic 
research, thereby promoting a multidisciplinary understanding of fragility fractures. It has 
also changed the view of skeletal health towards a construct that may be characterized and 
understood using a life course approach. Building on this multidimensional view, numerous 
advances in basic and applied research of bone fragility have been possible in the last decade.
At an individual level, the functions of the skeleton in keeping the mechanical integrity of the 
organism, providing of leverage for locomotion, and maintaining in calcium and phosphate ho-
meostasis have been long known [3]. Nevertheless, beyond those functions, bone has recently 
been recognized as an endocrine organ with a fundamental role in whole-organism physiology, 
as part of a fat-bone-pancreas loop [4]. Because of these multiple dimensions of very different 
nature, the skeleton becomes a particularly complex, but interesting and relevant object of 
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research. A more complete understanding of bone dynamics as a fundamental part of human 
health will ultimately allow for the future promotion of individual and population well-being.
1.1. The population burden of fragility fractures
A fracture is said to occur when there is a disruption in the continuity of bone tissue, thereby 
disturbing the skeletal function of mechanical support. As seen in Figure 1, the distribution of 
the age of fracture in the general population is bimodal, with a peak in childhood and another 
in old age [5]. This age-dependent pattern results from the relative bone fragility observed in 
these two periods of life, due first to skeletal immaturity (and partly also to increased trauma 
frequency) and then to age-related structural deterioration. Fracture incidence increases with 
age partly because of worsening intrinsic physical properties of bone tissue, and also due to in-
creasing probability of falling, and to poorer neuromuscular response to trauma. With increas-
ing age, the anatomical sites of highest susceptibility to fracture change, and the prognosis 
of each fracture worsens, due to a generally debilitated health status and to the presence of 
important co-morbidities [2].
Figure 1. Annual fracture incidence per 100 people, by age and sex,  
English general population 2002–2004 (reproduced from Donaldson LJ et al.[5]).
Because a categorical definition of bone fragility is particularly difficult to formulate, fragility 
fractures have been operationally defined as those resulting from low-energy trauma, such 
as a fall from standing height or from stairs, steps or curbs, or from moderate trauma other 
than a fall, such as a collision with an object during daily activities [6]. An alternative definition 
characterizes fragility fractures as those occurring at an anatomical site associated with de-
creased bone quality and whose incidence increases after the age of 50 years [7]. Even though 
in older white women the vast majority of fractures is due to bone fragility [8], the hip, verte-
brae and distal forearm are the anatomical sites where most fractures due to deterioration of 
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skeletal resistance are likely to occur [9]. Worldwide, hip fractures have become the standard 
for estimating the burden of fragility fractures since they are typically related with decreased 
mechanical bone strength, and are very frequently a cause of major temporary or permanent 
functional disability [2]. Their societal relevance is also related to the fact that they almost 
always involve hospital admission, complex surgical procedures and functional rehabilitation 
in high-income countries. As a consequence of their pathophysiology and natural history, hip 
fracture frequency is also the most valid measure of the burden of bone fragility within and be-
tween populations, for example comparatively to vertebral fractures, which frequently remain 
subclinical [9].
A striking gender-effect in the susceptibility to fracture has been identified: the woman to 
man ratio in fracture frequency varies with the population considered and the estimation 
method, but it is generally between 2:1 and 3:1 [10-13]. Several explanations have been 
proposed for the higher fracture risk in women than in men. Firstly, the female skeleton has 
lower mechanical resistance throughout life, partly due to a smaller bone size and diameter 
than that found in men [14]. Additionally, women go through menopause, a transition when 
profound hormonal changes take place. This biological process involves a decrease in the 
systemic levels of endogenous estrogen, which produces important changes in bone me-
tabolism that shift mineral homeostasis in favor of resorption. These changes cause a rapid 
increase in the rate of bone loss in the postmenopausal years. Besides these factors intrinsic 
to bone mechanical properties, women also fall more frequently than men, which is an im-
portant point since over 90% of fragility fractures are estimated to originate from a fall [15]. 
Lastly, women also live longer than men, which by itself increases the fracture susceptibility 
period [9]. As a result, even though there is evidence of higher case fatality rates among 
men after hip fracture [16], the overall burden of fragility fractures is clearly heavier on the 
female gender [17].
Particularly in high-income countries, age-related fragility fractures in women are frequent 
events. It was estimated that crude lifetime hip fracture risk was 12% in 2007/2008 in Canadian 
women [10]. A particularly high fracture risk was found in women of a Norwegian cohort, 
where the ten-year absolute risks of hip fractures at the ages of 65 and 80 years were 9% and 
24% [11]. Substantially lower rates were found in Poland: the remaining lifetime hip fracture 
risk at 50 years of age was 4% in women [12]. A study in Belgium estimated lifetime absolute 
risks of hip fracture and of any major osteoporotic fracture of 25% and 44%, respectively [18]. 
In the United Kingdom, the estimated lifetime risk of fracture at 50 years of age was 53% for 
any anatomical site and 11% for the hip [13]. The residual lifetime risk of hip fracture at 50 
years of age was 20% in women in Japan [19] and 44% in women of an Australian cohort [20]. 
As part of the validation of the FRAX® algorithm in France, the lifetime probability of sustaining 
a hip fracture at 50 years of age was estimated in 18.5% among women, whereas over one-
third of women were expected to have a major osteoporotic fracture [21]. In Switzerland, also 
in a FRAX®  validation research, there were 23% and 51% remaining lifetime probabilities of hip 
and major osteoporotic fractures, respectively, at age 50 [22].
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As a public health issue, fragility fractures are relevant because of their high associated mor-
tality as well as important short- and long-term morbidity [2]. A prospective study of adult 
women showed that 12 months after discharge from an admission due to hip fracture, 30% of 
patients under 80 years of age remained unable to walk without assistance, while the same 
happened with 56% of patients over 80 years of age [23]. In the USA, secular trends show that 
the mortality after hip fracture decreased between 1986 and 1995 in women but no further 
improvement was seen from 1995 onwards: in 2004, 30-day mortality after hip fracture in 
women was still 5%, whereas 180-day mortality was 14% and 360-day mortality was 22% 
[24]. In relative terms, the expression of short-term case fatality remains high, as estimated 
among German women newly admitted to nursing homes, where there was a significant ex-
cess mortality restricted to the first three months after hip fracture when compared to resi-
dents without fracture (hazard ratio: 1.72; 95% CI: 1.59-1.86) [25]. A large study in Australia 
comprising the first 5 years after fracture found standardized mortality ratios of 1.60 (95% CI: 
1.20-2.13) after a major osteoporotic fracture and 2.53 (95% CI: 2.04-3.13) after hip fracture 
in women [26]. 
Because of their high frequency and associated incapacity, fragility fractures also pose an im-
portant financial burden on individuals, health systems and ultimately on societies. The two 
million estimated incident osteoporotic fractures in the United States during 2005 had a cost of 
17 billion dollars, considering inpatient, outpatient, and long-term care components. This total 
cost was predicted to rise up to 25 billion dollars in 2025 [27]. A study of five European coun-
tries (Belgium, France, Italy, Spain and the United Kingdom) estimated similarly high direct 
costs of hip fractures across countries, ranging from 8346€ in Italy to 9907€ in France [28].
Studies of secular trends conducted in Europe and North America report an increase in crude 
hip fracture incidence rates during the second half of the 20th century [29]. However, as shown 
in Figure 2, a number of studies have reported recent decreasing trends of age-adjusted frac-
ture incidence [10, 24, 30]. Nevertheless, the decreasing age-specific risk should be regarded 
with caution as a measure of disease burden, since concomitant aging trends have caused the 
absolute number of fractures to remain constant or increase in the same period.
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Figure 2. Secular trends in hip fracture worldwide: annual change in age- and sex-adjusted 
hip fracture incidence (reproduced from Cooper C et al. [17]).
Notwithstanding, it has been suggested that the observed age-specific decrease may be due to 
changes in risk factors or improved coverage of diagnosis and treatment of bone fragility, but 
correlations between population trends of fractures and putative causes have been conducted 
at an ecological level, making causal inference particularly difficult [24]. In an attempt to 
assess whether changes in fracture risk could be explained by corresponding trends of im-
proved bone properties the prevalence of osteoporosis was quantified in the United States 
using data from NHANES (National Health and Nutrition Examination Survey) III (1988-1994) 
and NHANES 2005-2006 [31]. In the period considered, the age-standardized prevalence of 
osteoporosis decreased significantly from 18% to 11% in women and may be a plausible ex-
planation for the decreasing trend of fracture incidence. However, in Sweden, age-adjusted 
osteoporosis prevalence had not changed significantly between 1970-1974 and 1998-1999, 
even though there was concomitant evidence of decreasing fracture rates [30, 32].
1.2. Bone fragility and fractures
In a mechanical perspective, bone fractures result from the release of energy by bone tis-
sue as a response to loading. Trauma transfers energy to the bone tissue and fracture occurs 
when that energy exceeds the amount that bone can absorb [33]. The total energy required for 
fracture (or toughness) translates the quality of bone’s response to trauma. Observed tough-
ness depends on material properties of bone tissue, namely stiffness (the relation between 
imposed stress and observed strain within limits where bone maintains elastic properties) and 
ultimate strength (the maximum stress that the bone can sustain without fracture) [33]. As 
seen in Figure 3, beyond the intrinsic susceptibility of bone tissue to fracture, there are other 
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important external determinants of the effective load exerted on bone, such as the magnitude 
and type of trauma, as well as the quality of the neuromuscular response of the organism to 
that trauma. Together, these factors determine the effective load applied to the bone [34].
measurements in assessing fracture risk and monitoring the response to therapy. These
observations have brought renewed attention to the broader array of factors that
influence fracture risk, including those that are directly related to skeletal fragility as
well as those related to skeletal loading. In support of this view, a recent consensus
conference has defined osteoporosis as ‘a skeletal disorder characterized by
compromised bone strength leading to an increased risk of fracture’.2 This definition
underscores the role of bone strength, and implies that understanding bone strength is
key to understanding fracture risk.
This chapter reviews the etiology of age-related fractures from a biomechanics
viewpoint by introducing a standard engineering concept used to evaluate structural
failures, and by considering the various components that influence whole bone
strength. Finally, the potential of new non-invasive techniques to assess bone strength is
considered.
BIOMECHANICS OF AGE-RELATED FRACTURES
From a mechanical perspective, fractures represent a structural failure of the bone,
whereby the forces applied to the bone exceed its load-bearing capacity (Figure 1). The
forces applied to the bone will depend on the specific activity, and will vary with the rate
and direction of the applied loads. For example, the loads applied to the proximal femur
during a fall will depend on the height of the fall, the direction of the fall (forwards,
backwards, sideways), the impact surface, the extent of soft tissue overlying the hip, and
the ability of the individual to protect her/himself from the fall impact by extending a
hand.
The load-bearing capacity of a bone (or ‘whole bone strength’) depends on the
amount of bone (i.e. size), the spatial distribution of the bone mass (i.e. shape), and the
intrinsic properties of the materials that comprise the bone.3 Moreover, the mechanical
behavior of a bone will depend on the direction and magnitude of the loads applied t it.
For example, a proximal femur withstands much higher loads when tested in a single-leg
stance configuration than it does when tested in a configuration designed to simulate a
sideways fall.4–6 Further discussion of the determinants of whole bone strength is
presented in the next section.
FRACTURE?
Loads Applied to the Bone
Whole Bone Strength
Specific  Activity
(e.g., trauma versus controlled action)
Direction and Magnitude of
Applied Forces
Properties of the Materials
That Comprise Bone
Bone Geometry/Morphology
(size, shape, architecture)
Figure 1. Etiology of age-related fractures.
898 M. L. Bouxsein
Figure 3. Etiology of age-related fractures (reproduced from Bouxsein ML. [34]).
Overall bone strength is a complex multidimensional concept that simultaneously conveys the 
spatial distribution of bone tissue (size, shape and architecture) and its material properties, 
such as density. Maintenance of the shape, mass and size of the skeleton depends on the con-
tinuous process of turnover named remodeling. Through remodeling, bone tissue is able to 
repair microfractures and to modify its structure in response to biomechanical stress [35]. 
Mechanical properties are maintained or modified through constant metabolic activity in four 
different bone surfaces: periosteal, encodortical, trabecular and intracortical (or Haversian). 
Remodeling is characterized by the coupled actions of matrix formation and resorption in each 
of these envelopes, and is achieved by basic multicellular units that comprise osteoblasts and 
osteoclasts that act in discrete units and in a coordinated manner, following an activation-
resorption-formation sequence [36]. Specifically, osteoclasts remove mineralized bone tissue 
and are followed by osteoblasts that synthesize osteoid matrix composed mostly of type I col-
lagen, which is then mineralized with hydroxyapatite crystals (Ca10(PO4)6(OH)2). Within each 
envelope, the balance of bone formation and resorption allows bone to adapt its structure to its 
function, in order to optimize resistance to stress. The process of remodeling occurs through-
out the life course and is essential for the maintenance of overall strength and for the repairing 
of damaged tissue (Figure 4).
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with the same BMD, because the load applied during a fall will be much greater for the
larger than the smaller individual. However, this being said, it is important to realize that
the smaller person may have less natural ‘trochanteric padding’, and therefore, at
impact following a sideways fall, greater forces will be applied to the femur than in the
individual with more natural padding. This routine clinical example underscores the
need to consider more than just BMD when assessing fracture risk.
DETERMINANTS OF WHOLE BONE STRENGTH
The ability of a bone to resist fracture (or ‘whole bone strength’) depends on the
amount of bone (i.e. mass), the spatial distribution of the bone mass (i.e. shape and
microarchitecture), and the intrinsic properties of the materials that comprise the bone
(Figure 3). Bone remodeling—specifically the balance between formation and
resorption—is the biologic process that mediates changes in the traits that influence
bone strength. Thus, diseases and drugs that impact bone remodeling will influence
bone’s resistance to fracture.
In considering these determinants of bone strength, one must keep in mind several
important concepts. First, unlike most engineering materials, bone is continually
adapting to changes in its mechanical and hormonal environment, and is capable of self-
renewal and repair. Thus, in response to increased mechanical loading, bone may adapt
by altering its size, shape and/or matrix properties. This type of adaptation is readily
seen by the greater size of the bones in the dominant versus non-dominant arm of
tennis players.9 In addition, favorable changes in bone geometry may occur in response
to deleterious changes in bone matrix properties. For example, in a mouse model of
osteogenesis imperfecta, a defect in the collagen that leads to increased bone fragility
can be compensated for by a favorable change in bone geometry to preserve whole
bone strength.10 Thus, the loss of bone strength with age likely reflects the ongoing
skeletal response to changes in its hormonal (i.e. a decline in gonadal steroids) and
mechanical environments (i.e. decreased physical activity).
A second important concept concerns the hierarchical nature of the factors that
influence whole bone strength. Thus, properties at the cellular, matrix,
BONE REMODELING
Balance of formation / resorption
WHOLE BONE STRENGTH
PROPERTIES OF BONE MATERIAL
density
matrix mineralization
collagen traits
microdamage
BONE MORPHOLOGY
shape (distribution of bone mass)
microarchitecture
BONE SIZE
mass
Figure 3. Determinants of whole bone strength.
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Figure 4. Determinants of whole bone strength (reproduced from Bouxsein ML. [34]).
1.3. Estimating bone fragility
For a number of reasons that included population ageing trends in high-income countries, dur-
ing the 1980s and 1990s there was an increasing awareness of the individual and social impact 
of fractures cause by low-energy trauma in old age. Even though it is now clear that fragility 
fractures are the result of multiple influences including trauma probability and biomechanics, 
it is undeniable that bone physical properties contribute in a great extent to fracture risk [34]. 
In fact, it had been well-known within the medical community, since the 19th century, that 
old age was associated with increased porosity of bone that predisposed it to fracture [37]. 
In 1851, Astley Cooper published the original clinical description of these fractures that were 
associated with increasing age, female gender, moderate trauma and anatomical sites with 
predominance of trabecular bone [38].The term osteoporosis came to use in order to describe, 
in qualitative terms, a “condition of generalized skeletal fragility in which bone strength is 
sufficiently weak that fractures occur with minimal trauma, often no more than is applied by 
routine daily activity” [3]. Later, in an National Institute of Health Consensus Development 
Conference osteoporosis was defined as “a disease characterized by low bone strength, lead-
ing to enhanced bone fragility and a consequent increase in fracture risk” [39]. These defini-
tions imply that osteoporosis is actually the result of a set of disorders that impair normal bone 
metabolism giving rise to increased fragility.
The evolving knowledge on the pathophysiology of fragility fractures and a growing concern 
about their impact on population health brought about increasing attention to the investigation 
of bone physical properties. An effort was made to identify a single trait that could: 1) quan-
tify fracture susceptibility; 2) be modifiable through intervention; and 3) be easily quantifiable 
without the need for invasive testing. The development and improvement of dual-energy X-ray 
absorptiometry made it possible to estimate bone mass rapidly and safely, and also to quantify 
a relative measure of bone quality, the ratio between bone mass and projected bone area. 
Dual-energy X-ray absorptiometry uses the transmission of X-rays through the body using high 
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energy photons (attenuated by bone tissue) and low energy photons (attenuated by soft tis-
sue). Attenuation values are obtained pixel by pixel and converted into areal bone mineral den-
sity by comparison with a standard phantom. Bone mineral density was considered a useful 
biological measure since it provided a quantitative dimension to osteoporosis, and dual-energy 
X-ray absorptiometry became the reference method for the diagnosis of osteoporosis. In 1994, 
the condition was given a quantitative definition by the World Health Organization, in relation to 
cutoffs obtained in relation to a reference sample of healthy young women [40]. More recently, 
femoral neck bone mineral density has been proposed as the gold-standard for the description 
of osteoporosis, using as reference data the normative database of femoral neck measure-
ments obtained as part of the NHANES III in women aged 20 to 29 years [41].
As a disease entity, the importance of the identification of osteoporosis at the individual and 
population levels is owed virtually exclusively to its associated fractures [9]. It is estimated 
that the predictive ability of bone mineral density for fracture is comparable of that of serum 
cholesterol for myocardial infarction or that of blood pressure for stroke [3]. The inverse rela-
tion between bone mineral density and fracture risk was confirmed in a meta-analysis of 12 
cohort studies including almost 39 000 participants followed for over 168 000 person-years, 
where it was estimated that for each standard-deviation decrease in bone mineral density, the 
relative risk of osteoporotic fracture in women was on average 1.53 (95% CI: 1.46-1.52) and 
the relative risk of hip fracture was 2.03 (95% CI: 1.87, 2.21) [42]. Nevertheless, there has 
been increasing concern about the inaccuracy of bone mineral density for fracture prediction 
at the individual level [43].
1.4. The life course approach to bone fragility
The profound political and social changes that took place during the first half of the 20th cen-
tury were an opportunity to study the growth of children in relation to important individual and 
contextual contrasts. Longitudinal studies of children born in the 1920s and 1930s showed that 
the circumstances of an individual’s life could be explained as a function not only of the present 
context but also of an accumulation of personal, family, and social experiences throughout the 
life course of that individual. In this context, the following four core principles of the life course 
theory applied to sociology were proposed [44]:
1. Historical time and place: the life of individuals is embedded in and  shaped by the 
historical times and places they experience over their lifetime;
2. Timing in lives: the developmental impact of a succession of life transitions or events is 
contingent on when they occur in a person’s life;
3. Linked lives: lives are lived interdependently, and social and historical influences are 
expressed through this network of shared relationships;
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4. Human agency: individuals construct their own life course through the choices and 
actions they take within the opportunities and constraints of history and social circum-
stances.
The life course theory builds on the premise that “changing lives alter developmental trajecto-
ries” [44]. Its main implication is conversely that individual trajectories may be acted upon by 
intervening at different but interconnected levels of human living. Predictably, this life course 
approach had application to the study of the distribution and determinants of diseases in 
human populations. Life course epidemiology emerged as a discipline that aimed at providing 
and testing theoretical models of human disease that postulate pathways linking exposures 
across the life course to later-life health outcomes. Taking this approach, health outcomes in 
adult life may be seen as long-term effects of exposures acting during gestation, childhood, 
adolescence, young adulthood and later adult life [45]. Relevant exposures throughout the life 
course may be biological, behavioral and psychosocial, as well as an incalculable number of 
interactions between those. As a reaction to the limitations of conventional adult cohort stud-
ies in clarifying early causes of disease, this model tries to obviate some of the reductionist 
aspects of previous models of disease etiology, by providing a common framework for the un-
derstanding of such different sets of disease causes as adult lifestyle, biological programming 
and social context. Life course epidemiology has been particularly helpful in the development 
of the theoretical basis for the complex pathways of the etiology of chronic diseases, such as 
bone fragility.
Today, fragility fractures in old age are seen as the result of multiple influences acting through-
out the whole life course [46]. Two major aspects are thought to determine the ultimate risk of 
fracture in adults: the amount of bone mineral lost with advancing age, whose rate increases 
drastically in women after menopause, and the maximum amount of bone strength attained 
during the first decades of life [47]. Figure 5 presents a schematic representation of the most 
widely accepted model to explain major changes in total body bone mass throughout the life 
course. Total body bone mass increases rapidly early in life and maintains a relatively constant 
level throughout adulthood. Whereas in men age-related bone loss has a smooth slope, in 
women, menopause marks a time of profound hormonal changes following which bone mass 
starts to rapidly decline causing increased risk of fracture. During adulthood, the main tar-
get in reducing fracture risk is therefore to minimize the rate of age-related bone loss after 
menopause. However, a consequence of this life course model is that another strategy may be 
of major relevance in the primary prevention of fragility fractures: to increase the maximum 
resistance of bone attained early in life [48]. Since bone strength is a complex construct for 
which there is no consensual operational definition and because body size changes substan-
tially along the life course, total body bone mass is used to translate individual trajectories 
throughout life. The maximum amount of bone obtained throughout life is denominated peak 
bone mass. Optimized peak bone mass is believed to reduce the impact of age-related bone 
loss later in life. It has been suggested that bone accrual before peak bone mass may be more 
important than resorption in adulthood since the variance in bone mass at the completion of 
growth is substantially greater than the variance in rates of bone loss with ageing [49, 50].
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Figure 5. Diagrammatic representation of the bone mass life-line in individuals who achieve their full 
genetic potential for skeletal mass and in those who do not (reproduced from Heaney R et al. [47]).
Because adolescence is a period of rapid change in bone mass, it is likely to present greater 
scope for modification or adaptation than other life periods. According to the life course para-
digm, such a period of high mineral accrual before peak bone mass may be conceptualized as a 
critical or sensitive period, i.e., a time frame during which beneficial or harmful exposures have 
lasting and irreversible effects on bone health that determine later fracture risk. Theoretically, 
a certain period of life can be considered critical if it is the only time frame throughout life when 
an exposure is causally linked to an outcome. The causal pathway mediating the exposure-
outcome relation would only be available during that period, which would be the single time 
window when a preventive intervention would result in a decreased risk of developing the 
disease. Regarding bone health, as well as many other chronic diseases, it seems more likely 
that adolescence is instead a sensitive period: a time frame when an exposure has a stronger 
effect than it would have in other stages of life. This role is probably more consistent with what 
is known about the effects of modifiable factors such as calcium intake and physical activity on 
bone quality. Indeed, although it is believed they play a particularly important role before peak 
bone mass acquisition, there is evidence that their levels later in life may also be associated 
with fracture risk, although more weakly [47].
In the case of the etiology of bone fragility, the distinction between effects on structure and 
on function [45] seems particularly appropriate: influences in the first decades of life have an 
effect on peak bone mass (structure is affected) but fracture risk may remain low throughout 
most of the life course (function remains similar). In this way, no increased fracture risk is 
seen in the short-term. It is only when other factors along the aging process appear (e.g. 
menopause) that the structural impact of the exposures in early life on bone strength becomes 
evident and observable through increased fracture risk. Later life circumstances may be seen 
either as independent risk factors or as modifiers of the effect of early life exposures.
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1.5. Growth-related changes to the skeleton
Growth involves enormous changes in body size and composition since intrauterine life. The 
velocity of linear growth is highest at 18 weeks of gestational age and decreases towards the 
end of gestation [51]. During the first year of life, linear growth is on average 25 cm and de-
creases to 12.5 cm in the second year. In girls, growth rate continues to decrease throughout 
childhood up to approximately 5.5 cm/year at 9 years of age, when the pubertal growth spurt 
begins. This is a phase of rapid growth which lasts up to 14 years of age and occurs during 
Tanner breast stages 2 and 3, during which peak height velocity increases to about 8.3 cm/
year. The common endocrine control of body composition determines that maximum linear 
growth drives other peak tissue velocities. Indeed, peak height velocity was documented to 
occur at a mean (standard-deviation) 11.8 (0.9) years in girls, while peak lean mass velocity 
was observed at 12.1 (1.0) years, followed by peak bone mineral content velocity (12.5 (0.9) 
years) and by peak fat mass velocity (12.6 (2.0) years) [52]. In the three years around peak 
height velocity, over 20% of total body bone mineral content is acquired. As shown in Table 1, 
there are no significant increases in bone area in any site after four years since peak height 
velocity and no increases in bone mineral content in the 6 years subsequent to peak height ve-
locity [53]. Longitudinal evidence shows that peak bone mineral content velocity is coincident 
with mean age at menarche (12.5 (0.86) years at peak bone mass content accrual and 12.7 
(0.98) years at menarche) [54]. 
Table 1. Peak bone area and bone mineral content in relation to peak height velocity 
(from Baxter-Jones et al. [53]).
Mean (SD) percentage of peak 
value acquired at PHV age
Years from peak height 
velocity at peak value
Total body bone area 71 (6) 4
Total body bone mineral content 59 (7) 6
Lumbar spine bone area 74 (6) 3
Lumbar spine bone mineral content 51 (6) 4
Total hip bone area 82 (6) 2
Total hip bone mineral content 64 (8) 4
Femoral neck bone area 88 (6) 2
Femoral neck bone mineral content 73 (9) 2
  
PHV: peak height velocity
The outline of the human skeleton, including the shape and position of long bones, is attained 
during fetal life and is known as skeletal patterning [55]. Subsequently, mineral accrual up to 
peak bone mass is a continuous process of bone growth in length and diameter that occurs 
throughout the first decades of life. Longitudinal growth of long bones occurs through endo-
condral ossification, where new trabecular bone is formed by using a cartilaginous template 
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generated by the growth plate [56]. During linear bone growth, prechondrocytes in growth 
plates differentiate into proliferative and then hypertrophic chondrocytes, which are then re-
placed with mineralized tissue, in that way increasing the size of the metaphyseal compart-
ment. Linear growth ceases when chondrocytes at growth plates exhaust their proliferative 
capacity and the closure of epiphyses occurs. Additionally, in order to achieve substantial 
changes in diameter and shape in the diaphysis, bone tissue requires a process that allows it 
to increase formation relative to resorption, thereby causing a net gain of mineral mass. This 
process is known as modeling, and involves the uncoupling of formation and resorption, allow-
ing for bone formation to occur in the periosteal surface, while resorption takes place within 
the endosteal surface. Overall, the net balance of this cellular activity is in favor of formation 
and causes an increase in bone diameter and cortical thickness. As a result of these model-
ing drifts, substantial changes are made to the size and shape of bone, thereby optimizing its 
geometry with respect to mechanical properties [36]. The end result of the modeling process 
is an altered spatial disposition of bone tissue that happens in coordination with linear growth. 
Once the skeleton reaches maturity, modeling rates reduce substantially but homeostatic re-
modeling remains active throughout the life course.
As a result of bone development, physical properties improve substantially, as recently shown 
in published reference curves for bone mineral content and areal bone mineral density from 5 
to 20 years of age [57]. In another study that followed children from 8 to 16 years of age, bone 
mineral content tripled at all sites (hip, spine and total body) and areal bone mineral density 
increased 60% at the spine, 56% at the hip and 35% in the whole body. Bone mineral appar-
ent density at the spine increased 22% and 21% at the hip in females [58]. The importance 
of adolescence as a particularly important stage of mineral accrual is also elucidated by the 
observation that 26% of adult calcium is gained in the 2 years of peak skeletal growth [59]. 
Compartment volumetric bone mineral density does not change substantially in the phase of 
fastest linear growth but there is evidence that an increase of up to 30% occurs during late 
puberty [60, 61].
Recent prospective studies on the accrual of bone mass or density have found early track-
ing of these characteristics by demonstrating that individuals within a sample are likely to 
maintain their relative position in the distribution of bone properties throughout childhood or 
adolescence [58, 62, 63]. However, ranking systems based on quantiles or z-scores do not 
take into account the fact that, even if individuals remain in the same class of bone status 
throughout follow-up, differences in the absolute values of bone properties between classes 
may widen or narrow in this period depending on changes in the underlying distribution. 
Additionally, since extreme categories span across wider ranges of values, for the same 
absolute change throughout time, tracking is overestimated in the tails when compared to 
the center of the distribution. Moreover, when tracking is studied by comparing children or 
adolescents of the same chronologic age, there is probably substantial heterogeneity in skel-
etal maturity within the sample. Individuals in earlier phases of skeletal development are 
likely to remain biologically younger throughout the whole follow-up period and therefore to 
reach lower bone strength, even if the final peak bone quality to be attained in the future will 
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become similar to the one observable in early developers. In fact, there is evidence that late 
maturing girls benefit from an additional period of normal growth before epiphyseal closure 
when compared to average maturers or early maturers [54] and that differences in bone 
properties according to maturational timing are no longer observable in young adulthood 
[64].These points are important terms of public health, since a high degree of tracking would 
imply somewhat deterministically that there is limited role for interventions on modifiable 
factors for the attainment of optimal skeletal health.
As described, bone growth is characterized by substantial changes in size and shape in order 
to attain the best material resistance to mechanical strain with the least possible mass [65]. 
It should be noted, however, that from a biomechanical point of view, bone mass changes have 
limitations in describing peak bone strength attainment. In fact, the evolutionary process de-
termined that bone development should aim at attaining the best possible resistance to stress 
with as little material as possible [49]. Growth in size requires a correspondent improvement 
in bone strength, which is not simply attained via increasing mass but essentially through a 
change in the spatial distribution of bone tissue. The implication is that bone growth cannot 
strictly be described as an increase in the material density of existing tissue [49], but rather as 
a redistribution of bone tissue that causes an increase in mass in areas where it optimizes bone 
strength for the least material [65]. Those changes are conducted mainly through periosteal 
expansion, thus increasing the diameter of the bone cross-section. This process is capable of 
improving architectural parameters of bone strength, namely polar moment of inertia and sec-
tion modulus1, without altering cortical area or volumetric bone density of the bone material. 
As shown in Figure 6, in a study on the development of bone strength at the proximal radius 
it was observed that, after pubertal stage 2, males have stronger bones for the same mass 
than females. This happens because bone formation occurs more extensively in the periosteal 
surface in the former and the resistance to stress becomes increased even though cortical 
area remains unaltered [66]. The endocortical apposition among females during puberty is ap-
parently mechanically inefficient, since it does not improve resistance to mechanical stress. It 
has been hypothesized that this accumulation of mineral of little mechanical value in females 
serves the physiological function of a reservoir of calcium that can be mobilized during preg-
nancy and lactation, without compromising overall bone strength.
1  Polar moment of inertia = Σ(d2 x A) [in mm4]
Section modulus = [Σ(d2 x A)]/dmax [in mm
3]
A: cross-sectional area of a voxel (volumetric pixel); d: distance of the voxel from the center of gravity; dmax: maximum 
distance of any of the voxels of the cortical cross-section from the center of gravity.
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Figure 6. Schematic representation of the effect of bone cross-sectional geometry on parameters of bone stability 
(reproduced from Schoenau et al. [66]).
As described above, during growth, peak height velocity and peak lean mass velocity precede 
peak bone accrual [52]. The implication of this asynchrony is that there is a phase of transient 
fragility where bone mass is not perfectly adapted to body height and lean mass, resulting in a 
period of increased fracture risk [5]. A study that used quantitative computed tomography of 
the distal radius has shown that, at the bone tissue level, the most likely explanation for this 
fragility is a transient decrease in the proportion of load borne by cortical bone and in the ratio 
of cortical to trabecular bone during mid-puberty, accompanied by increased cortical porosity 
[67]. Those growth-related changes are clearly reflected in the population: according to the 
United Kingdom General Practice Research database, first fracture incidence in childhood was 
133/10 000 person-years and the most frequent anatomical site of fracture was the radius/
ulna, with an incidence of about 40 fractures per 10 000 person-years (57% higher in boys) 
[68]. Fracture incidence peaked at 11 years of age in girls and at 14 years of age in boys, con-
firming the expected coincidence with the previously-described phase of relative mechanical 
fragility caused by a discrepancy between height gain and bone mineral accrual.
1.6. The role of genetic and environmental determinants 
on bone accrual
The observed population variance in the distribution of quantitative phenotypes of multifacto-
rial etiology such as bone properties is a result of interactions between genetic and environ-
mental circumstances [69]. Genetic factors seem to be particularly important in the etiology of 
bone fragility, since several studies comparing within-pair correlations between monozygotic 
and dizygotic twins showed that genetic factors account for about 75 to 80% of the observed 
variability in bone mineral density and content in the proximal femur, vertebrae and forearm 
[37]. Notwithstanding, the magnitude of the effect of most genetic polymorphisms on bone 
properties up to peak bone mass has yet to be clarified [55]. Although many more have been 
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identified as plausible candidates, there is currently evidence that the following 15 genes can 
be classified as determinants of bone fragility: VDR, ERS1, ESR2, LRP5, LRP4, SOST, GRP177, 
OPG, RANK, RANKL, COLIA1, SPP1, ITGA1, SP7, SOX6 [70]. It is accepted that, because the 
genetic component of bone quality has polygenic nature, each of the several genes involved 
has a small contribution to the observed phenotype, being probably responsible for under 5% 
of the population variability in bone properties [71]. Indeed, even though there has been great 
recent progress in identifying genetic causes of bone fragility, a recent study has shown that 
the combination of the 15 most important single nucleotide polymorphisms associated with 
lumbar spine bone mineral density explained only about 2.9% of the variance in that bone 
property and the 10 top single nucleotide polymorphisms associated with femoral neck bone 
mineral density explained 1.9% [72].
It is important to emphasize that weak associations of each genetic variant with bone phe-
notypes are to be expected, since there is a need for genetic mechanisms that govern key 
functions such as skeletal integrity to be redundant, pleiotropic and polygenic, in order to avoid 
significant disturbance due to environmental factors [73]. An evolutionary perspective of os-
teoporosis has described the condition as a result of increased life expectancy combined with 
a misadaptation to a still young bipedal status. Given that bone fragility becomes apparent as a 
phenotype only in old age, there is apparently no adaptive advantage to stronger bones before 
and during the reproductive period. This would result in unchanged, “archaic” genes that inter-
act with the modern environment causing a response that can lead to inefficient adaptation, i.e. 
bone fragility and subsequent fracture (Figure 7).
Figure 7. Gene-environment interaction model applied to osteoporosis by Karasik, 2008 
(reproduced from Karasik [73]).
As in many other conditions, gene-environment interactions should be considered in the con-
text of bone development, and modifiable factors may be seen as modulators of the attainment 
of a genetically-determined optimal peak bone mass, as well as of the rate of bone loss. It has 
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been suggested that environmental factors are relevant to bone accrual to the extent that they 
may or may not allow for the full genetic potential for bone strength to be achieved [47]. The 
hypothesis that bone fragility might have important environmental causes in addition to known 
genetic factors is compatible with the clear geographical variation in hip fracture incidence [9]. 
Even between European countries, age-standardized fracture incidence in women has been 
documented to vary between under 350 per 100 000 population in Switzerland and over 920 
per 100 000 in Norway [74]. Varying time trends in the age-specific incidence of hip fractures 
throughout the 20th century in most populations are also in favor of the relevance of environ-
mental influences on bone fragility and fracture [17, 29].
One of the most important environmental influences on bone properties is related to exter-
nal mechanical stress. Experimental studies have shown that bone properties adapt to usual 
strains and physical activity has been long postulated as an important determinant of bone 
quality [46]. Trials have demonstrated that dynamic activities of different kinds can improve 
bone mass from 1 to 6% in the short-term in children [75]. However, it seems likely that the 
effect of non-athlete levels of physical activity may be much smaller: a large cohort study in 
the general population has shown that only vigorous physical activity was associated with im-
proved bone properties in children and that moderate levels of activity did not confer increased 
protection, when compared to low activity levels [76]. An additional relevant observation that 
questions the long-term importance of physical activity in childhood in fracture prevention is 
that a number of prospective studies conducted among professional athletes have shown that 
the benefit gained by exercising is in a large part lost after cessation of exercise [77, 78].
Nutritional factors have also been long recognized as targets for intervention, but it seems 
that their limiting (dose-response) role on bone accrual is more important in case of specific 
nutritional deficiency. Calcium is considered a threshold nutrient, meaning that there is a direct 
relation between bone mass and calcium consumption below but not above a certain intake 
level [47]. In fact, it has been found that, even though calcium retention in adolescents con-
tinues to increase at levels over 1500 mg/day [79], when intakes are lowered to 400 mg/day, 
calcium retention efficiency increases from 40 to 50% [80]. Vitamin D status (obtained either 
through ultraviolet exposure or through dietary sources) is also an important determinant of 
bone health in the physically active adolescent population [81]. However, in generally healthy 
children there is no evidence of additional benefit of supplementation on bone in the presence 
of adequate levels of serum vitamin D [82].
Lifestyles and contextual factors have also been proposed as early causes of bone fragility 
but findings at the population level have shown little consistency. Among those, associations 
have been found between behaviors such as smoking and alcohol drinking and fracture risk 
in adults [83, 84], but evidence of such effects early in life is less clear. Contextual factors 
such as adverse socioeconomic circumstances seem to have an association with worse bone 
properties in adults [85] but this socioeconomic gradient was less clear in children born in the 
United Kingdom [86] or among Spanish adolescents [87].
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With the growing recognition of a number of factors as determinants or regulators of bone 
development, one of the most consistent frameworks to explain the action of environmen-
tal determinants of bone mineral accrual is the one proposed by Rauch and Schoenau [88], 
based on the mechanostat theory published by Frost in 1987 [89]. The model builds on the 
premise that one-way relations of molecular, cellular and epidemiologic factors with bone ac-
crual are frequently implicit in but are clearly overly simplistic. The authors recognize that 
“self-assembling” of the skeleton is compatible with biological patterning that occurs during 
embryonic development, where bone morphology is still relatively simple. However, such self-
assembly is hardly plausible later in the life course, once mineralization has taken place. On 
the one hand the need for constant regulation is explained by the enormous physiological and 
even anatomic complexity of mineralized bone, and, on the other hand, due to the need for the 
skeletal framework to adapt to changing external circumstances. The implication is that bone 
physiology needs to be a controlled effector-sensor system where the purpose of homeostatic 
mechanisms is to maintain the strain (i.e. the mechanically induced deformation of bone) to a 
certain predetermined level or set point. This may be accomplished through changes in mass 
but also, and independently, through changes in the macro or microscopic architecture of bone 
tissue. The authors propose that, during growth, bone stability is continuously challenged by 
increases in bone length and muscle mass and the resulting bone deformation is sensed by 
osteocytes which in turn signal for bone formation. This model portrays known influences on 
bone homeostasis (such as hormonal, nutritional, or behavioral) as components that act by 
altering the mechanostat set point or the response to disturbance to that point, and therefore 
by modifying the effect of mechanical strain on bone. Nevertheless, the most relevant aspect 
of the model is that it places the maintenance of mechanical properties at the center of the 
bone development process.
1.6.1. Associations between fat and bone before peak bone mass
The interest in the study of the relations between fat and bone has stemmed from epidemiolog-
ical observations in adults of higher risk of osteoporotic fracture among individuals of slender 
body build. For a long time, this observation was explained essentially by adipose tissue being 
seen as an insulator of the skeleton against trauma and as a mechanical stimulus for perios-
teal bone formation [90]. This long-reported protective effect of increased weight has been 
confirmed more recently in a meta-analysis including almost 60 000 individuals of 12 prospec-
tive cohorts, where the pooled relative risk of hip fracture per unit increase in body mass index 
was estimated in 0.93 (95% CI: 0.91-0.94) [91]. An additional clarifying finding was that this 
association was probably mediated by bone mineral density, as illustrated in Figure 8. 
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Figure 8. Relative fracture risk in relation to body mass index (BMI). Bold solid line - hip fracture; 
Solid line - any osteoporotic fracture; Dotted line - any fracture (BMD: bone mineral density) 
(reproduced from De Laet et al. [91])
Such observations clearly raise questions about the population impact of the obesity epidemic 
on adolescent bone, especially since increasing trends of overweight and obesity in adoles-
cents have been described during the last two decades of the 20th century. A study that com-
pared population body mass index in the USA from 1959 to 2004 found that body mass index 
increased on average 2 kg/m2 during that period in early adolescence. However, this increase 
was only noticeable from 1988-1994 onwards and the most dramatic rise (about half of the 
total observed in 12-year-olds) occurred around 2000 [92]. The body mass index increase 
was on average 0.89 kg/m2 higher in female when compared to male adolescents. A recent 
NHANES study that updated that information by estimating obesity trends from 1999 to 2010 
found that, even though there was an increase in mean body mass index and obesity preva-
lence among males, there was no recent evidence of such an increase in girls [93]. Another 
study in 15 high-income countries showed that, in 1997-1998, the prevalence of overweight in 
13-year-old girls (at or above the 85th percentile of the reference population) was lowest in 
Lithuania (9%) and the Czech Republic (10%) and highest in the United States (27%), Portugal 
and Finland (23% in both) [94]. This has been primarily regarded as a worrying picture in terms 
of cardiovascular disease risk, but it also brought increasing attention to the possibility that 
the overweight epidemic among children and adolescents could seriously affect other sys-
tems and organs. In this context, there has been a rising interest in the study of the effect of 
increased body fat on bone health in children, in various perspectives, from molecular biology 
to epidemiologic studies in human populations.
At a population level, a strong crude relation between body fat and bone mineral density or con-
tent has been consistently found in children, similarly to previous findings in adults [95-104]. 
As a consequence, increased adiposity was considered protective against low bone strength 
in children. However, the observation that obese individuals were frequently overrepresented 
among samples of children with forearm fractures challenged the view of a protective effect 
of adiposity [105]. Even though the associations of obesity with fractures may be explained by 
factors independent of bone properties, such as gait changes and increased fall risk in obese 
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children, this discussion gave rise to the more recent hypothesis that obesity could be a risk 
factor for suboptimal bone quality by directly interfering with bone properties. In the past few 
years, there has been a growing number of observations that suggest deleterious effects of 
adiposity on bone strength [58, 106-118].
One of the main mechanisms that may explain the positive associations between crude mea-
sures of fat mass and bone size and mass is a mechanical one [96]. On the one hand, increased 
amounts of fat lead to higher load on bone tissue which may be by itself osteogenic. On the 
other hand, higher adiposity is associated with a compensatory increase in muscle mass which 
also promotes bone formation. Although there is no consensus as to whether gravitational or 
muscle forces predominate as the major osteogenic stimulus [119], it is accepted that loads 
are sensed by osteocytes in bone tissue which are responsible for translating that stimulus 
into matrix synthesis [88].
The other main pathway by which fat can influence bone is an endocrine one, since the adipose 
tissue secretes a multiplicity of bioactive molecules, and might have an overall positive or 
negative effect on bone mass depending on its distribution (visceral or subcutaneous) and its 
predominant secretory products (hormones, adipokines, growth factors and other chemical 
mediators) [90]. It has been known for a long time that the adipose tissue is an extra-ovarian 
site of estrogen synthesis through the expression of aromatase and that, consequently, in-
creased adiposity leads to increased estrogen aromatization and bioactivity [120]. Estrogen 
has a major role on the regulation of bone growth through its actions on osteoblasts, since in 
small amounts it stimulates linear growth and in higher amounts it promotes epyphiseal clo-
sure and cessation of growth [121]. However, higher estrogen levels associated with obesity 
would be a factor preferentially stimulating endosteal bone apposition in detriment of peri-
osteal expansion [122]. This is relevant from the mechanical point of view, since periosteal 
apposition is a more effective process of gain in bone strength than endosteal synthesis, as 
previously referred [66].
The recognition of a common precursor cell to osteoblasts and adipocytes has led to an 
increased interest in the study of potential mediators of such an association [123]. Pro-
inflammatory cytokines such as TNF-α or IL-6 produced by adipocytes were suggested to have 
a deleterious effect on bone mass through promoting a chronic state of low-grade systemic in-
flammation [124]. In addition, adipokines, particularly leptin and adiponectin, were recognized 
as major mediators of the communication between adipocytes and osteoblasts [123]. Leptin, 
in particular, has been paradoxically suggested both as a positive and a detrimental influence 
on bone properties, since there is strong evidence that it has a peripheral osteogenic action on 
osteoblasts but an opposing hypothalamic action [123]. More recently, adiponectin has also 
been recognized as an important influence on bone mechanical properties that might have an 
even larger influence on bone phenotypes than leptin [125].
Another way by which adiposity is thought to affect bone quality is through its association with 
insulin resistance. In fact, beyond the observed association between type 2 diabetes mellitus 
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and increased fracture risk in adults [126], a recent study has suggested that insulin resistance 
may already be involved in suboptimal bone accrual during childhood [110]. This pathway has 
gained major importance because of the recent discovery of a fat-bone-pancreas endocrine 
loop that allows for the two-way communication between these organs. The major new piece 
to this pathway is osteocalcin, which is secreted by osteoblasts, and was found to act systemi-
cally on the regulation of fat and energy metabolism by increasing the expression of insulin 
on β-cells and of adiponectin by adipocytes, as well as by increasing insulin sensitivity [127].
Because there are several potential mechanical and endocrine mechanisms by which adi-
posity can influence bone properties during childhood and ultimately determine fracture 
risk, the overall effect of overweight on bone in the pediatric population remains particularly 
controversial. Indeed, populational studies have not been able to answer this question or 
to provide robust evidence for preventive strategies. Particularly with regard to the estima-
tion and interpretation of the fat-bone association during childhood, some methodological 
aspects seem noteworthy. Epidemiologic studies have spanned across different stages of 
childhood and adolescence and it is possible that effects are not uniform throughout the life 
course. Recently, an extensive review of studies on the association between fat and bone 
health has proposed changing relations in different stages of life [128]. A positive effect 
of adiposity in prepuberty was proposed, through an increase in rate of modeling and bone 
mass. This effect would become harmful in adolescence through increased cortical porosity 
caused by excess fat.
Additionally, there has been a concern to correct fat-bone associations for overall body size 
or for fat-free mass measures in order to overcome potential confounding by these factors 
[96]. Overall, when aiming at estimating the associations between adiposity and bone qual-
ity, studies that found negative effects have generally used some kind of adjustment for body 
size, whereas those that suggested a beneficial effect have not conducted such adjustment. 
Another relevant point is that overweight children usually have earlier pubertal development 
when compared to normal weight children. This implies that, at the same chronologic age, bio-
logical age and skeletal development may be different and the differences found may not have 
significant impact throughout the life course. Moreover, it is frequently assumed that there is a 
monotonic relation between body fat and bone strength, but this relation may have a different 
nature, such as J-shaped (as suggested for adults in Figure 8, panel B). This could account 
for the inconsistency of findings between studies, since the ranges of adiposity are naturally 
heterogeneous across different samples and the comparison of non-overlapping areas of that 
spectrum may be misleading. In addition, a multiplicity of methods and parameters have been 
used for the assessment of the mechanical properties of bone, namely dual-energy X-ray ab-
sorptiometry, peripheral quantitative computed tomography, and quantitative ultrasound, inde-
pendently of their fracture prediction ability. This becomes relevant since a number of studies 
have reported effects on some but not other parameters of bone strength. More importantly, 
there is evidence that the effects of fat may indeed be differential according to the type of bone, 
cortical or trabecular. Trabecular bone is considerably more available for metabolic processes 
and systemic influences are expected to have higher impact on this type of bone tissue [129]. 
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This issue also raises questions about the comparability of studies where different anatomical 
sites of measurement are chosen.
Beyond a number of other possible methodological explanations for the disparity of associa-
tion between fat and bone during childhood, a key aspect is that the specific effect of physi-
ological amounts of fat on bone strength might not have enough magnitude to be reproducible 
across different settings and research methods. It seems plausible that only if the exposure 
has a high enough dose, i.e., in the overweight or obese range, will an important positive or 
harmful effect be detectable, beyond random error.
An additional point is that bone dimensions measured have been in some cases physical prop-
erties and markers of turnover in other cases. According to the mechanostat theory, the major 
driving force that determines the observed physical properties of bone is their functional re-
quirement in response to the mechanical stress exerted on bone through gravitational and 
muscle forces [66]. Therefore, in order to achieve a predetermined bone strength set point, 
turnover is modulated in such a way that final physical properties are maintained. As a result, 
the study of bone turnover during adolescence may provide an important dynamic dimension 
that would not be captured by examining only the resulting physical properties.
1.7. An epidemiologic approach to bone accrual
The unique aspect of epidemiology in contrast with other disciplines that aim directly at under-
standing human health and disease is that its object is the population. In this perspective, be-
yond biological organization, epidemiology encompasses additional layers of complexity, such 
as behavioral and social contexts. Epidemiologic research becomes faced with the challenge 
of dealing with this succession of multiple levels and their interactions. While there has been 
debate over the comparative usefulness of reductionist versus systems approaches, it is very 
hard to conceive the very foundation of epidemiology without systems thinking [130], even if 
not formally explicit. A system can be described as a set or assembly of factors connected with 
each other in some form or coherent relationship [131]. Each system defines a particular level 
of organization and structure that cannot be viewed in isolation, but rather as successive and 
interactive levels of organization nested within each other, whose effects are not predictable 
from the decomposition into individual elements [132].
Up to the present, scientific evidence has accumulated suggesting that the development of 
bone fragility is better seen as a stochastic process where multiple genetic and environmental 
factors act and interact to cause disease [3], similarly to the pathogenesis of other chronic 
diseases. The epidemiologic approach is consistent with this view since it departs from a 
reductionist perspective and tries to deal with an evident complexity by identifying relevant 
phenomena at the population level. By having population as the object, epidemiology does not 
ignore that there are numerous biological pathways that may link any two characteristics, but 
acknowledges that the measurement the overall result of all those pathways is a valid and 
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useful approach, since it may provide knowledge at a level that is greater than the sum of its 
parts.
The unique perspective that etiological epidemiology can provide to the understanding of bone 
accrual throughout the first decades of life is therefore a multidimensional one, where new 
biomedical technologies used for understanding bone tissue physiology are complemented 
with approaches where behaviors, and social contexts are incorporated. Ultimately, the epide-
miologic approach is useful for providing new insights for basic research. Conversely, it is also 
essential for assessing if mechanistic explanations obtained from basic research are observ-
able at the population level and can be acted upon to effectively improve human health.
2. Study objectives and major assumptions
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By using prospective data from girls in the EPITeen cohort, our objectives (Figure 9) were:
1. To quantify the potential for an endocrine effect of adiposity on bone mechanical proper-
ties in the general adolescent population (Paper I)
a) To assess if overweight may elicit a harmful effect of fat on bone mineral density medi-
ated by low-grade systemic inflammation (Paper II)
2. To characterize the associations between bone turnover markers (including osteoclast 
regulators) and bone physical properties throughout adolescence (Paper III)
a) To understand if physiological mediators of the fat-bone communication may have 
different effects on bone turnover and physical properties (Paper IV)
3. To assess whether early smoking and alcohol drinking are longitudinal predictors of bone 
mineral density and if that association may be mediated by body size (Paper V)
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Figure 9. Diagram summarizing the objectives of the present work
The present work is based on the following assumptions:
– Bone strength attained during the first decades of life is a determinant of fracture risk in 
adulthood;
– There is an inverse monotonic relation between bone strength and fracture risk (so that bone 
mineral density optimization strategies should take a population approach);
– Areal bone mineral density, which simultaneously conveys true material density and bone 
size, is a good indicator of overall bone strength and therefore of the resistance to fracture;
– Forearm measures of bone mineral density can be used as surrogates of systemic bone 
strength;
– Epidemiologic research can add a systems approach to the relevance of causal mechanisms 
at a population level.
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3.1. The EPITeen cohort study
The Epidemiological Health Investigation of Teenagers in Porto (EPITeen study) was set up 
in 2003. This prospective investigation aims at studying growth, development and health from 
adolescence to young adulthood by using data from a population-based cohort recruited in 
Porto, Portugal [133]. From inception, broad research areas have been: 1) growth and physical 
development; 2) behavioral and biological risk factors; 3) frequency of selected diseases with 
large public health impact; 4) psychosocial health; and 5) tracking of risk factors and effects 
on adult health.
3.1.1. Participants
A cohort of adolescents born in 1990 was assembled in Porto schools during the 2003/2004 
school year. In order to identify eligible participants, the regional board of education allowed 
the research team to contact all public and private schools that provided teaching from the 5th 
to the 9th grade in the city of Porto, Portugal. Subsequently, executive boards in each of the 51 
schools were contacted and invited to participate, by providing contact details for all students 
who met the single eligibility criterion of having been born in 1990. All 27 public schools and 
19 of the 24 private schools accepted to participate (Figure 10). Special meetings with legal 
guardians were arranged in each school in order to present detailed information on study aims 
and procedures. Written materials were also provided to complement oral information. 
All the phases of the study complied with the Ethical Principles for Medical Research Involving 
Human Subjects expressed in the Declaration of Helsinki [134]. Ethical approval was obtained 
from the Ethics Committee of the São João University Hospital, in Porto, Portugal. Scientific 
and technical aspects of the study were accompanied by a Steering Committee established for 
the purpose.
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Figure 10. Geographical distribution of participating schools and students
Of the 2787 participants identified as eligible using the approach previously described, 2160 
(78%) provided information for at least one of the major sections of the planned evaluation 
(questionnaire and/or physical examination), thereby being considered participants. Extensive 
accounts of study methods and procedures have been previously published [133, 135]. 
3.1.2 Data collection
In all evaluations, data have been collected by a team of trained health professionals through 
the use of structured questionnaires and an extensive physical examination. As of May 2012, 
the following data collection periods had taken place:
– 2003/2004: 13 years old evaluation (78% participation; n=2160);
– 2007/2008: 17 years old evaluation  (21% attrition from baseline; n=1716);
– 2011/2012: 21 years old evaluation (ongoing).
The present work includes data obtained in the first two evaluations of the cohort. For that 
reason, the following data collection sections will refer only to procedures applied in those 
evaluations.
a) Questionnaires
Two self-administered structured questionnaires were applied. One of the questionnaires was 
administered at home with parental assistance and collected information on the following 
areas:
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  – Adolescent medical history: early life variables, chronic diseases and medication, vita-
min and mineral supplements, healthcare use;
  – Food intake: average nutrient intake evaluated through an 86-item food frequency ques-
tionnaire validated in Portuguese adults [136] and adapted to adolescent food choices;
  – Physical activity: leisure time (extra-school) activities, including sedentary activities, 
and organized or unorganized sports practice;
  – Family characteristics: parental educational level, parental weight and height, parental 
smoking, household crowding.
The other questionnaire was filled in at school by the adolescent alone and included informa-
tion on sensitive topics, such as smoking and drinking habits (life experience and consumption 
frequency), eating disorders and depressive symptoms.
b) Physical examination
The physical examination was conducted at school while the subject stood barefoot in light 
indoor clothing and included the following exams:
  – Forearm bone mineral density: measured at the non-dominant distal forearm with a 
GE Lunar Peripheral Instant X-ray Imager (PIXI®) device. In case of fracture of the non-
dominant forearm the dominant arm was the one measured. Short-term in vivo preci-
sion was calculated according to the recommendations of the International Society for 
Clinical Densitometry [137] using two measurements for each of 30 consecutive girls. 
Root mean square standard-deviation was 0.022g/cm2 at a 95% confidence level.
  – Anthropometric assessment: height (Seca®), weight (TANITA®), body composition by 
bioelectric impedance (TANITA®), waist, hip and arm circumferences (flexible and non-
distensible tape), tricipital and bicipital skinfolds thickness (Harpenden® calliper).
c) Blood samples
Venous blood was collected from an antecubital vein into vacuum tubes between 8.00 and 
10.00 am after a 12-hour overnight fast. Samples were centrifuged and sera were stored fro-
zen at -80ºC until the moment of analysis. High-sensitivity C-reactive protein was quantified 
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using particle enhanced immunonephelometry. Adipokines (leptin and adiponectin), osteoclast 
regulators and collagenous markers of bone turnover were quantified using commercially 
available enzyme-linked immunosorbent assay kits.
Figure 11 presents the outline of each of the studies conducted regarding main exposures and 
outcomes, sample size and design.
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4.1. Description of forearm bone mineral density in girls of the 
EPITeen cohort
In the EPITeen cohort study, 944 girls had data on forearm bone mineral density at 13 years of 
age and 731 (77%) of these also had bone densitometry at 17 years old (Figure 12).
2787 eligible 
adolescents 2160 participants 
1116 girls 
evaluated at 13 
years of age 
944 girls with 
bone
densitometry at 
13 years of age 
731 girls with 
bone
densitometry at 
13 and 17 years 
of age 
Figure 12. Flow-chart of participants evaluated in early and late adolescence
Mean (standard-deviation) forearm bone mineral density at 13 years of age was 0.357 (0.057) 
g/cm2 and the coefficient of variation was 17%. At 17 years of age, bone mineral density in-
creased to 0.433 (0.051) g/cm2 with a 12% coefficient of variation (Figure 13). There was a 
significant decrease in variance from early to late adolescence (variance ratio test p-value: 
0.010). However, when bone mineral density z-scores were calculated at each age [(BMD-mean 
BMDsample) /SDsample] (Figure 14), there was a high agreement between baseline and follow-up 
evaluation regarding the position of individuals in the BMD distribution: the concordance cor-
relation coefficient [138] (95% confidence interval) was 0.71 (0.68, 0.75). As shown in Table 2, 
observed agreement between quarters of BMD distribution was over 90% and weighted kappa 
(95% confidence interval) was 0.67 (0.62, 0.71).
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Figure 14. Agreement between 13 and 17 bone mineral density z-scores
Table 2. Agreement between quarters of bone mineral density at 13 and 17 years of age
17-year-old BMD
13-year-old BMD
1st quarter 
(<0.399)
2nd quarter 
(0.399-0.431)
3rd quarter 
(0.432-0.464)
4th quarter 
(≥0.465)
1st quarter (<0.318) 119 (65.0) 45 (24.6) 15 (8.2) 4 (2.2)
2nd quarter (0.318-0.351) 46 (25.6) 65 (36.1) 55 (30.6) 14 (7.8)
3rd quarter (0.352-0.395) 14 (7.7) 56 (30.8) 63 (34.6) 49 (26.9)
4th quarter (≥0.396) 4 (2.3) 15 (8.5) 45 (25.4) 113 (63.8)
Results 51
Tables 3 to 7 present the mean values of forearm bone mineral density in early and late adoles-
cence according to socio-demographic and behavioral characteristics of girls. There were no 
significant differences in mean BMD at any age according to type of school, household crowd-
ing, maternal education or occupation and paternal education or occupation (Table 3).
Table 3. Mean (SD) bone mineral density at 13 and 17 years of age, according to social characteristics.
n (%) BMD13 BMD17
Type of school at 13 years old
Public
Private
526 (72.0)
205 (28.0)
0.358 (0.059)
0.356 (0.052)
0.434 (0.053)
0.434 (0.048)
p (t test) 0.701 0.959
Household crowding index (persons/room)
<1.0
1.0
1.1-1.9
2.0
>2.0
Missing
50 (6.8)
168 (23.0)
364 (49.8)
95 (13.0)
30 (4.1)
24 (3.3)
0.360 (0.057)
0.352 (0.054)
0.360 (0.057)
0.359 (0.058)
0.347 (0.064)
0.357 (0.062)
0.439 (0.062)
0.424 (0.051)
0.436 (0.048)
0.437 (0.047)
0.441 (0.080)
0.438 (0.053)
p (ANOVA) 0.431 0.082
Maternal education (schooling years)
0-4
5-6
7-9
10-12
>12
Missing
142 (19.4)
96 (13.1)
123 (16.8)
165 (22.6)
154 (21.1)
51 (7.0)
0.356 (0.057)
0.362 (0.065)
0.361 (0.055)
0.357 (0.053)
0.357 (0.054)
0.350 (0.065)
0.431 (0.050)
0.439 (0.055)
0.436 (0.052)
0.433 (0.048)
0.435 (0.055)
0.430 (0.052)
p (ANOVA) 0.855 0.779
Paternal education (schooling years)
0-4
5-6
7-9
10-12
>12
Missing
154 (21.1)
63 (8.6)
133 (18.2)
175 (23.9)
138 (18.9)
68 (9.3)
0.356 (0.060)
0.368 (0.063)
0.361 (0.056)
0.357 (0.051)
0.357 (0.057)
0.348 (0.061)
0.432 (0.053)
0.438 (0.056)
0.437 (0.048)
0.433 (0.047)
0.434 (0.057)
0.429 (0.051)
p (ANOVA) 0.643 0.885
Maternal occupation
Upper white collar 
Lower white collar
Blue collar
Other
Stay-at-home
Missing
185 (25.3)
199 (27.2)
147 (20.1)
11 (1.5)
118 (16.1)
71 (9.7)
0.353 (0.053)
0.365 (0.056)
0.355 (0.059)
0.361 (0.029)
0.363 (0.060)
0.344 (0.060)
0.433 (0.051)
0.439 (0.052)
0.433 (0.051)
0.432 (0.069)
0.436 (0.052)
0.422 (0.048)
p (ANOVA) 0.280 0.761
Paternal occupation
Upper white collar 
Lower white collar
Blue collar
Other
Stay-at-home
Missing
198 (27.1)
218 (29.8)
185 (25.3)
13 (1.8)
23 (3.2)
94 (12.9)
0.360 (0.056)
0.356 (0.053)
0.360 (0.061)
0.354 (0.051)
0.354 (0.062)
0.352 (0.059)
0.433 (0.052)
0.435 (0.051)
0.433 (0.054)
0.423 (0.023)
0.437 (0.060)
0.434 (0.050)
p (ANOVA) 0.927 0.927
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We found an increasing trend of mean bone mineral density in early and late adolescence with 
increasing maternal and paternal self-reported body mass index (Table 4).
Table 4. Mean (SD) bone mineral density at 13 and 17 years of age, according to parental smoking status 
and anthropometry
n (%) BMD13 BMD17
Maternal smoking
Never
Ever but not while pregnant
Ever including while pregnant
Missing
338 (46.2)
238 (32.6)
97 (13.3)
58 (7.9)
0.359 (0.061)
0.354 (0.052)
0.371 (0.052)
0.339 (0.056)
0.435 (0.054)
0.429 (0.048)
0.448 (0.051)
0.422 (0.045)
p (ANOVA) 0.050 0.007
Paternal smoking
Never
Ever
Missing
167 (22.8)
486 (66.5)
78 (10.7)
0.358 (0.055)
0.359 (0.057)
0.351 (0.059)
0.434 (0.052)
0.434 (0.052)
0.431 (0.048)
p (ANOVA) 0.816 0.999
Maternal height (cm)
<155
156-159
160-164
165-169
≥170
Missing
96 (13.1)
171 (23.4)
222 (30.4)
107 (14.6)
54 (7.4)
81 (11.1)
0.362 (0.061)
0.365 (0.060)
0.358 (0.055)
0.359 (0.051)
0.352 (0.058)
0.338 (0.056)
0.436 (0.055)
0.436 (0.052)
0.435 (0.053)
0.434 (0.044)
0.434 (0.054)
0.423 (0.052)
p (ANOVA) 0.591 0.997
Paternal height (cm)
<165
165-169
170-174
175-169
≥180
Missing
58 (7.9)
110 (15.0)
183 (25.0)
136 (18.6)
117 (16.0)
127 (17.4)
0.380 (0.074)
0.361 (0.056)
0.361 (0.057)
0.349 (0.051)
0.360 (0.053)
0.348 (0.055)
0.453 (0.061)
0.438 (0.050)
0.436 (0.050)
0.424 (0.049)
0.438 (0.053)
0.425 (0.050)
p (ANOVA) 0.012 0.007
Maternal body mass index (kg/m2)
<18.5
18.5-24.9
25.0-29.9
≥30.0
Missing
23 (3.2)
376 (51.4)
167 (22.8)
74 (10.1)
91 (12.4)
0.345 (0.052)
0.353 (0.054)
0.368 (0.060)
0.378 (0.057)
0.342 (0.057)
0.418 (0.040)
0.431 (0.052)
0.443 (0.052)
0.444 (0.051)
0.426 (0.051)
p (ANOVA) <0.001 0.008
Paternal body mass index (kg/m2)
<20.5
25.0-29.9
≥30.0
Missing
269 (36.8)
244 (33.4)
71 (9.7)
147 (20.1)
0.349 (0.055)
0.367 (0.058)
0.378 (0.052)
0.349 (0.056)
0.428 (0.052)
0.440 (0.051)
0.451 (0.051)
0.427 (0.050)
p (ANOVA) <0.001 <0.001
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There were no clear associations between bone mineral density at 13 or 17 years old and his-
tory of chronic disease, regular use of medication, or number of school days missed for health 
reasons, as reported by parents. There were also no BMD differences between health care 
service most frequently used or number of medical or dentist appointments (Table 5).
Table 5. Mean (SD) bone mineral density at 13 and 17 years of age, according to disease history and health care use
 
n (%) BMD13 BMD17
Chronic disease
No
Yes
Missing
545 (74.6)
131 (17.9)
55 (7.5)
0.360 (0.056)
0.354 (0.055)
0.344 (0.064)
0.436 (0.051)
0.430 (0.053)
0.419 (0.048)
p (ANOVA) 0.271 0.200
Regular use of any medication
No
Yes, not in the previous month
Yes, in the previous month
Missing
292 (40.0)
213 (29.1)
175 (23.9)
51 (7.0)
0.354 (0.055)
0.356 (0.061)
0.367 (0.052)
0.349 (0.063)
0.431 (0.052)
0.436 (0.050)
0.438 (0.054)
0.429 (0.048)
p (ANOVA) 0.052 0.308
School days missed for health-related reasons in 
the previous year
None
1-4
5-9
≥10
Missing
255 (34.9)
290 (39.7)
72 (9.8)
38 (5.2)
76 (10.4)
0.356 (0.053)
0.361 (0.057)
0.358 (0.057)
0.358 (0.059)
0.349 (0.068)
0.433 (0.051)
0.438 (0.052)
0.434 (0.049)
0.434 (0.058)
0.423 (0.052)
p (ANOVA) 0.754 0.763
Dentist appointments in the previous year
0
1
2
≥3
Missing
124 (17.0)
160 (21.9)
107 (14.6)
256 (35.0)
84 (11.5)
0.354 (0.0525)
0.355 (0.0547)
0.368 (0.0547)
0.355 (0.0572)
0.362 (0.0686)
0.427 (0.050)
0.437 (0.051)
0.443 (0.0.50)
0.431 (0.053)
0.437 (0.052)
p (ANOVA) 0.187 0.075
Medical appointments in the previous year
0
1
2
≥3
Missing
81 (11.1)
187 (25.6)
159 (21.8)
217 (29.7)
87 (11.9)
0.358 (0.052)
0.354 (0.056)
0.354 (0.056)
0.366 (0.058)
0.351 (0.060)
0.434 (0.050)
0.430 (0.053)
0.436 (0.049)
0.437 (0.053)
0.429 (0.050)
p (ANOVA) 0.118 0.574
Health care provision
NHS GP
Private doctor
Hospital clinic
Other 
Missing
344 (47.1)
216 (29.6)
54 (7.4)
38 (5.2)
79 (10.8)
0.359 (0.058)
0.356 (0.054)
0.364 (0.058)
0.353 (0.052)
0.354 (0.063)
0.436 (0.051)
0.432 (0.052)
0.433 (0.053)
0.438 (0.061)
0.428 (0.050)
p (ANOVA) 0.745 0.830
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Table 6. Mean (SD) bone mineral density at 13 and 17 years of age, according to extra-school physical activity 
n (%) BMD13 BMD17
Physical activity in free time outside school
Most of the time sitting
Most of the time standing or walking
Half of the time active and the other half inactive
Most of the time running or playing sports
Missing
207 (28.3)
192 (26.3)
171 (23.4)
82 (11.2)
79 (10.8)
0.359 (0.060)
0.365 (0.055)
0.350 (0.052)
0.360 (0.055)
0.350 (0.064)
0.433 (0.053)
0.437 (0.050)
0.432 (0.050)
0.445 (0.051)
0.422 (0.054)
p (ANOVA) 0.066 0.243
Average time spent watching TV per weekday (minutes)
<60
60-119
120-179
≥180
Missing
80 (10.9)
210 (28.7)
181 (24.8)
181 (24.8)
79 (10.8)
0.357 (0.056)
0.355 (0.054)
0.357 (0.061)
0.366 (0.055)
0.350 (0.061)
0.435 (0.051)
0.433 (0.046)
0.437 (0.056)
0.437 (0.055)
0.422 (0.049)
p (ANOVA) 0.273 0.886
Average time spent watching TV per weekend (minutes)
<180
180-239
240-359
≥360
Missing
162 (22.2)
92 (12.6)
186 (25.4)
212 (29.0)
79 (10.8)
0.357 (0.056)
0.346 (0.050)
0.353 (0.055)
0.369 (0.058)
0.353 (0.063)
0.434 (0.048)
0.428 (0.051)
0.431 (0.051)
0.442 (0.055)
0.424 (0.049)
p (ANOVA) 0.004 0.082
Sports practice outside school 
No
Yes
Missing
392 (53.6)
281 (38.4)
58 (7.9)
0.361 (0.058)
0.356 (0.054)
0.343 (0.064)
0.436 (0.051)
0.435 (0.052)
0.416 (0.050)
p (ANOVA) 0.312 0.779
Time spent in sports practice to the point of 
breathlessness per week (hours)
None
<1
1-3
4-6
≥7
Missing
299 (40.9)
223 (30.5)
136 (18.6)
33 (4.5)
16 (2.2)
24 (3.3)
0.355 (0.059)
0.358 (0.055)
0.360 (0.056)
0.374 (0.055)
0.370 (0.052)
0.345 (0.059)
0.431 (0.055)
0.435 (0.049)
0.437 (0.051)
0.442 (0.049)
0.448 (0.053)
0.427 (0.043)
p (ANOVA) 0.410 0.484
Sports competition 
Never
In the past
Currently, at school level
Currently, as part of a club
Currently, at national or international level
Missing
301 (41.7)
227 (31.0)
84 (11.5)
66 (9.1)
20 (2.7)
29 (4.0)
0.356 (0.059)
0.362 (0.056)
0.357 (0.054)
0.352 (0.050)
0.390 (0.060)
0.330 (0.055)
0.434 (0.053)
0.436 (0.050)
0.429 (0.045)
0.431 (0.048)
0.460 (0.065)
0.415 (0.054) 
p (ANOVA) 0.083 0.192
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There were no clear dose-response relations between physical activity measures and bone 
mineral density (Table 6), and daily calcium or vitamin intakes were also not associated with 
BMD in early or late adolescence (Table 7).
Table 7. Mean (SD) bone mineral density at 13 and 17 years of age, according to calcium, 
vitamin D and total energy intakes
n (%) BMD13 BMD17
Calcium intake (mg/day)
<800
800-999
1000-1199
1200-1499
≥1500
Missing
148 (20.2)
98 (13.4)
93 (12.7)
143 (19.6)
117 (16.0)
132 (18.1)
0.362 (0.060)
0.359 (0.058)
0.357 (0.052)
0.361 (0.056)
0.360 (0.056)
0.346 (0.056)
0.432 (0.053)
0.433 (0.056)
0.430 (0.052)
0.439 (0.050)
0.443 (0.052)
0.426 (0.048)
p (ANOVA) 0.965 0.325
Vitamin D intake (≥g/day)
<4.99
5.00-9.99
≥10.00
Missing
421 (57.6)
155 (21.2)
23 (3.2)
132 (18.1)
0.360 (0.056)
0.363 (0.059)
0.353 (0.052)
0.346 (0.056)
0.433 (0.052)
0.445 (0.053)
0.423 (0.043)
0.426 (0.048)
p (ANOVA) 0.680 0.028
Total energy intake (kcal/day)
<1500
1500-1999
2000-2499
2500-2999
≥3000
Missing
47 (6.4)
123 (16.8)
150 (20.5)
139 (19.0)
123 (16.8)
149 (20.4)
0.361 (0.058)
0.371 (0.055)
0.351 (0.058)
0.360 (0.056)
0.361 (0.057)
0.347 (0.056)
0.429 (0.050)
0.436 (0.050)
0.428 (0.052)
0.441 (0.054)
0.440 (0.050)
0.428 (0.049)
p (ANOVA) 0.103 0.142
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4.2. Potential for a direct weight-independent association 
between adiposity and forearm bone mineral density 
during adolescence
Raquel Lucas, Milton Severo, Elisabete Ramos, Henrique Barros
(Am J Epidemiol. 2011 Sep 15;174(6):691-700)
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To estimate the potential for a nonmechanical association between fat and bone mineral density (BMD), the
authors evaluated a sample of 868 13-year-old girls attending schools in Porto, Portugal (2003–2004). Adiposity
was estimated using fat mass from bioelectrical impedance analysis and fat area from a skinfold equation. Forearm
BMD was measured by dual-energy x-ray absorptiometry. Associations were quantiﬁed with coefﬁcients obtained
using standard multivariate regression and residuals regression. Path analysis was used to assess the plausibility
of the causal assumptions. Crude adiposity was positively associated with BMD; standardized menarcheal-
age-adjusted coefﬁcients (bst) for fat mass and fat area were 20.7 (95% conﬁdence interval (CI): 17.6, 23.9) and
17.8 (95% CI: 14.6, 21.0), respectively. After standard weight adjustment, the association with adiposity decreased
(bst ¼ �2.30 (95% CI: �12.0, 7.37) and bst ¼ 1.96 (95% CI: �2.84, 6.76), respectively), and the effect of residuals
was small. In path analysis, direct effects were negligible (bst ¼ �1.57 (95% CI: �11.9, 8.75) and bst ¼ 1.89 (95%
CI: �3.13, 6.91), respectively), and adiposity did not contribute to the overall model ﬁt. The association between
adiposity and BMDwas strongly mediated by weight, and estimates were consistent between methods. No speciﬁc
beneﬁt in bone quality should be expected from relative increases in adiposity.
adiposity; adolescent; bias (epidemiology); body composition; body size; bone and bones; bone mineral density;
epidemiologic methods
Abbreviations: BIA, bioelectrical impedance analysis; BMD, bone mineral density; SD, standard deviation.
The ultimate impact of age-related bone loss is believed
to depend on bone quality achieved in the first decades of
life (1). This life-course effect provides a rationale for peak
bone mass optimization as a primary strategy for preventing
fragility fractures later in life (2, 3). In order to estimate the
potential for bone quality improvement, it is essential to
understand the extent to which modifiable factors act on
bone accrual during adolescence.
Anthropometry, which reflects complex gene-environment
interactions, comprises a set of partially modifiable bone
quality correlates during childhood and adolescence (2–5).
However, while positive associations between lean mass
and bone quality have been found consistently (6, 7), diverg-
ing results have been produced concerning adiposity (8). As
an intuitive extension of the observed lower fracture rate in
overweight adults as compared with normal-weight persons
(9), a beneficial effect of fat on bone strength during child-
hood and adolescence has been observed (10–13). Positive
associations have been attributed to stimulation of bone
formation by peripheral leptin and increased estradiol, lead-
ing to decreased bone resorption and increased bone forma-
tion (14, 15). More recently, however, challenging evidence
has accumulated that suggests a deleterious effect of adipos-
ity on bone accrual (6, 16–19). This detrimental effect has
been explained through impairment of bone formation by
inflammatory cytokines, centrally acting leptin, hyperglyce-
mia, and insulinopenia and through increased bone resorp-
tion mediated by fatty acids (15, 19).
Despite the variety of endocrine mechanisms proposed to
explain these findings, an issue particular to bone health is
that the ultimate role of fat in bone mineral accrual probably
results from a combination of several of the above-mentioned
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pathways with a mechanical effect of weight. Since the
strength of the skeletal framework is related to the mass
of soft tissue that it supports (14), as body fat increases,
so does loading on the cortical skeleton, an effect which is
osteogenic but not specific to adipose tissue (15).
Therefore, it is relevant to distinguish a possible direct,
nonmechanical association between adiposity and bone min-
eral density (BMD) from its indirect association mediated
by body mass. In the causal graph framework, this translates
into assessing which of the directed acyclic graphs shown in
Figure 1 is consistent with the observed data. Because body
mass becomes a causal intermediate under this framework,
limitations in interpreting standard adjusted regression coef-
ficients may be present (20). In fact, this issue was suggested
to account for the above-mentioned conflicting findings (14).
Estimation of direct effects may benefit from the use of tech-
niques to evaluate the plausibility of the set of causal assump-
tions. By applying and comparing different methodological
approaches to the evaluation of a population-based sample of
13-year-old girls, we aimed to quantify the potential for
a specific nonmechanical effect of fat on BMD.
MATERIALS AND METHODS
Cohort recruitment
We evaluated cross-sectional information collected from
adolescent girls at recruitment of the Epidemiological Health
Investigation of Teenagers in Porto (EPITeen) cohort. This
cohort was assembled during the 2003/2004 school year,
when all public and private schools in Porto, Portugal, that
provided teaching to 13-year-olds were approached. Exec-
utive boards were asked to provide contact information for
each student’s family. We thereby identified 2,787 eligible
adolescents, of whom 78% (1,116 girls and 1,044 boys)
agreed to participate and provided information for at least
part of the protocol. Similar participation proportions were
obtained in public and private schools. Sampling procedures
and detailed methods have been described elsewhere (21).
This recruitment comprised extensive data collection, in-
cluding 2 self-administered questionnaires, and a physical
examination conducted at school. Parents and children re-
ceived written information explaining the purpose and design
of the study. Additionally, the study steps were described in
each school during meetings arranged according to parents’
convenience. Written informed consent was obtained from
both parents and children. The Ethics Committee of the
University Hospital of Sa˜o Joa˜o, Porto, approved the study.
Pubertal maturity and anthropometry
Pubertal development was estimated using menarcheal
age. Girls were categorized into one of the following 3 class-
es, according to self-reported age at first menses: 11 years or
earlier, 12 years, or 13 years or later. The latter category
included premenarcheal girls.
Anthropometric information was obtained while the stu-
dent stood barefoot in light indoor clothing. Weight was
measured to the nearest 0.1 kg (Tanita Corporation, Tokyo,
Japan), and height was measured to the nearest 0.1 cm
using a portable stadiometer (Seca Deutschland, Hamburg,
Germany). According to the reference percentiles developed
by the US Centers for Disease Control and Prevention, par-
ticipants were classified as normal-weight (<85th percen-
tile), overweight (85th–94th percentiles), or obese (�95th
percentile) (22). Foot-to-foot bioelectrical impedance anal-
ysis (BIA) was used to estimate body composition (Tanita,
model TBF-300) to the nearest 0.1 kg. We additionally es-
timated body composition using a skinfold-based method
validated in children (23), based on the assumption that
the unrolled fat rim is a rectangle whose length equals the
upper arm circumference (C) and whose width equals half of
the triceps skinfold thickness. The resulting body composi-
tion indexes, in cm2, are defined as follows: total upper arm
area ¼ C2/4p; upper arm fat area estimate ¼ C 3 (triceps
skinfold thickness/2); and upper armmuscle area estimate¼
total upper arm area� upper arm fat area estimate. To assess
the extent to which these indexes were measuring adiposity in
our sample, we calculated Pearson’s correlation coefficients
for fat area versus body mass index (weight (kg)/height (m)2)
and fat area versus BIA-derived fat mass; these coefficients
were 0.86 and 0.84, respectively.
Forearm BMD
BMD was measured in g/cm2 at the ultradistal and prox-
imal radius (at a point one-third distal between the styloid
process and the tip of the olecranon) of the nondominant
forearm by means of dual-energy x-ray absorptiometry, us-
ing a Lunar PIXI device (GE Medical Systems, Madison,
Wisconsin). In case of reported previous fracture of the non-
dominant arm, the dominant arm was assessed.
Data analysis
Among 1,116 girls recruited, 868 (78%) had complete
information on forearm BMD, pubertal status, and all body
size and composition variables. Girls with complete infor-
mation had slightly lower mean values for height (158.0 cm
Weight Bone Mineral DensityAdiposity
Weight Bone Mineral DensityAdiposity
A)
B)
Figure 1. Two hypothesized mechanisms linking adiposity with
bone mineral density in female adolescents: A) an overall effect totally
mediated by weight and B) an overall effect with direct and indirect
components.
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(standard deviation (SD), 6.4) vs. 158.8 cm (SD, 6.3)),
weight (52.7 kg (SD, 10.1) vs. 54.2 kg (SD, 10.2)), and body
mass index (21.1 (SD, 3.5) vs. 21.4 (SD, 3.4)) than girls who
were not included. Correspondingly, girls whowere included
had a later menarche; 34.2% experienced menarche after age
12 years and 31.0% before age 12 years, while these pro-
portions were 27.7% and 35.0%, respectively, among girls
not included.
Forearm BMD was normally distributed in the sample.
Mean BMD values and their standard deviations were calcu-
lated according to classes of body size and body composition
measures. Crude and adjusted associations between anthro-
pometric traits and BMD were quantified using linear regres-
sion coefficients with 95% confidence intervals.We estimated
the crude effects of total weight and fat mass or fat area on
BMD (model 1: BMD� b0þ b1(weight); model 2a: BMD�
b0 þ b2(fat mass); model 2b: BMD � b0 þ b2(fat area)).
Standard multivariate analysis
To evaluate the contribution of adiposity (fat mass or fat
area) to BMD independently of body weight, we used stan-
dard multivariate models (model 3a: BMD � b0 þ b3(fat
mass) þ b4(weight); model 3b: BMD � b0 þ b3(fat area) þ
b4(weight)).
Residuals analysis
Taking into account the fact that the high observed cor-
relation between total body weight and adiposity (in our
sample, 0.95 for fat mass and 0.79 for fat area) may limit
the interpretation of adjusted regression coefficients in stan-
dard multivariate analysis, we estimated the effect of the re-
siduals from regressions of adiposity on weight (model 4a:
BMD� b0þ b2(fat mass residuals)þ b5(weight); model 4b:
BMD � b0 þ b2(fat area residuals) þ b5(weight)) (24). We
assumed that the residuals represented the nonmechanical
component of adiposity. BIA-derived fat mass residuals rela-
tive to weight had a standard deviation of 2.08 (range, �7.88
to 5.71) and were positively correlated with fat mass and
negatively correlated with fat-free mass (Pearson’s correlation
coefficients were 0.31 and �0.49, respectively). Skinfold-
based fat area residuals had a standard deviation of 4.90
(range, �14.5 to 20.3), and their correlation with fat area
was 0.62, while the correlation with muscle area was �0.08.
Path analysis
Path analysis is an extension of regression analysis which
allows for simultaneous estimation of the interrelations be-
tween variables in a set (25). This technique is being increas-
ingly used to decompose and compare the magnitudes of
effects between variables with complex interrelations or to
test the plausibility of mediation effects (26, 27). We con-
ducted path analysis assuming each of the 2 possible causal
models depicted in Figure 1. Because of its association with
body weight and BMD, we additionally entered menarcheal
age. Models were fitted with Mplus software (Muthe´n and
Muthe´n, Los Angeles, California); 95% confidence intervals
were calculated by bootstrapping; and goodness of fit was
evaluated using the comparative fit index and the Akaike
and Bayesian information criteria.
For all models, we present effect estimates as standard-
ized coefficients (bst) to improve comparability between the
effects of variables with different ranges. BMD was used in
mg/cm2.
RESULTS
In this sample, mean forearm BMDwas 0.359 g/cm2 (SD,
0.057), ranging from 0.206 g/cm2 to 0.569 g/cm2. Table 1
presents mean BMD values and anthropometric character-
istics in the total sample and in each class of increasing
pubertal maturity. We observed a substantial increase in
mean BMD with decreasing menarcheal age.
BMD and body size measures
A positive association was found between BMD and
height, mainly in the later menarche group. Mean BMD in-
creased linearly with body weight, from 0.314 g/cm2 (SD,
0.045) in the first quarter (quartile) to 0.396 g/cm2 (SD,
0.056) in the fourth quarter, as well as with body mass index,
from 0.347 g/cm2 (SD, 0.052) in normal-weight adolescents
to 0.402 g/cm2 (SD, 0.059) in obese adolescents. The ob-
served linear associations between BMD and both body
weight and body mass index were similar across menarcheal
age classes (Table 1).
BMD and body composition measures
We found crude dose-response associations between BMD
and both BIA-estimated components of total weight: Mean
BMD increased from 0.315 g/cm2 (SD, 0.046) in the lowest
quarter of fat mass to 0.397 g/cm2 (SD, 0.054) in the high-
est quarter, and a similar relation was found for fat-free
mass (from 0.327 g/cm2 (SD, 0.051) in the first quarter to
0.386 g/cm2 (SD, 0.055) in the fourth quarter). Similar trends
were found when body composition was assessed using the
skinfold-based method: BMD increased from 0.322 g/cm2
(SD, 0.050) to 0.394 g/cm2 (SD, 0.056) between the first and
fourth quarters of fat area distribution and from 0.322 g/cm2
(SD, 0.052) to 0.395 g/cm2 (SD, 0.056) between the first
and fourth quarters of muscle area distribution. The shapes
of these associations were similar between menarcheal age
strata (Table 1).
Nonmechanical association between adiposity and BMD
Table 2 presents linear regression coefficients and 95%
confidence intervals for the associations between BMD (in
mg/cm2) and total weight (model 1) and between BMD and
adiposity (models 2a and 2b), as well as the measures of the
independent effect of body composition on BMD, using 2
approaches for removing confounding by body size (stan-
dard multivariate models—models 3a and 3b—and residuals
models—models 4a and 4b). Both crude estimates and es-
timates adjusted for menarcheal age are presented.
The overall association between adiposity and BMD
was positive and significant in the unadjusted model
Direct Association of Adiposity With Bone Mineral Density 693
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Table 1. Forearm Bone Mineral Density and Anthropometric Characteristics in Female Adolescents, Overall and by Menarcheal Age, Porto,
Portugal, 2003–2004
Total (n 5 868)
Age at Menarche, years
‡13 (n 5 297) 12 (n 5 302) £11 (n 5 269)
Mean bone mineral density, g/cm2 0.359 (0.057)a 0.323 (0.046) 0.360 (0.051) 0.398 (0.050)
Body size
Quarter of height, cm
154.0 0.346 (0.062) 0.310 (0.046) 0.350 (0.052) 0.402 (0.053)
154.1–158.0 0.360 (0.057) 0.326 (0.042) 0.356 (0.051) 0.399 (0.051)
158.1–162.1 0.368 (0.053) 0.331 (0.044) 0.370 (0.044) 0.397 (0.051)
162.2 0.365 (0.055) 0.336 (0.046) 0.363 (0.057) 0.394 (0.045)
P for linear trendb <0.001 <0.001 0.048 0.464
Quarter of weight, kg
<46.2 0.314 (0.045) 0.302 (0.038) 0.320 (0.040) 0.362 (0.048)
46.3–51.4 0.355 (0.047) 0.332 (0.041) 0.350 (0.042) 0.390 (0.041)
51.5–58.1 0.373 (0.047) 0.349 (0.047) 0.367 (0.046) 0.390 (0.041)
58.2 0.396 (0.056) 0.353 (0.042) 0.391 (0.051) 0.421 (0.053)
P for linear trend <0.001 <0.001 <0.001 <0.001
Body mass indexc
Normal-weight (<85th percentile) 0.347 (0.052) 0.318 (0.043) 0.349 (0.047) 0.385 (0.043)
Overweight (85th–94th percentiles) 0.397 (0.055) 0.364 (0.046) 0.387 (0.050) 0.418 (0.053)
Obese (95th percentile) 0.402 (0.059) 0.344 (0.050) 0.404 (0.049) 0.429 (0.051)
P for linear trend <0.001 <0.001 <0.001 <0.001
Body composition
Quarter of BIA fat mass, kg
9.8 0.315 (0.046) 0.301 (0.038) 0.336 (0.047) 0.363 (0.044)
9.9–13.4 0.352 (0.045) 0.333 (0.039) 0.346 (0.043) 0.384 (0.038)
13.5–17.6 0.373 (0.050) 0.352 (0.042) 0.363 (0.050) 0.391 (0.048)
17.7 0.397 (0.054) 0.357 (0.045) 0.390 (0.049) 0.419 (0.052)
P for linear trend <0.001 <0.001 <0.001 <0.001
Quarter of BIA fat-free mass, kg
35.5 0.327 (0.051) 0.304 (0.043) 0.330 (0.040) 0.375 (0.046)
35.6–37.9 0.352 (0.047) 0.327 (0.038) 0.353 (0.046) 0.384 (0.039)
38.0–40.7 0.373 (0.058) 0.336 (0.048) 0.364 (0.049) 0.410 (0.053)
40.8 0.386 (0.055) 0.348 (0.044) 0.384 (0.052) 0.412 (0.049)
P for linear trend <0.001 <0.001 <0.001 <0.001
Quarter of skinfold fat area, cm2
13.7 0.322 (0.050) 0.303 (0.042) 0.338 (0.047) 0.368 (0.040)
13.8–20.0 0.354 (0.050) 0.329 (0.039) 0.353 (0.046) 0.388 (0.047)
20.1–24.7 0.368 (0.050) 0.342 (0.042) 0.358 (0.050) 0.393 (0.043)
24.8 0.394 (0.056) 0.354 (0.044) 0.385 (0.050) 0.419 (0.053)
P for linear trend <0.001 <0.001 <0.001 <0.001
Quarter of skinfold muscle area, cm2
28.0 0.322 (0.052) 0.302 (0.044) 0.325 (0.044) 0.375 (0.050)
28.1–32.0 0.351 (0.047) 0.321 (0.035) 0.349 (0.042) 0.386 (0.042)
32.1–36.9 0.369 (0.048) 0.338 (0.040) 0.369 (0.047) 0.394 (0.040)
37.0 0.395 (0.056) 0.358 (0.044) 0.392 (0.049) 0.420 (0.054)
P for linear trend <0.001 <0.001 <0.001 <0.001
Abbreviation: BIA, bioelectrical impedance analysis.
a Numbers in parentheses, standard deviation.
b P values for linear trend are 2-sided and were calculated using linear regression.
c Weight (kg)/height (m)2.
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Table 2. Associations Between Bone Mineral Density (mg/cm2) and Adiposity (Fat Mass and Fat Area) and Total
Weight Among Female Adolescents (Linear Regression Analysis), Porto, Portugal, 2003–2004
Modela
Change per Unit Increase Change per SD Increase
Unstandardized
Coefﬁcient (b)
95% CI
Standardized
Coefﬁcient (bst)
95% CI
Model 1: total weight
Unadjusted 2.93 2.60, 3.25 29.7 26.4, 33.0
Adjusted for menarcheal age 2.22 1.91, 2.53 22.5 19.4, 25.5
Model 2a: BIA fat mass
Unadjusted 4.24 3.75, 4.73 28.8 25.5, 32.2
Adjusted for menarcheal age 3.11 2.64, 3.58 20.7 17.6, 23.9
Model 2b: skinfold fat area
Unadjusted 3.11 2.68, 3.55 24.8 21.4, 28.2
Adjusted for menarcheal age 2.24 1.83, 2.64 17.8 14.6, 21.0
Model 3a (standard multivariate model)
Total weight
Unadjusted 2.31 1.26, 3.36 23.4 12.8, 34.1
Adjusted for menarcheal age 2.43 1.48, 3.38 24.6 15.0, 34.2
BIA fat mass
Unadjusted 0.963 �0.601, 2.53 6.55 �4.09, 17.2
Adjusted for menarcheal age �0.338 �1.76, 1.08 �2.30 �12.0, 7.37
Model 3b (standard multivariate model)
Total weight
Unadjusted 2.64 2.11, 3.16 26.7 21.4, 32.0
Adjusted for menarcheal age 2.07 1.59, 2.55 21.0 16.1, 25.8
Skinfold fat area
Unadjusted 0.470 �0.199, 1.14 3.74 �1.58, 9.06
Adjusted for menarcheal age 0.246 �0.357, 0.850 1.96 �2.84, 6.76
Model 4a (residuals model)
Total weight
Unadjusted 2.93 2.60, 3.25 29.7 26.4, 33.0
Adjusted for menarcheal age 2.22 1.91, 2.52 22.5 19.3, 25.6
BIA fat mass residualsb
Unadjusted 0.963 �0.601, 2.53 2.02 �1.26, 5.29
Adjusted for menarcheal age �0.338 �1.76, 1.08 �0.707 �3.68, 2.27
Model 4b (residuals model)
Total weight
Unadjusted 2.93 2.60, 3.25 29.7 26.4, 32.9
Adjusted for menarcheal age 2.22 1.91, 2.53 22.5 19.4, 25.6
Skinfold fat area residualsb
Unadjusted 0.470 �0.20, 1.14 2.30 �0.97, 5.58
Adjusted for menarcheal age 0.246 �0.36, 0.85 1.21 �1.75, 4.16
Abbreviations: BIA, bioelectrical impedance analysis; BMD, bone mineral density; CI, conﬁdence interval; SD,
standard deviation.
a Model 1: BMD � b0 þ b1(weight); model 2a: BMD � b0 þ b2(fat mass); model 2b: BMD � b0 þ b2(fat area);
model 3a: BMD� b0þ b3(fat mass)þ b4(weight); model 3b: BMD� b0þ b3(fat area)þ b4(weight); model 4a: BMD�
b0 þ b2(fat mass residuals) (relative to weight)þ b5(weight); model 4b: BMD � b0 þ b2(fat area residuals) (relative to
weight) þ b5(weight).
b Adiposity residuals relative to weight: residuals from the regression of fat mass or fat area (dependent variable)
on weight (independent variable), representing the variation in adiposity after removing extraneous variation due to
total weight. By deﬁnition, these residuals are uncorrelated with total weight.
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(bst ¼ 28.8 mg/cm2 for fat mass and bst ¼ 24.8 mg/cm2 for
fat area) and also after adjustment for menarcheal age (bst ¼
20.7 mg/cm2 for fat mass and bst¼ 17.8 mg/cm2 for fat area).
After weight adjustment, in the standard multivariate
models (models 3a and 3b), the magnitude of the menarcheal-
age-adjusted effect of adiposity decreased substantially
(bst ¼ �2.30 mg/cm2 for fat mass and bst ¼ 1.96 mg/cm2 for
fat area). Concordantly, the magnitudes of the effects of re-
siduals (models 4a and 4b) were substantially lower than those
of total weight and were nonsignificant (bst¼ �0.707 mg/cm2
for fat mass and bst ¼ 1.21 mg/cm2 for fat area).
Figure 2 presents the causal pathways tested using path
analysis to assess the plausibility of a direct effect of adipos-
ity, measured as fat mass or fat area, on BMD. Standardized
regression coefficients and 95% confidence intervals (in pa-
rentheses) are shown. Table 3 presents the total and indirect
effects of adiposity on bone quality according to each model
and the values for goodness-of-fit criteria. We observed a
negligible direct effect of adiposity on BMD, both in terms
of the magnitude of the coefficient (per 1-SD increase in
fat mass, bst ¼ �1.57, 95% confidence interval: �11.9,
8.75; per 1-SD increase in fat area, bst ¼ 1.89, 95% confi-
dence interval: �3.13, 6.91) and in terms of the overall fit of
the model, which improved when the direct effect estimation
was excluded from both paths, according to the Akaike and
Bayesian information criteria.
DISCUSSION
In this large, population-based sample of 13-year-old girls,
we observed that the direction and magnitude of the mea-
sures of association between adiposity and forearm BMD
were strongly explained by the contribution of fat to body
weight. The potential for a specific, nonmechanical effect of
adiposity on BMD was small.
Dual-energy x-ray absorptiometry is a 2-dimensional
technique which does not capture true volumetric density
or bone geometry (28). In fact, in a study byWren et al. (29),
areal BMD estimated by dual-energy x-ray absorptiometry in
children was only weakly correlated with volumetric BMD
measured with computed tomography, and BMD measure-
ments were strongly dependent on growth-related changes in
body and skeletal size. However, regarding its most relevant
outcome, BMD remains a valid index of bone quality, as
confirmed in a longitudinal study wherein areal BMD was
a good predictor of fracture during puberty (30). Other studies
have even suggested that areal BMD may be a more accurate
indication of bone strength relative to size than volumetric
BMD, through assigning lower values to smaller bones as
compared with larger bones with the same volumetric BMD,
since bone size influences strength independently of mass
(31, 32). In order to optimize feasibility and minimize radia-
tion exposure, we used forearm BMD to estimate bone quality.
Our sample size and evaluation setting also required prac-
tical methods for the estimation of adiposity. BIA has low
accuracy in predicting metabolic risk at the individual level
(33, 34). However, a previous study showed that, whereas
the Tanita body composition analyzer underestimated fat
mass in white boys, it did not do so in white girls (35).
Nevertheless, BIA-derived prediction of body composition
is based not only on impedance but also on other variables,
namely weight, which was our main mediating variable and
a term in the regression models, raising the problem of
possible overadjustment. To assess the impact of this limi-
tation on our conclusions, we used a skinfold equation to
estimate upper arm fat area as a second measure of adipos-
ity. Although skinfold thickness equations also have validity
limitations (33), which we minimized through continuous
training of our field researchers, we estimated high correla-
tion between measures of adiposity obtained with these
methods, and the magnitude and direction of the effect of
fat on bone were also consistent between them.
We observed a marked increase in BMD with menarcheal
precocity. Modulation of bone remodeling by gonadal hor-
mones is well established (4), and estrogen plays a critical
role in the attainment of normal BMD by stimulating bone
formation, augmenting mineralization, promoting epiphy-
seal maturation, and establishing skeletal proportion (5).
Therefore, it is expected that the period of exposure to en-
dogenous estrogen is directly associated with improved
forearm bone microstructure (36). We did not find evidence
of modification of the effect of pubertal stage on the asso-
ciation between fat and bone quality, similarly to previous
findings in girls (37).
We observed positive associations of BMD with body
size measures (weight, body mass index, and height—the
latter mainly in the later menarche group) and with absolute
measures of adiposity (BIA or skinfold-derived). These cor-
roborate previous findings that the net effect of body size
and mass on bone strength is positive (7, 11, 13, 37, 38). In
fact, increased external dynamic load, even at non-weight-
bearing sites, is beneficial to bone strength, regardless of the
composition of the load (39, 40). The expected crude effect
of body mass is greater at weight-bearing sites, which was
not the case in the present study, where we measured the
forearm. Our estimates of the crude (mechanical plus non-
mechanical) effect are not generalizable to sites at which the
expected effect of body mass is greater. However, the dif-
ferences in that crude effect between weight-bearing and
non-weight-bearing sites should be due to its mechanical
component. We expect the variation between anatomical
sites in the magnitude of the systemic nonmechanical effect
of adiposity to be minimal. Therefore, we believe that the
anatomical site chosen is particularly suitable for estimation
of the nonmechanical effect of adiposity.
We have used different methodological approaches to
answer our main scientific question, and these approaches
have yielded consistent results in terms of magnitude and
direction of the effects investigated. However, the cross-
sectional nature of our study demands a careful interpreta-
tion of associations with regard to causality. Indeed, it should
be noted that path analysis, as well as the other analytical
approaches that we used in this work, does not aim at prov-
ing causation but rather at testing whether the observed
data are consistent with an a priori hypothesis (25). As in
any estimation of causal effects, this study was based on the
assumption of no unmeasured confounding, a premise that
has been considered particularly relevant in direct effects
estimation (20). Additionally, since all statistical models
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Weight Bone Mineral DensityFat Mass (BIA)
A1)
Weight Bone Mineral DensityFat Area (Skinfold)
A2)
0.952 
(0.931, 0.974)
Gynecologic Age
Gynecologic Age
Weight Bone Mineral DensityFat Mass (BIA)
B1)
Weight Bone Mineral DensityFat Area(Skinfold)
B2)
Gynecologic Age
Gynecologic Age
22.9 
(19.5, 26.2)
–0.002 
(–0.027, 0.023)
27.4 
(23.7, 31.0)
0.757 
(0.707, 0.806)
0.134 
(0.080, 0.188)
22.9 
(19.5, 26.2)
27.4 
(23.7, 31.0)
24.3 
(14.4, 34.3)
27.4
(23.7, 31.2)
–0.002
(–0.027, 0.023)
0.952
(0.931, 0.974)
–1.57
(–11.9, 8.75)
21.4 
(16.0, 26.8)
27.3
(23.6, 31.0)
0.134
(0.080, 0.188)
0.757
(0.707, 0.806)
1.89
(–3.13, 6.91)
Figure 2. Magnitudes of standardized direct and indirect effects of adiposity on bone mineral density among female adolescents, calculated by
path analysis using 2 methods to estimate adiposity, Porto, Portugal, 2003–2004. Regression coefﬁcients and 95% conﬁdence intervals (shown in
parentheses) were calculated by bootstrapping using 1,000 draws. Gynecologic age was measured in years. Path A1: total effect of fat mass is
assumed to be indirect; path A2: total effect of fat area is assumed to be indirect; path B1: total effect of fat mass is assumed to be the sum of direct
and indirect components; path B2: total effect of fat area is assumed to be the sum of direct and indirect components. (BIA, bioelectrical impedance
analysis).
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are necessarily oversimplifications, associations estimated
here comprise a summary of many probable effects, inte-
grated in complex, feedback-controlled pathways in which
reverse causation represents a biologic fact and is certainly
present given our cross-sectional approach (41).
Research on the role of adiposity in bone quality has
focused on the effects of adipose tissue as an endocrine
organ (8, 15, 42). Most investigators present several possible
explanations for positive or deleterious associations (10, 11,
16, 37, 43). In children, leptin and adiponectin have been
implicated in the proposed differential roles of subcutaneous
fat and total body fat in bone homeostasis (44), whereas an-
other study has suggested a large number of cellular and
molecular mechanisms linking adipocytes and osteoblasts
(19). In a birth cohort study, Clark et al. (12) referred to a dual
role of fat mass, both as a secretor organ and as a marker of
other endocrine factors. While we do not intend the present
work to contribute to the debate on which biologic mecha-
nism predominates in the potential direct effect of adiposity
on bone quality, we believe that this discussion should be
preceded by estimation of the magnitude and therefore pop-
ulational relevance of that direct effect. As a means to achieve
this goal, we believe that control for total bodymass is a meth-
odological challenge which demands alternative approaches.
By using and comparing standard multivariate regression,
residuals regression, and path analysis, we found a negligible
direct effect of adiposity on BMD at the forearm, indicating
a narrow scope for a nonmechanical effect of fat on bone
quality. Indeed, a study in prepubertal children showed that
a number of known major mediators of the endocrine effect
of adipose tissue on bone (insulin-like growth factor 1, sex
steroids, and leptin) explained only a small fraction of the
variability in bone mineral content and density (45). By
fitting a model in which we examined the effect of increasing
adiposity while keeping total mass controlled, we compared
the effect of fat-mediated weight with other forms of weight,
namely lean mass and height. We recognize that the weight-
independent variability in adiposity is inevitably related to
height and fat-free mass to some extent. Therefore, there
was a possibility of inducing spurious associations between
fat and BMD by controlling for weight, which would be
explained by a real association between height or fat-free
mass and BMD (20). However, in order for an unblocked
path to emerge between fat free-mass or height and BMD
after adjustment for weight, there would have to be a direct
association between adiposity and BMD, since the indirect
path was blocked by weight adjustment. Since we found no
such direct path after weight adjustment, we believe there is
a low probability that such spurious associations occurred.
Physical activity, a possible confounder, was not associ-
ated with BMD (data not shown). One possible explanation
is low validity of self-reported information to assess true
physical activity levels. However, the most probable reason
is high sedentarism in this population, previously described
in adults as well as in these adolescents (21, 46), which
probably situated the vast majority of the sample below
the threshold level for exercise-induced bone formation. In
fact, there is recent evidence that light or moderate physical
activity is not associated with bone properties (47).
Using different methodological approaches and methods
of exposure assessment, we quantified a consistently small
scope for a specific association between adiposity and fore-
arm BMD in a large sample of 13-year-old girls, eliminating
confounding by birth cohort or calendar period. The magni-
tude of the direct effect of fat on forearm BMD seems to be
negligible. From a public health viewpoint, although bone
responds positively to increases in weight, no specific benefit
should be expected from relative increases in adiposity, and
exercise-based strategies aimed at reducing the burden of
overweight in adolescence should be preferred to improve
skeletal health in adulthood.
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O R I G I N A L A R T I C L E
Low-grade systemic inflammation and suboptimal bone mineral
density throughout adolescence: a prospective study in girls
Raquel Lucas*,†,‡, Elisabete Ramos*,†,‡, Andreia Oliveira*,†,‡, Teresa Monjardino*,†,‡ and Henrique Barros*,†,‡
*Department of Hygiene and Epidemiology, University of Porto Medical School, †Institute of Public Health, University of Porto, and
‡Cardiovascular R&D Unit, University of Porto Medical School, Porto, Portugal
Summary
Objective We aimed at quantifying the associations between
high-sensitivity C-reactive protein (hs-CRP) and forearm bone
mineral density (BMD) throughout adolescence in overweight
and normal-weight girls.
Design Prospective cohort study.
Patients 346 girls born in 1990 and attending schools in Porto,
Portugal.
Measurements Adolescents were evaluated at 13 and 17 years
of age2 using a standard protocol. Forearm BMD was measured
by dual-energy X-ray absorptiometry. Anthropometric assess-
ment included weight, height, body fat percentage and waist
circumference. Girls were categorized according to age- and
sex-specific body mass index (BMI) percentiles as normal weight
in both evaluations or overweight in at least one assessment.
Pubertal development was estimated using menarche age. Serum
hs-CRP was determined using particle-enhanced immunonephel-
ometry. Hs-CRP was log-transformed, and associations were
quantified using linear regression coefficients and 95% confi-
dence intervals (95%CI).
Results An inverse association between hs-CRP and BMD was
observed from 13 years of age in overweight girls [11·26 mg/
cm2 (21·99, 0·52)]. Among normal-weight adolescents, 13-
year-old hs-CRP was negatively associated with prospective
BMD variation between 13 and 17 years of age [1·903 mg/
cm2 year (3·35, 0·45)]. Overweight girls who maintained
higher levels of hs-CRP throughout adolescence had lower 17-
year-old BMD (adjusted mean 0·441 vs 0·483 g/cm2 in those
who remained with lower levels of hs-CRP). At 17 years of age,
significant inverse associations were found between hs-CRP and
BMD among normal-weight and overweight girls.
Conclusions Obesity-related early systemic inflammation might
be involved in suboptimal bone accrual, particularly in over-
weight girls.
(Received 6 March 2012; returned for revision 29 March 2012;
finally revised 17 April 2012; accepted 26 April 2012)
Introduction
Bone quality is a multidimensional trait currently believed to
track substantially from the first decades of life up to adult-
hood.1,2 In this life course approach, optimization of bone prop-
erties during childhood and adolescence is seen as a relevant
goal in the primary prevention of fragility fractures occurring in
old age.3,4 The search for potentially modifiable factors that
determine bone accrual during growth has raised an increasing
interest on the impact of childhood overweight and concomitant
metabolic changes.5–7
Early continuous exposure to low-grade systemic inflamma-
tion has been proposed as a key mechanism by which childhood
obesity is associated with cardiovascular disease.8–11 There is
recent evidence that low-grade inflammation also affects physio-
logical bone turnover and may play an important role in skeletal
conditions whose aetiology was not considered primarily inflam-
matory, such as adult osteoporosis.5,12 Epidemiological studies
in adults have supported this relation through the associations
of low-grade inflammation with increased bone resorption,13,14
decreased bone strength15–18 and higher fracture incidence.19
Recent evidence obtained cross-sectionally suggests that this
association may already be present in overweight adoles-
cents.20,21 However, it remains unclear whether such relation
might translate a long-term harmful effect.
Prospective research in the general population addressing
these issues is particularly relevant in a life stage when bone
acquisition predominates over resorption, and bone properties
may be more responsive to intervention. Additionally, as periods
of exposure to adiposity and to its metabolic effects are neces-
sarily short, there is a reduced probability of reverse causation,
as well as of confounding by inflammatory conditions other
than obesity.10
Using data from a population-based cohort, our objective was
to quantify the prospective associations between low-grade sys-
temic inflammation and forearm bone mineral density in nor-
mal-weight and overweight adolescent girls.
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Patients and methods
This study included a sample of 346 girls recruited and followed
as part of a cohort of adolescents born in 1990 who were evalu-
ated in early (13 years of age) and late adolescence (17 years of
age).
Cohort recruitment (13 years of age)
During the 2003/2004 school year, all public and private schools
in Porto, Portugal, that provided teaching to children born in
1990 were approached by the research team. Of the 51 eligible
schools, 46 allowed the researchers to contact students and fami-
lies. Meetings were arranged with parents and teachers in each
school to explain research aims and procedures. Both legal
guardians and children were asked for written informed consent
to participate. Using this procedure, 2787 eligible students were
identified, among which 78% agreed to participate. The study
protocol complied with the Declaration of Helsinki and was
approved by the Ethics Committee of the University Hospital of
Sa˜o Joa˜o in Porto, Portugal. The study methods have been
described in detail elsewhere.22
Follow-up evaluation (17 years of age)
The first follow-up evaluation of this cohort was conducted
from 2007 to 2008, after a median (25th–75th percentiles) 37·9
(34·9–42·6) months from the first evaluation. Re-evaluations
were scheduled by contacting schools or participants directly.
Baseline and follow-up evaluations were conducted using the
same protocol. Written informed consent was again obtained
from all participants and their guardians. Attrition between eval-
uations was 21%.
Physical examination
Bone quality was estimated through bone mineral density, mea-
sured in g/cm2 at the ultradistal and proximal radius (one-third
of distal point between the styloid process and the tip of the
olecranon) of the nondominant forearm by dual-energy X-ray
absorptiometry (DXA) using a4 Lunar® Peripheral Instantaneous
X-ray Imager. In case of reported previous fracture of the non-
dominant arm, the dominant arm was the one assessed.
Anthropometry was obtained while the student stood barefoot
in light indoor clothing. Weight was measured to the nearest
tenth of kilogram (5 Tanita®), and height was measured in centi-
metres, to the nearest tenth, using a portable stadiometer
(6 Seca®). Sex- and age-specific body mass index percentiles devel-
oped by the United States Centers for Disease Control and Pre-
vention (CDC) were used.23 Participants were classified as
normal weight, if their body mass index (BMI) was below the
85th percentile, or overweight, if their BMI was at or above
the 85th percentile. Underweight was defined as a BMI below
the 5th sex- and age-specific percentile. Because none of the par-
ticipants was classified as underweight at 13 years of age and
only two were underweight at 17, these were included in the
normal-weight category for analysis. Waist circumference was
measured at the midpoint between the lower limit of the rib
cage and the iliac crest, to the nearest tenth of centimetre with a
flexible and nondistensible tape with the subject standing. Body
fat was estimated as a proportion of total body mass, using bio-
electrical impedance (Tanita® TBF-300). Pubertal development
status was estimated using menarche age in years, obtained using
a self-administered questionnaire.
A 12-h overnight fasting blood sample was collected from an
antecubital vein. The level of low-grade systemic inflammation
was quantified through serum concentration of high-sensitivity
C-reactive protein (hs-CRP), determined using particle-
enhanced immunonephelometry with a BNTM II nephelometer
( 7Dade Behring®) (coefficient of variation = 7·6%). Girls with
hs-CRP concentration above 10 mg/l in any of the evaluations,
suggesting acute infection or a clinically relevant inflammatory
condition other than obesity, were excluded from analysis
(n = 29).
From a total of 1116 girls recruited at 13 years of age, 892
participated in both evaluations, and a subsample of 346 had
complete data for both evaluations regarding bone mineral den-
sity and anthropometric variables, and provided a blood sample,
allowing for the measurement of hs-CRP. By comparing the 346
girls selected for the present study with those not included, we
found no significant differences in mean baseline BMI (21·2 vs
21·1 kg/m2, P = 0·407), mean baseline forearm BMD (0·363 vs
0·358 g/cm2, P = 0·388) or on the proportion of girls who were
premenarcheal at baseline (13·4% vs 16·0%, P = 0·284). How-
ever, girls who were included in the present study had slightly
lower hs-CRP concentration at baseline than those not included
(median 0·02 mg/dl vs 0·03 mg/dl, P = 0·042).
Data analysis
Data analysis was stratified by body mass index: participants
were classified as normal weight if they remained below the
CDC 85th sex- and age-specific reference BMI percentile in both
evaluations or overweight if they were classified at or above the
85th percentile in at least one of the evaluations. The main
exposures were hs-CRP at 13 and at 17 years of age, as well as
annual hs-CRP variation. Distributions of hs-CRP concentra-
tions at each age were significantly skewed, and in regression
analysis, they were log-transformed to obtain symmetrical distri-
butions. Participants were also grouped according to the follow-
ing categories: hs-CRP levels below the median in both
evaluations, hs-CRP concentration below the median at 13 but
above it at 17 years of age, hs-CRP concentration above the
median at 13 and below that value at 17 years of age and hs-
CRP above the median in both evaluations. The main outcomes
considered were BMD at 13 and at 17 years of age and annual
BMD variation between those ages.
The significance of differences between proportions was calcu-
lated using chi-square test. Mean and standard deviation (SD)
were used to describe variables with normal distributions. Differ-
ences between means were tested using Student’s t-test, when
two groups were compared, or ANOVA, when more than two
© 2012 Blackwell Publishing Ltd
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groups were compared. Variables with non-normal distribution
were summarized using median and 25th and 75th percentiles
and compared between groups using Wilcoxon’s rank-sum test8 .
Associations between adiposity measures, hs-CRP and BMD
were estimated cross-sectionally at each age and prospectively,
using linear regression coefficients and 95% confidence intervals
(95% CI). In addition to crude estimates, coefficients were also
adjusted for menarche age and for BMI at the time of BMD
measurement or for the mean BMI between evaluations when
BMD variation was the outcome. Data were analysed using9 Sta-
ta® 9.2.
Results
Mean (95% CI) forearm bone mineral density increased from
0·362 (0·356; 0·369) at 13 years of age to 0·437 (0·431; 0·442) g/
cm2 at 17 years of age. Most girls (72·7%) remained in the nor-
mal-weight range throughout follow-up. The remaining adoles-
cents were included in the overweight category (14·6% were
overweight in both evaluations, 10·0% changed from overweight
at 13 to normal weight at 17 years of age, and the opposite was
observed among 2·6%). As shown in Table 1, when compared
with normal BMI girls, overweight adolescents had higher mean
body fat percentage and waist circumference in both evaluations,
as well as higher average values of C-reactive protein in early
and late adolescence. Mean BMD remained higher in overweight
than in normal-weight girls.
Table 2 presents the estimates of linear correlations between
annual variation in the measures of adiposity and variations in
hs-CRP (our main exposure) and BMD (our main outcome), in
normal-weight and overweight adolescents. Among overweight
girls, the magnitude of change in hs-CRP throughout adoles-
cence was directly and significantly correlated with the annual
variations of all measures of adiposity (BMI, body fat percentage
and waist circumference). In normal-weight adolescents, no such
associations were found. Regarding bone accrual, in both nor-
mal-weight and overweight adolescents, there were positive cor-
relations between changes in BMI, body fat percentage and waist
circumference and changes in BMD throughout adolescence.
Early adolescence bone mineral density
Hs-CRP at 13 years of age was inversely and significantly associ-
ated with BMD at the same age among overweight girls
[adjusted coefficient (95% CI): 11·26 (21·99, 0·52)]. In
normal-weight girls, this cross-sectional relation in early adoles-
cence was weak and nonsignificant (Table 3).
Annual change in bone mineral density
Hs-CRP at 13 years of age showed a negative association with
the annual change in BMD up to 17 years of age among nor-
mal-weight girls [adjusted coefficient (95% CI): 1·90 (3·35,
0·45)], but no effect was found in overweight adolescents.
Regarding hs-CRP change throughout follow-up, there was a
nonsignificant decreasing trend of BMD change with increasing
annual hs-CRP variation in normal-weight girls [10·25
(37·69, 17·18)]. This trend was not observable among over-
weight girls (Table 3).
Table 1. Description of average bone mineral density and
cardiometabolic variables in girls, at 13 years of age (baseline evaluation)
and at 17 years of age (first follow-up evaluation)
Normal weight
(n = 251)
Overweight
(n = 95) P
Median (P25–P75)
menarche age (years)
12 (12, 13) 12 (11, 13) <0·001
Mean (SD) weight (kg)
Baseline
(13 years of age)
49·3 (6·0) 64·8 (9·1) <0·001
Follow-up
(17 years of age)
54·4 (6·0) 67·4 (9·8) <0·001
Annual variation 1·6 (1·3) 0·9 (2·1) <0·001
Mean (SD) height (cm)
Baseline
(13 years of age)
158·6 (6·1) 158·4 (6·0) 0·747
Follow-up
(17 years of age)
161·7 (5·9) 160·9 (5·9) 0·261
Annual variation 1·0 (0·8) 0·8 (0·5) 0·014
Mean (SD) body mass index (kg/m2)
Baseline
(13 years of age)
19·6 (1·6) 25·8 (3·0) <0·001
Follow-up
(17 years of age)
20·8 (1·7) 26·0 (3·4) <0·001
Annual variation 0·4 (0·4) 0·1 (0·8) <0·001
Mean (SD) body fat (%)
Baseline
(13 years of age)
23·6 (5·5) 35·0 (5·3) <0·001
Follow-up
(17 years of age)
22·9 (5·4) 31·3 (6·2) <0·001
Annual variation 0·2 (1·6) 1·1 (1·8) <0·001
Mean (SD) waist circumference (cm)
Baseline
(13 years of age)
68·5 (4·6) 81·1 (7·8) <0·001
Follow-up
(17 years of age)
71·5 (5·8) 82·0 (8·7) <0·001
Annual variation 1·0 (1·8) 0·3 (2·3) 0·006
Median (P25–P75) high-sensitivity C-reactive protein (mg/dl)
Baseline
(13 years of age)
0·02 (<0·02, 0·05) 0·04 (0·02, 0·07) <0·001
Follow-up
(17 years of age)
0·06 (0·02, 0·15) 0·07 (0·03, 0·22) 0·161
Annual variation 0·02 (0·06) 0·02 (0·06) 0·836
Mean (SD) bone mineral density (g/cm2)
Baseline
(13 years of age)
0·349 (0·052) 0·398 (0·058) <0·001
Follow-up
(17 years of age)
0·428 (0·047) 0·461 (0·055) <0·001
Annual variation 0·024 (0·013) 0·020 (0·014) 0·003
Normal weight: adolescents whose weight remained in the normal range
(<85th CDC sex- and age-specific percentile) at 13 and 17 years of age;
Overweight: adolescents who were overweight ( 85th CDC sex- and
age-specific percentile) at 13 or 17 years of age; SD, standard deviation;
P25–P75, 25th–75th percentiles.
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Late adolescence bone mineral density
When prospective associations were quantified (BMD at 17 vs
hs-CRP at 13 and BMD at 17 vs change in hs-CRP during ado-
lescence), negative but nonsignificant associations were observed
in both normal-weight and overweight adolescents (Table 3). To
describe the bone density attained according to hs-CRP trajecto-
ries throughout adolescence, crude and adjusted mean 17-year-
old BMD is presented in Fig. 1, in each of the four classes that
combine hs-CRP at 13 and at 17 years of age. Late adolescence
BMD was highest among those whose hs-CRP remained below
the median in both evaluations and lowest among those whose
hs-CRP remained above the median. This difference was sub-
stantial and significant in overweight adolescents (adjusted mean
BMD: 0·483 vs 0·441 g/cm2, P = 0·024) but not among normal-
weight girls (0·435 vs 0·418 g/cm2, P = 0·133).
Cross-sectionally, hs-CRP at 17 years of age was inversely
associated with BMD at the same age, both in normal-weight
and overweight girls [adjusted coefficients (95% CI): 5·02
(9·44, 0·60) and 9·16 (17·91, 0·42), respectively]
(Table 3).
Discussion
Throughout adolescence, higher levels of serum high-sensitivity
C-reactive protein were associated with lower forearm bone
mineral density among overweight girls. This association was
greater in girls who remained in the upper half of the hs-CRP
distribution between 13 and 17 years of age. Among normal-
weight adolescents, a significant inverse association between
hs-CRP and BMD emerged only in late adolescence.
Bone mineral density in early and late adolescence remained
higher among overweight than normal-weight girls and increased
prospectively with increasing adiposity in both groups, consis-
tently with the well-documented net positive effect of body size
on bone mass.7,24 As expected, overweight girls had higher aver-
Table 2. Linear regression coefficients (95% confidence intervals) for the associations between variation in adiposity indices and variation in hs-CRP
and BMD throughout adolescence, in normal-weight and overweight girls
Annual hs-CRP variation (mg/l year) Annual BMD variation (mg/cm2 year)
Normal weight Overweight Normal weight Overweight
Annual BMI variation (per kg/m2 year) 2·90 (1·89, 1·31) 20·19 (4·92, 35·46) 10·25 (6·79, 13·70) 4·73 (1·33, 8·13)
Annual body fat variation (per%/year) 3·00 (7·41, 1·41) 10·40 (3·72, 17·14) 2·94 (1·99, 3·88) 2·48 (0·92, 4·04)
Annual waist circumference variation (per cm/year) 1·21 (2·80, 5·23) 6·66 (1·31, 12·00) 1·30 (0·39, 2·20) 1·21 (0·00, 2·42)
Table 3. Linear regression coefficients (95% confidence intervals) for the cross-sectional and prospective associations between serum high-sensitivity C-
reactive protein and bone mineral density (BMD) in mg/cm2 among girls, according to body mass index categories
BMD13 (mg/cm
2)
Annual BMD variation (mg/
cm2 year) BMD17 (mg/cm
2)
Crude Adjusted* Crude Adjusted† Crude Adjusted‡
log (hs-CRP13) Normal weight 4·90
(1·30, 11·09)
1·53
(3·59, 6·64)
2·27
(3·82, 0·72)
1·90
(3·35, 0·45)
2·36
(7·97, 3·24)
3·00
(8·27, 2·27)
Overweight 9·48
(21·17, 2·20)
11·26
(21·99, 0·52)
0·40
(2·40, 3·20)
0·06
(2·88, 3·00)
7·53
(18·52, 3·47)
7·28
(18·41, 3·85)
Annual CRP
variation
Normal weight – – 21·54
(49·94, 6·87)
10·25
(37·69, 17·18)
39·47
(140·76, 61·82)
60·00
(158·67, 38·67)
Overweight – – 0·03
(46·08, 46·08)
0·02
(45·00, 44·97)
133·44
(313·10, 47·02)
140·54
(313·24, 32·15)
log (hs-CRP17) Normal weight – – – – 2·95
(7·63, 1·72)
5·02
(9·44, 0·60)
Overweight – – – – 7·25
(15·99, 1·48)
9·16
(17·91, 0·42)
*Adjusted for menarche age and body mass index (BMI) at 13 years of age.
†Adjusted for menarche age and mean BMI between 13 and 17 years of age.
‡Adjusted for menarche age and BMI at 17 years of age.
Normal weight: adolescents whose weight remained in the normal range (<85th CDC sex- and age-specific percentile) at 13 and 17 years of age;
Overweight: adolescents who were overweight ( 85th CDC sex- and age-specific percentile) at 13 or 17 years of age; BMD13: bone mineral
density (mg/cm2) at 13 years of age; BMD17: bone mineral density (mg/cm
2) at 17 years of age; hs-CRP13: serum concentration of high-sensitivity
C-reactive protein at 13 years of age; hs-CRP17: serum concentration of high-sensitivity C-reactive protein at 17 years of age.
© 2012 Blackwell Publishing Ltd
Clinical Endocrinology (2012), 77, 1–7
4 R. Lucas et al.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
Results 75
age values of body fat percentage, waist circumference, and
serum concentration of hs-CRP. Body fat as a major cause of sys-
temic low-grade inflammation has been well-documented among
children and adolescents,10,25 and such findings reflect relevant
differences in metabolic environments between normal-weight
and overweight girls. It is therefore plausible that a potential
effect of low-grade inflammation on bone health becomes detect-
able only with the higher level of inflammatory activation found
in the presence of excess adiposity. This hypothesis may explain
our finding that inverse associations between hs-CRP and BMD
in early adolescence were restricted to overweight girls. The
observed prospective association between changes in adiposity
and variation in hs-CRP during adolescence only among over-
weight girls is also compatible with this hypothesis. Concor-
dantly, the previous cross-sectional findings of inverse relations
between bone quality and cardiometabolic risk factors in child-
hood have been restricted to overweight participants.20,21,26
By 17 years of age, hs-CRP was negatively associated with
BMD in all girls, independently of BMI. In overweight girls,
such an effect would probably be mediated by the already lower
BMD at 13, while in normal-weight girls, it suggests a later onset
of a potential harmful effect of low-grade inflammation. Another
relevant finding of our study was a relation between hs-CRP tra-
jectories and BMD, by which overweight girls whose hs-CRP
remained below the median in both evaluations had the highest
17-year-old BMD followed by those whose hs-CRP changed cat-
egories and finally by those whose hs-CRP remained in the
upper half of the distribution. Such results may also suggest
some degree of reversibility of potential harmful effects of sys-
temic inflammation on bone density. Currently, there is evi-
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Fig. 1 Mean and 95% confidence intervals for bone mineral density (g/cm2) at 17 years of age, crude (dark grey) and adjusted for menarche age and
body mass index (light grey), according to high-sensitivity C-reactive protein level below or above the median (hs-CRP) at 13 and 17 years of age in
normal-weight (upper panel) and overweight (lower panel) girls. Normal weight: adolescents whose weight remained in the normal range (<85th CDC
sex- and age-specific percentile) at 13 and 17 years of age; Overweight: adolescents who were overweight ( 85th CDC sex- and age-specific percentile)
at 13 or 17 years of age; CRP: high-sensitivity C-reactive protein; median hs-CRP at 13 years of age: 0·02 mg/dl in normal weight and 0·06 mg/dl in
overweight girls; median hs-CRP at 17 years of age: 0·04 mg/dl in normal-weight and 0·07 mg/dl in overweight girls.
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dence that interventions aiming at reducing obesity in children
are indeed effective in decreasing circulating markers of systemic
inflammation27,28 and could therefore have additional benefits to
bone health.
Basic research has provided evidence of the association
between adiposity and increased expression of pro-inflammatory
cytokines including interleukin-1, interleukin-6 and tumour
necrosis factor-alpha.9,10,25 The recent focus on the role of
inflammation in the pathophysiology of osteoporosis has
brought attention to those cytokines as regulators of bone turn-
over.29 Indeed, inflammatory cytokines act on bone homoeosta-
sis by several mechanisms, namely through the regulation of
osteoclastogenesis and osteoclast survival, regulation of osteo-
blast activity, as well as modification of the responses of B and
T lymphocytes and dendritic cells.30 Even though the associa-
tions found in observational studies of human populations can-
not necessarily clarify the existence or direction of causal
mechanisms, particularly when considering the enormous com-
plexity of the pathways involved, the present data are consistent
with the hypothesis that low-grade systemic inflammation, in
addition to worse cardiovascular health, may also have an obser-
vable effect on bone physical properties in adolescent girls. A
recent cross-sectional study in overweight children aged 7 to
11 years found that total body bone mineral content was lower,
and C-reactive protein concentration was higher among children
with prediabetes than in those without the condition.20 The
same team found similar results among overweight adolescents
aged 14–18 years, in whom the presence of one or more cardio-
metabolic risk factors had a negative association with bone
parameters.21 Our study adds prospective support to those
observations. The present findings are also coherent with obser-
vations from some longitudinal studies in adults using bone
properties13,17,18 and incident fracture19,31,32 as outcomes. How-
ever, it should be noted that in other studies in adults, no clear
associations were found.33,34 Nevertheless, there may be limita-
tions in directly transposing results from adults to adolescents,
because in the former group the process of bone remodelling is
the major concern while, during growth, modelling is most rele-
vant. Additionally, during adulthood, it is more likely that
reverse causation or confounding because of accumulated expo-
sures or chronic conditions might interfere with the assessment
of the association under study.10
Regarding the present study, some methodological options
and limitations should be noted. Firstly, even though all adoles-
cents were born in 1990 and efforts were made so that evalua-
tion periods were narrow, not all participants had the same
interval between evaluations. However, after adjusting our analy-
ses for age in months at each evaluation, we found that those
differences had negligible impact on the present findings. Addi-
tionally, we worked under the assumption that changes in sys-
temic inflammation and bone density occurred linearly
throughout follow-up, although we recognize that multiple tra-
jectories are possible between these two points, which could
influence the magnitude of the associations under study.
Another important point is that we used forearm areal BMD
measured by dual-energy X-ray absorptiometry to estimate bone
quality, even though peripheral measures of BMD are not per-
fect substitutes of whole body or axial measures.35 Additionally,
we acknowledge that areal BMD partially reflects bone size
rather than its intrinsic volumetric density. However, size is an
important component of overall strength, and areal bone density
is an accurate predictor of fracture risk, which is ultimately the
goal of bone quality assessment.36 Lastly, CRP is synthesized as a
response to circulating IL-6 and is probably not causally
involved in pathophysiologic processes.9 However, it provides a
meaningful quantitative measure of low-grade systemic inflam-
mation, especially after high-sensitivity assays were introduced.37
In fact, hs-CRP has been a good marker of cardiovascular risk
in children and adolescents.38
Despite the above-mentioned issues, we were able to estimate
short- and long-term associations between low-grade systemic
inflammation and bone mineral density with relevant generaliz-
ability, because they were observed in a population-based sample
of adolescents. Another major strength is that we conducted our
study with a prospective design, and the follow-up period cap-
tured most of adolescence. We were able not only to quantify
these associations in overweight girls, but also to extend them to
the normal-weight range. Additionally, using a sample of adoles-
cents born in the same year, we avoided cohort or period effects.
Our findings suggest that low-grade systemic inflammation
may be an important determinant of suboptimal bone quality in
late adolescence. Among overweight girls, this association was
present since early adolescence, and those who maintained
higher levels of low-grade systemic inflammation during follow-
up had the lowest bone mineral density in late adolescence.
Therefore, beyond its recognized cardiovascular consequences,
adiposity-related low-grade systemic inflammation might also be
involved in suboptimal bone acquisition during adolescence.
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4.4. Longitudinal changes in serum RANKL and OPG and 
their associations with bone turnover and bone mineral 
density in healthy adolescent girls
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Abstract
Objective: Our objective was to assess whether serum osteoprotegerin (OPG) and RANK li-
gand (RANKL) reflect bone turnover and bone mineral density (BMD) in early and late adoles-
cence. We also aimed at describing changes in OPG and RANKL according to menarche timing. 
Methods: We used data from 300 girls recruited as part of the EPITeen cohort study, in Porto, 
Portugal. Girls were evaluated at 13 and 17 years of age. Anthropometry included weight and 
height. Areal BMD was measured at the distal forearm. Fasting blood samples were collected 
and the following substances were quantified: RANKL, OPG, C-terminal telopeptide of type I 
collagen (CTX), procollagen type I N propeptide (PINP). Correlation coefficients were used 
to quantify the associations between those substances at 13 and 17 years of age. Random-
effects linear models were used to quantify associations between anthropometric and bone 
parameters and sexual development, measured as time relative to menarche.
Results: RANKL was positively correlated with bone resorption (CTX) in early and late ado-
lescence (r13=0.15 and r17=0.23) and the OPG/RANKL ratio correlated inversely with CTX at 17 
(r17=-0.24). No significant associations were found between RANKL and OPG and bone forma-
tion (PINP). In early adolescence, there was an inverse and significant correlation of BMD with 
CTX (r13=-0.52) but no significant correlations were found between osteoclast regulators and 
BMD. We observed a linear decrease in serum RANKL with increasing time relative to men-
arche (-0.09 pmol/l per year, 95% CI:-0.10, -0.07), while OPG increased linearly (0.02 pmol/l 
per year, 95% CI: 0.01, 0.04).
Conclusion: Serum RANKL and OPG levels varied markedly between early and late adoles-
cence, independently of menarche timing. RANKL and OPG/RANKL were not correlated with 
bone turnover at 13 years of age, but became associated with bone resorption in late adoles-
cence.
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Introduction
Fracture risk combines genetic background with a complex set of exposures that act through-
out the life course, influencing the resistance of bone to trauma [1]. Bone strength is the com-
plex end result of size, morphology, material properties and peak bone mass attained during 
the first three decades of life [2], in addition to subsequent mineral loss. Understanding how 
bone dynamics evolves early in life is a key component of research on the etiology of adult bone 
fragility. The potential for prevention is particularly interesting in the female gender, where the 
burden of fragility fractures is disproportionately high [3].
The final physical properties of bone tissue are dependent on its continuous turnover [4]. In 
adults, the main homeostatic mechanism driving bone dynamics at the local level is remod-
eling, which involves coupling of bone formation and resorption in such a way that overall 
mineral mass remains fairly constant [4]. During childhood, in addition to remodeling, growth 
demands for substantial changes in bone size and shape that are achieved through modeling, 
in which matrix synthesis and degradation take place in different locations within the bone tis-
sue and are thus said to be uncoupled [5]. Since modeling is a vigorous process that results in 
rapid longitudinal changes in bone structure and material, bone is an even more dynamic organ 
during childhood and adolescence.
Bone status can be characterized by physical properties that reflect the cumulative process 
of bone accrual up to the time of measurement, and also by turnover parameters, which are a 
dynamic measure of the short-term effects of systemic metabolism [6, 7]. A major regulator 
of turnover at the bone tissue level is the osteoprotegerin (OPG) / receptor activator of nuclear 
factor kB (RANK) / RANK-ligand (RANKL) system, which mediates the local effects of sys-
temic factors, such as hormones and cytokines [8, 9]. Throughout the life course, this system 
is essential for bone turnover since the relative expression of RANKL and its decoy receptor 
OPG regulates osteoclast differentiation, activation and survival [8, 10]. There is evidence that 
these mediators may have a particularly relevant role in early life, as they are expressed by 
hypertrophic chondrocytes in epiphyseal plates, probably regulating linear bone growth [11]. 
Despite their essential role in bone metabolism [12, 13], little is known about how circulating 
levels of these cytokines evolve before peak bone mass or on whether they directly relate to 
bone strength and turnover markers [14, 15]. On the other hand, collagen turnover markers 
are indicators of bone formation or resorption rates, although high inter- and intra-individual 
variability have led to low application in clinical practice. [16]. The International Osteoporosis 
Foundation and the International Federation of Clinical Chemistry and Laboratory Medicine 
recently recommended the use of serum procollagen type I N propeptide (PINP) and serum 
C-terminal telopeptide of type I collagen (CTX), respectively, as markers of formation and 
resorption in adults [17]. It is unclear whether this set of markers and their relative concen-
tration may also be responsive to intraindividual changes in bone metabolism during normal 
growth.
During early adolescence, a stage of rapid bone accrual, sexual maturation regulates the 
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cessation of linear growth and the improvement in bone mechanical resistance after peak 
height velocity [18]. Therefore, changes in bone properties during adolescence should be re-
garded as a function of sexual development, in addition to chronologic age. Previous studies 
describing bone status and turnover parameters in adolescence have been mostly conducted 
cross-sectionally in samples with wide age ranges, impairing the detection of heterogeneity 
across ages or sexual development stages [19-22]. Other studies were conducted among 
children with disorders that potentially disturb normal bone metabolism and therefore have 
limited generalizability [23-25]. 
In the present study, our objective was to assess if serum levels of OPG and RANKL reflect 
bone turnover and forearm bone mineral density in early and late adolescence, and to describe 
changes in those cytokines in relation to menarche timing.
Material and methods
We used data from a sample of 300 adolescent girls, recruited and followed-up as part of the 
EPITeen prospective investigation, comprising a cohort of adolescents born in 1990 and at-
tending public and private schools in Porto, Portugal.
EPITeen cohort assembly and follow-up
Recruitment of the cohort took place during the 2003/2004 school year. All 51 schools in the 
city attended by children born in 1990 were contacted and 46 agreed to provide contact de-
tails for students and their families. Study objectives and procedures were explained in detail 
in meetings with teachers and parents, as well as through written materials. Students and 
their legal guardians were contacted and asked to participate. Among the 2787 eligible ado-
lescents identified, 78% agreed to participate by providing information for at least part of the 
planned protocol, which included questionnaires, physical examination, and blood sample col-
lection. After this early adolescence evaluation, participants were contacted again during the 
2007/2008 school year for a reevaluation using the same protocol. Of the initial cohort, 80% 
completed the late adolescence assessment. In both evaluations, written informed consent 
was obtained from adolescents and legal guardians. The study protocol complied with the 
Declaration of Helsinki and was approved by the Ethics Committee of the University Hospital of 
São João in Porto, Portugal. Methods have been described in detail elsewhere [26].
Study sample
For the present study, we selected a subsample of 300 girls who completed both evaluations. 
Sample size was calculated based on the expected correlations between bone parameters, in 
order to allow for a 0.16 linear correlation coefficient with an 80% power at a 0.05 significance 
level.
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Physical examination
In both evaluations, bone mass was estimated through areal bone mineral density (BMD), 
measured in g/cm2 at the distal radius of the non-dominant forearm by dual-energy X-ray ab-
sorptiometry (DXA) using a Lunar® Peripheral Instantaneous X-ray Imager (PIXI) device. In 
case of reported previous fracture of the non-dominant arm, the dominant arm was the one 
assessed. Anthropometry was obtained while the student stood barefoot in light indoor cloth-
ing. Weight was measured to the nearest tenth of kilogram (Tanita® scales), and height was 
measured in centimeters, to the nearest tenth, using a portable stadiometer (Seca®). 
Clinical and behavioral information
Clinical and behavioral characteristics were collected in both evaluations using self-admin-
istered questionnaires. One of the questionnaires was completed at home with parental as-
sistance and included clinical history (chronic diseases and medication use in the previous 
month) and use of vitamin or mineral supplements, including calcium and vitamin D prepara-
tions. Oral contraceptive use at the time of inquiry was collected through a questionnaire filled 
in at school. Menarche age was also inquired at school and time relative to menarche age in 
each evaluation was estimated, as the absolute difference in years between menarche age re-
ported in late adolescence and the age at each assessment (e.g. for a girl whose menarche age 
was 12 years and was evaluated at 13 and 17 years of age, time relative to menarche would be 
-1 in the first and 5 in the second assessment).
Serum determinations
For each girl, two 12-hour overnight fasting blood samples were collected, at 13 and 17 years 
of age. Samples were drawn from an antecubital vein between 8.00 and 10.00 am, centrifuged 
for 15 minutes at 1500 × g, aliquoted and stored until the day of analysis. In order to reduce 
extraneous variability, samples were paired so that both sera of each participant were exam-
ined in the same plate. We quantified the soluble form of receptor activator of nuclear factor kB 
ligand (RANKL) with a highly sensitive assay (Promokine, PromoCell GmbH, Germany). This kit 
included an additional enhancement system for the amplification of the detection signal, low-
ering the detection limit to 0.02 pmol/l. RANKL levels below the limit of detection were found 
in four samples at 13 and in 73 samples at 17 years of age. In order to avoid left-censoring of 
the distribution due to exclusion of these observations, we used as imputation value for these 
individuals a concentration equal to the detection level divided by the square-root of two (0.01 
pmol/l). For quantifying osteoprotegerin (OPG) we used a kit that quantified serum concentra-
tion of all forms of this cytokine: monomer, dimer and bound to RANKL (RayBiotech, Inc., USA), 
with a detection limit of 1 pg/ml (0.014 pmol/l). As a measure of RANKL bioactivity, serum 
OPG/RANKL molar ratio was calculated after converting the serum OPG metric concentra-
tions (molecular weight 71 kDa) to pmol/l. C-terminal telopeptide of type I collagen (CTX), 
an eight-aminoacid fragment from the C-terminal telopeptide region of the α1 chain of type I 
collagen was determined using a Serum Cross Laps assay (Immunodiagnostic Systems Ltd.). 
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The detection limit was less than 0.020 ng/ml. Procollagen type I N propeptide (PINP) is the 
N-terminal extension removed from procollagen during collagen type I synthesis. This marker 
of bone formation was quantified using a Cusabio Biotech Co. kit with a detection limit under 
4.7 pg/ml. As a relative measure of resorption to formation, we calculated the ratio between 
CTX and PINP concentrations expressed as a percentage.
Data analysis
Height, weight, forearm BMD and serum levels of bone parameters were described as means 
and 95% confidence intervals (95% CI) at 13 and 17 years of age and as average variation per 
follow-up year. To assess whether the ranks of individuals in the distributions of bone param-
eters were maintained during follow-up, we calculated Spearman’s correlation coefficients 
between these variables at 13 and 17. These coefficients were also used to quantify the crude 
associations between height, weight, BMD and all of the serum parameters at each age, as well 
as between variations in these parameters from 13 to 17 years of age. Individual trajectories 
of each bone parameter were graphically represented according to time relative to menarche 
in years, and overall trajectories were depicted using lowess regressions. In order to account 
for intra-individual dependency, we quantified the associations between bone parameters and 
time relative to menarche using a random-effects linear regression model with random inter-
cepts fitted via maximum restricted likelihood, using the xtmixed command in Stata 12.0.
Results
Sample characteristics
In this sample of 300 girls, 13.8% were premenarcheal at 13 years of age and all were post-
menarcheal by 17. The presence of conditions associated with altered bone metabolism was 
reported by three adolescents (1% of the sample) and included hyperthyroidism, anorexia ner-
vosa, and renal disease. The use of medication with a potential deleterious effect on bone mass 
(inhaled corticosteroids, anticonvulsants, and thyroid hormone replacement therapy were re-
ported) was also infrequent: 2.7% of girls at 13 and 3.3% at 17 years of age. Calcium or vitamin 
D supplement use was uncommon in both evaluations (1% at 13 and 0.7% at 17 years of age). 
At 17 years of age, 76 (25.4%) girls reported using oral contraceptives.
Changes in bone parameters during adolescence
Between 13 and 17 years of age, forearm bone mineral density increased on average 0.023 g/
cm2*year (95% CI: 0.022, 0.025), height 0.92 cm/year (95% CI: 0.83, 1.01) and weight 1.40 kg/
year (95% CI: 1.21, 1.59). RANKL changed -0.12 (95% CI: -0.13, -0.10) pmol/l*year while OPG 
varied on average 0.03 pmol/ml*year (95% CI: 0.01, 0.04). Mean variation in serum CTX was 
-0.10 (95% CI: -0.12, -0.08) ng/ml*year and PINP changed -0.34 ng/ml*year (95% CI: -0.38, 
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-0.30) between 13 and 17 years of age (Table 1).
Correlations between osteoclast regulators, markers of turnover and bone mineral density
Pairwise correlation coefficients between variables presented in Table 2 were calculated 
cross-sectionally, at each age (r13 and r17) and also regarding the change observed between 
evaluations (rchange). Regarding associations between markers of bone turnover, at 13 years 
of age, the correlation between serum RANKL and CTX was positive and significant and it in-
creased by 17 years of age (r13=0.15 and r17=0.23). OPG was only weakly correlated with PINP 
in late adolescence (r17=-0.13). The OPG/RANKL ratio was inversely correlated with serum 
CTX at 17 years of age (r17=-0.24) (Table 2). 
Analyzing the association between those parameters and BMD, at 13 years of age we observed 
an inverse and significant correlation of CTX with BMD (r13=-0.52), which was vastly attenu-
ated by 17 years of age (r17=-0.12). No significant correlations were found between osteoclast 
regulators (RANKL, OPG or the OPG/RANKL ratio) and BMD at 13 or 17 years of age (Table 2). 
There were no significant longitudinal associations between osteoclast regulators or markers 
of bone turnover measured at 13 and BMD at 17 years of age.
Time relative to menarche and changes in bone parameters
With the objective of exploring the possible effect of sexual development, in addition to chrono-
logic age, on serum levels of osteoclast regulators and turnover markers, Figure 1 presents 
adolescents’ individual and average trajectories of bone and anthropometric parameters from 
13 to 17 years of age, according to time relative to menarche (i.e. the difference between the 
age at each evaluation and menarche age). Table 3 provides the corresponding linear regres-
sion coefficients for the effects of time relative to menarche, taking into account the random 
effect of the individual. Bone mineral density, height and weight increased more steeply up to 
the time of menarche but the rates decreased thereafter, as seen by the significant quadratic 
term for time relative to menarche, which shows that menarche timing added important infor-
mation on the rate of change in addition to chronologic age.  Consistently, serum CTX and the 
CTX/PINP ratio decreased at a higher rate in earlier stages of gynecologic development and 
at a lower rate in post-menarcheal years. In contrast, serum RANKL, OPG and PINP changed 
at an approximately constant rate throughout time relative to menarche (i.e. menarche timing 
did not add relevant information on the rate of change, in addition to the average trajectory 
predicted by chronologic age): we observed a linear decrease in serum RANKL with increasing 
time relative to menarche (-0.09 pmol/l per year, 95% CI:-0.10, -0.07) that remained signifi-
cant after log-transformation, while OPG increased linearly in this period (0.02 pmol/l per year, 
95% CI: 0.01, 0.04) and PINP changed -0.22 ng/ml per year (95% CI: -0.26, -0.18). RANKL 
bioactivity, measured as serum OPG/RANKL, increased at a higher rate with increasing sexual 
development, as seen through the lowess curve, but its variance also increased substantially 
in that period, which impaired fitting of a quadratic model. Log-transformed OPG/RANKL was 
linearly associated with time relative to menarche (Table 3).
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After taking into account menarche age, no further differences were found between girls who 
reported using oral contraceptives and those who did not. Additionally, the exclusion of the 13 
girls with clinical conditions that could affect bone metabolism had no significant impact on 
the results.
Discussion
In this population-based cohort of girls, serum RANKL and OPG levels varied markedly be-
tween early and late adolescence, independently of menarche timing. RANKL and OPG/RANKL 
were not correlated with turnover markers at 13 years of age, but became associated with 
bone resorption (CTX) in late adolescence.
Despite the major role of the RANK/RANKL/OPG system in the local regulation of bone turn-
over, there is a lack of prospective evidence on how serum levels of RANKL and OPG evolve 
throughout the life course. The absence of data on the relation between circulating levels of 
these cytokines and bone turnover is also recognized, and more so in females [14]. This scarci-
ty may partly be explained by the yet uncertain significance of serum levels of these cytokines, 
mainly since they have important roles in other physiological and pathological functions, such 
as lactation, adaptive immunity, tumour proliferation, and regulation of body temperature [13]. 
Because of their unclear specificity towards bone metabolism, we cannot discard the hypoth-
esis that the levels of OPG and/or RANKL in our study also reflected concomitant processes 
other than local communication within bone tissue.
Overall, we observed a decrease in serum RANKL between early and late adolescence, ac-
companied by an increase in serum OPG and a decrease in turnover markers of bone formation 
(PINP) and resorption (CTX). These changes occurred concomitantly with linear growth and 
with bone mineral accrual at the forearm, and are consistent with bone remodelling taking 
over, in relation to modeling, as the predominant process governing bone turnover in late ado-
lescence [5]. Our results also suggest heterogeneity in the rate of change in serum OPG to 
RANKL ratio according to time relative to menarche, even though the variance of this ratio 
increased with time and the rate of change in each of those cytokines individually remained 
constant throughout time.
In our study, serum RANKL levels decreased with increasing age, as previously described in 
adults [15, 27, 28]. This finding, along with the direct correlation of RANKL with CTX in late 
adolescence, brings prospective evidence that serum RANKL is inversely related with skeletal 
maturity. Our study extends previous knowledge by showing that a substantial decrease in 
this cytokine is observable between 13 and 17 years of age in healthy girls. It also adds that 
the rate of change in serum RANKL throughout adolescence was independent of the timing 
of menarche, but that RANKL bioactivity, measured through the OPG/RANKL ratio, may be 
related to gynecologic maturation. Accordingly, we observed a slight but significant increase in 
The dynamics of adolescent bone: a cohort study in girls88
serum OPG throughout adolescence, even though previous studies do not clearly support this 
finding. One of the few studies conducted in children showed decreasing OPG levels up to 4 
years of age, but constant levels from this age onwards up to adulthood  [23]. Another cross-
sectional study in adolescents found a gradual decrease in serum OPG with age but suggested 
that OPG levels in the postpubertal period were similar to those in young adults [29]. However, 
cross-sectional studies are clearly less robust for the estimation of average trajectories than 
our prospective design, since they underestimate underlying longitudinal changes [30]. Our 
finding of a weak association between serum levels of OPG and RANKL may be explained by a 
physiological dissociation between the relative expression of these cytokines during growth, 
previously reported in epiphyseal plates [11].
Most likely as a consequence of decreasing linear growth and bone modeling rates, average 
CTX and CTX/PINP levels in our sample decreased from early to late adolescence, in the over-
all sample, and a plateau was found in girls of older gynecologic age. This decreasing intensity 
of bone resorption towards the end of adolescence, because of diminishing rate or extension 
of matrix degradation, is consistent with the attainment of skeletal maturity, and has been 
described previously using cross-sectional evidence [22, 31, 32]. It is also compatible with our 
observation of an inverse correlation between BMD and CTX. We observed a small decrease in 
average PINP levels throughout adolescence, with no relation to menarche timing. This is in 
agreement with a previous study, in which a PINP peak in girls was found from 10 to 13 years 
of age (coinciding with peak height velocity) and then decreased at a lower rate up to early 
adulthood [33]. 
In addition to the expected average increase in height and forearm BMD between 13 and 17 
years of age in the whole sample, we observed a lower yearly rate of change in height as 
well as in bone density in girls with more advanced gynecologic development. Early maturing 
adolescents have younger average age at peak height and bone accrual velocities and, in the 
present sample, the fastest changes in bone size and mineralization probably occurred before 
13 years of age [34, 35]. Additionally, it is well-known that linear growth peaks earlier than 
bone accrual velocity [36, 37], which likely explains our stronger association of gynecologic 
age with BMD than with height. Overall, we observed weak correlations between forearm BMD 
and serum parameters, namely osteoclast-regulating cytokines and PINP, in early and late 
adolescence. This dissociation is compatible with BMD being the result of accumulated expo-
sures throughout life, while serum parameters are comparatively obtained as instantaneous 
measurements.
As dynamic measures, serum parameters of bone turnover may be subject to substantial vari-
ation, independently of meaningful differences between individuals or measurements [9]. We 
minimized preanalytical variability by collecting samples between 8 and 10 am and after a 12-
hour overnight fast, using the same protocol in both evaluations and standardizing specimen 
collection, processing and storage. Additionally, these sources of variability are more relevant 
at the individual level, when comparisons with reference values or prognosis monitoring are 
the aim. This study aimed at describing relative changes in bone parameters from early to late 
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adolescence and to assess the correlations between them rather than establishing normative 
values. Since we have no reason to believe that the ranks of individuals in the distributions 
were differentially affected, we do not think that intra-assay variability has substantially bi-
ased our conclusions. Another important aspect is that we assumed that variations in serum 
parameters could be validly described using linear trajectories. Although other trajectories are 
possible, previous studies have described nearly linear age-related decreases in bone turnover 
markers in the 13-17 years range [22, 31, 33]. Finally, due to the evaluation setting, we used 
peripheral dual-energy X-ray absorptiometry to estimate bone density. The main implication 
is that intraindividual differences in forearm areal BMD are partly due to linear growth rather 
than to changes in intrinsic bone strength. However, this is not a disadvantage since bone size 
is also an important determinant of overall resistance to fracture [38].
A major advantage of our study with relation to previously published research is that we used 
prospective data collected from girls born in the same year, thereby avoiding several sources 
of confounding. Additionally, our sample was population-based, which optimized the generaliz-
ability of our findings. External validity regarding the general population is confirmed by the 
low reported frequency of conditions or medications that interfere with normal bone accrual 
in the present sample. Another important strength of the study is that we were able to provide 
a multidimensional description of bone dynamics throughout adolescence by comprising pa-
rameters that represent different features of bone status and metabolism. This is particularly 
interesting regarding OPG and RANKL, since populational data were scarce.
In this cohort of healthy girls, serum RANKL decreased while OPG increased between early 
and late adolescence. Those cytokines were not correlated with bone mineral density or turn-
over markers at 13 years of age, but serum RANKL bioactivity reflected bone resorption in late 
adolescence.
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Table 1. Mean (95% confidence interval) values of bone mineral density, anthropometric variables, osteoclast 
regulators and turnover markers at 13 and 17 years old and annual rate of change, and correlations between values 
in early and late adolescence
13 years old 17 years old Annual variation
Spearman’s correlation 
(13 v. 17)
Forearm bone mineral 
density (g/cm2)
0.366 
(0.359, 0.372)
0.441 
(0.435, 0.446)
0.023
(0.022, 0.025)
0.67
(p<0.001)
Height (cm)
158.5 
(157.8, 159.2)
161.4 
(160.8, 162.1)
0.92
(0.83, 1.01)
0.91
(p<0.001)
Weight (kg)
54.9 
(53.7, 56.2)
59.4 
(58.2, 60.6)
1.40
(1.21, 1.59)
0.82
(p<0.001)
RANKL (pmol/l)
0.58 
(0.52, 0.63)
0.20 
(0.17, 0.24)
-0.12
(-0.13, -0.10)
0.54
(p<0.001)
OPG (pmol/l)
0.56 
(0.49, 0.63)
0.65 
(0.59, 0.70)
0.03
(0.01, 0.04)
0.41
(p<0.001)
OPG/RANKL
3.58 
(1.77, 5.40)
26.5 
(18.48, 34.49)
7.30
(4.61, 10.00)
0.47
(p<0.001)
CTX (ng/ml)
1.48 
(1.41, 1.55)
1.15 
(1.09, 1.20)
-0.10
(-0.12, -0.08)
0.48
(p<0.001)
PINP (ng/ml)
69.2 
(68.0, 69.3)
68.1 
(68.0, 68.2)
-0.34
(-0.38, -0.30)
0.30
(p<0.001)
CTX/PINP (%)
2.1 
(2.0, 2.2)
1.7 
(1.6, 1.8)
-0.14
(-0.17, -0.11)
0.49
(p<0.001)
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Table 2. Spearman’s rank correlation coefficients for the associations between height, bone density and serum 
parameters at 13 (r13) and 17 (r17) years of age and between annual rates of change (rchange).
Height 
(cm)
Weight 
(kg)
BMD
(g/cm2)
RANKL 
(pmol/l)
OPG 
(pmol/l)
OPG/RANKL
CTX 
(ng/ml)
PINP 
(ng/ml)
Height 
(cm)
1
r13=0.45
‡
r17=0.38
‡
rchange=0.40
‡
r13=0.18
†
r17=-0.06
rchange=0.44
‡
r13=0.01
r17=0.09
rchange=-0.01
r13=-0.02
r17=0.02
rchange=-0.07
r13=-0.04
r17=-0.11
rchange=-0.18
†
r13=-0.14*
r17=0.03
rchange=-0.38
‡
r13=0.06
r17=0.00
rchange=-0.01
Weight 
(kg)
1
r13=0.56
‡
r17=0.35
‡
rchange=0.44
‡
r13=-0.14*
r17=-0.07
rchange=-0.08
r13=-0.07
r17=0.07
rchange=-0.07
r13=0.06
r17=0.09
rchange=-0.08
r13=-0.37
‡
r17=-0.19
†
rchange=-0.25
‡
r13=-0.04
r17=-0.11*
rchange=-0.14*
BMD 
(g/cm2)
1
r13=-0.03
r17=-0.09
rchange=-0.01
r13=-0.03
r17=-0.01
rchange=-0.11
r13=0.01
r17=0.08
rchange=-0.06
r13=-0.52
‡
r17=-0.12*
rchange=-0.26
‡
r13=-0.01
r17=-0.02
rchange=-0.07
RANKL 
(pmol/l)
1
r13=0.05
r17=0.08
rchange=0.03
r13=-0.72
‡
r17=-0.92
‡
rchange=-0.08
r13=0.15*
r17=0.23
‡
rchange=0.03
r13=-0.03
r17=0.05
rchange=0.03
OPG 
(pmol/l)
1
r13=0.60
‡
r17=0.28
‡
rchange=0.23
‡
r13=0.05
r17=-0.02
rchange=0.01
r13=-0.11
r17=-0.13*
rchange=0.01
OPG/
RANKL
1
r13=-0.07
r17=-0.24
‡
rchange=-0.03
r13=-0.08
r17=-0.09
rchange=-0.11*
CTX 
(ng/ml)
1
r13=-0.05
r17=-0.01
rchange=-0.01
PINP 
(ng/ml)
1
* p<0.05; † p<0.01; ‡p<0.001
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Table 3. Fixed and random effects linear regression parameters for the associations between anthropometric and bone 
parameters and time relative to menarche
Fixed effects Random effects
Intercept Time (years) Squared time  
(years2)
Individual-level
standard-deviation
BMD (mg/cm2)
Model 0 402‡ --- --- 25.2
Model 1 348‡ 21.8‡ --- 39.2
Model 2 343‡ 31.4‡ -1.8‡ 40.8
Height (cm)
Model 0 160.0‡ --- --- 5.4
Model 1 157.7‡ 0.86‡ --- 5.6
Model 2 157.4‡ 1.62‡ -0.14‡ 5.6
Weight (kg)
Model 0 57.2‡ --- --- 9.8
Model 1 53.7‡ 1.35‡ --- 9.8
Model 2 53.3‡ 2.44‡ -0.21‡ 9.8
RANKL (pmol/l)
Model 0 0.39‡ --- --- 0.17
Model 1 0.62‡ -0.09‡ --- 0.26
OPG (pmol/l)
Model 0 0.60‡ --- --- 0.45
Model 1 0.54‡ 0.02‡ --- 0.45
log (OPG/RANKL)
Model 0 0.97‡ --- --- 0.32
Model 1 -0.25 0.48‡ --- 1.07
CTX (ng/ml)
Model 0 1.31‡ --- --- 0.34
Model 1 1.60‡ -0.11‡ --- 0.33
Model 2 1.63‡ -0.19‡ 0.01‡ 0.33
PINP (ng/ml)
Model 0 68.7‡ --- --- 0.40
Model 1 69.2‡ -0.22‡ --- 0.59
CTX/PINP (%)
Model 0 1.91‡ --- --- 0.51
Model 1 2.31‡ -0.16‡ --- 0.49
Model 2 2.35‡ -0.26‡ 0.02‡ 0.49
* p<0.05; † p<0.01; ‡p<0.001
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4.5. Adipokines and bone turnover throughout adolescence: 
an exploratory approach in a cohort of girls

Results 99
Abstract
Objectives: To identify population patterns linking adipokines and bone turnover in girls during 
early and late adolescence; to assess the associations of those patterns with forearm bone 
mineral density.
Methods: We used data from 300 girls evaluated at 13 and 17 years of age as part of the 
EPITeen cohort study conducted in Porto, Portugal. Anthropometric assessment included 
height, weight and body fat percentage. Bone mineral density (BMD) was measured at the 
distal forearm using dual-energy X-ray absorptiometry. Pubertal development status was es-
timated through menarche age. We quantified serum leptin, adiponectin, RANK ligand, osteo-
protegerin, C-terminal telopeptide of type I collagen (CTX), procollagen type I N propeptide 
(PINP). Exploratory factor analysis was used to identify patterns of associations between 
serum parameters at each age and to assess their maintenance between 13 and 17 years of 
age. Associations between factors at each age and BMD were estimated using linear regres-
sion coefficients (95% confidence intervals), crude and adjusted for height, weight and men-
arche age.
Results: We found that the same two factors at 13 and 17 years of age, named “Fat-bone in-
teraction” and “Local bone turnover”, accounted for more than 40% of the variability observed 
in the selected set of variables. “Fat-bone interaction” factors were positively associated with 
leptin and negatively with CTX and RANKL at 13 and at 17 years of age. There were crude posi-
tive associations between these factors and BMD, (β=25.1 (18.8, 31.4) at 13 and β=9.6 (3.8, 
15.3) at 17 years) that lost significance after adjustment. “Local bone turnover” was directly 
correlated with PINP and inversely with OPG but not associated with BMD. 
Conclusion: We identified an important pattern linking fat and bone in adolescent girls, involv-
ing systemic mediation by leptin and local mediation by RANKL, reflecting an effect on bone 
resorption. These results support the hypothesis that hormones and cytokines involved in the 
fat-bone axis may interfere mainly with bone turnover rather than with bone mineral density.
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Introduction
During the past few years, basic research has disclosed a growing number of biological in-
teractions between bone and fat [1-3]. The finding that adipocytes and osteoblasts share a 
mesenchymal cell precursor gave support to the recognition that homeostatic processes oc-
curring in adipose and bone tissues are closely linked [4]. It is now accepted that leptin, a cy-
tokine produced primarily by adipocytes, has a dual role on bone metabolism: on the one hand 
it stimulates resorption through a centrally-mediated adrenergic pathway but, on the other 
hand, it promotes formation through its action on local osteoblastic receptors [4]. Adiponectin, 
a cytokine exclusively produced by the adipose tissue, has been proposed as another important 
influence on bone turnover, by promoting osteoclastogenesis through the regulation of recep-
tor activator of nuclear factor kB ligand (RANKL) synthesis by osteoblasts [5]. More recently, 
it was shown that, beyond being a target tissue for many systemic influences, bone also acts 
as an endocrine organ with an important influence on glucose metabolism [6]. Explicitly, the 
discovery that osteocalcin secreted by osteoblasts increases the expression of adiponectin 
and insulin, thereby improving insulin sensitivity, uncovered a “bone-fat-pancreas” axis in the 
regulation of energy metabolism [3].
Since adolescence is viewed as a sensitive period for bone mineral accrual with lasting effects 
throughout the life course [7, 8], there has been an effort to assess whether the mechanisms 
identified by basic research may account for population-level associations between fat and 
bone quality throughout the life course [9]. Previous research has mainly focused on measur-
ing the associations of fat-derived hormones and cytokines with bone physical properties, an 
option with an ultimate public health ambition regarding fracture prevention [10-16]. However, 
particularly before peak bone mass, low cumulative exposure periods and compensatory 
“mechanostat”-type mechanisms may preclude the reflection of systemic changes in observed 
bone physical properties [17]. Therefore, if circulating levels of mediators of the communica-
tion between fat and bone have an important effect on turnover, such an influence should be 
primarily observable through local regulating systems such as osteoprotegerin/RANK ligand/
RANK, and also on levels of collagenous turnover markers.
Bone physiology is by nature a complex system and diverse biological pathways interact to 
have different end-results on bone phenotypes which are hardly predictable by quantifying 
single exposure-outcome associations. Population-based data allow for moving towards a 
multilayered approach by estimating the simultaneous statistical relations between media-
tors of the fat-bone relation previously identified through laboratory models [18]. A statistical 
exploratory approach can be helpful in clarifying the relative importance of different potential 
mechanisms in the population. It has also been suggested that the overall effect of fat on bone 
may vary throughout the life course, which is a proposition with very important public health 
implications [19]. Consequently, it is relevant to use longitudinal designs to assess if patterns 
of statistical associations between fat and bone metabolism products change throughout 
growth.
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By prospectively evaluating a cohort of girls, our objective was to identify population patterns link-
ing adipokines and bone turnover in early and late adolescence. We additionally aimed at assessing 
whether these physiological patterns could have an effect on forearm bone mineral density.
Methods
Our sample was composed of 300 girls born in 1990 and evaluated twice (at 13 and 17 years 
of age), as part of the EPITeen cohort study. This cohort was identified and recruited during 
the 2003/2004 school year by contacting all schools in the city of Porto, Portugal, that were 
attended by children born in 1990. Out of 51 schools, 46 agreed to provide contact details for 
eligible students. Among the 2787 eligible adolescents identified in participating schools, 78% 
agreed to participate by providing information for at least one part of the planned protocol for 
this 13-years-old evaluation. Participants were contacted again during the 2007/2008 school 
year for the 17-years-old evaluation using the same protocol (attrition from baseline was 
20%). In both evaluations, written informed consent was obtained from adolescents and legal 
guardians. The study protocol complied with the Declaration of Helsinki and was approved by 
the Ethics Committee of the University Hospital of São João in Porto, Portugal. Methods have 
been described in detail elsewhere [20].
Physical examination
In both evaluations, bone mineral density (BMD) was measured in g/cm2 at the distal radi-
us of the non-dominant forearm by dual-energy X-ray absorptiometry (DXA) using a Lunar® 
Peripheral Instantaneous X-ray Imager (PIXI) device. In case of reported previous fracture 
of the non-dominant arm, the dominant arm was the one assessed. Anthropometry was ob-
tained while the student stood barefoot in light indoor clothing. Weight was measured to the 
nearest tenth of kilogram (Tanita® scales), and height was measured in centimeters, to the 
nearest tenth, using a portable stadiometer (Seca®). Body fat was estimated as a proportion 
of total body mass, using bioelectrical impedance (Tanita® TBF-300). Pubertal development 
status was estimated using self-reported menarche age.
Serum determinations
For each girl, two 12-hour overnight fasting blood samples were collected, at 13 and 17 years 
of age. Samples were drawn from an antecubital vein between 8.00 and 10.00 am and cen-
trifuged for 15 minutes at 1500 × g, aliquoted and stored until the day of analysis. Serum 
leptin was measured with a commercially available enzyme-linked immunosorbent assay after 
50- or 75-fold dilutions with a sensitivity under 2 pg/ml (RayBiotech, Inc., USA). Serum adipo-
nectin levels were measured in 30,000-fold diluted samples by means of a kit that detected 
total adiponectin (trimer, hexamer and/or its high molecular weight form of 12 to 18 sub-
units) (RayBiotech, Inc., USA) with a sensitivity less than 25 pg/ml. We quantified the soluble 
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form of receptor activator of nuclear factor kB ligand (RANKL) with a highly sensitive assay 
(Promokine, PromoCell GmbH, Germany). This kit included an additional enhancement system 
for the amplification of the detection signal, lowering the detection limit to 0.02 pmol/l. We 
used a kit that quantified serum concentration of all osteoprotegerin (OPG) forms: monomer, 
dimer and bound to RANKL (RayBiotech, Inc., USA), with a detection limit of 1 pg/ml (0.014 
pmol/l). C-terminal telopeptide of type I collagen (CTX), an eight-aminoacid fragment from the 
C-terminal telopeptide region of the α1 chain of type I collagen, was determined using a Serum 
Cross Laps assay (Immunodiagnostic Systems Ltd.) with a detection limit less than 0.020 ng/
ml. Procollagen type I N propeptide (PINP) is the N-terminal extension removed from procol-
lagen during collagen type I synthesis. This marker of bone formation was quantified using a 
Cusabio Biotech Co. kit with a detection limit under 4.7 pg/ml.
Data analysis
Exploratory factor analysis (EFA) is a statistical technique that allows for the assessment of 
the dimensionality of data [21]. Using the data collected at each age separately, we applied fac-
tor analysis with varimax rotation to identify uncorrelated factors within the following seven 
log-transformed serum parameters: leptin, adiponectin, OPG, RANKL, PINP and CTX. The final 
number of factors retained was defined using eigenvalues above 1 and by visual inspection 
of screeplots. After choosing the final number of factors to retain, the stability of the factors 
from early to late adolescence was tested using exploratory factor analysis at two time points 
with factor loading invariance and correlated residuals across time, using software Mplus. The 
resulting model fit was assessed using a Chi-square test of model fit, the comparative fit index 
and root mean square error of approximation [22]. Pearson’s correlation coefficients between 
anthropometric parameters and EFA factors identified at each age were quantified. The as-
sociations between EFA factors and forearm bone mineral density (in mg/cm2) were estimated 
using linear regression coefficients and respective 95% confidence intervals (95% CI), crude 
and adjusted for height, weight and menarche age.
Results
In this sample of 300 girls, 84% were postmenarcheal at the 13 years old evaluation and all 
were postmenarcheal at the 17 years old evaluation. Mean (standard-deviation) bone mineral 
density at the forearm increased from 0.366 (0.059) to 0.441 (0.050) g/cm2 in that period, and 
height increased from 158.5 (6.1) to 161.4 (5.7) cm. While weight increased from 54.7 (10.6) 
to 59.1 (10.0) kg, body fat decreased from 27.6 (7.8) to 26.0 (7.0)% (Table 1).
Factor identification
Using serum concentrations of adipokines (leptin and adiponectin), osteoclast regulating cy-
tokines (RANKL and OPG), and bone turnover markers (CTX and PINP), at 13 years of age, 
Results 103
we identified two factors with eigenvalue above 1 that accounted for 44% of the variability 
observed in the data. At 17 years of age, the same number of factors was identified and ac-
counted for a similar proportion of the variability (43%). These results indicated that the EFA 
model to test the maintenance of the factors from early to late adolescence should include two 
factors at each age, named f1 and f3 (representing fat-bone interaction at 13 and 17 years of 
age, respectively), and f2 and f4 (representing local bone turnover at 13 and 17 years of age, 
respectively). Figure 1 shows a path diagram describing the EFA model tested and the result-
ing correlations between EFA factors and serum bone parameters. Overall, the model had fit, 
as assessed by Chi-square test (p=0.608), comparative fit index (1.000), and root mean square 
error of approximation (0.000).
Fat-bone interaction
At 13 and 17 years of age, factors f1 and f3 were characterized by a positive association with 
leptin (r13=0.38 and r17=0.40), and negative associations with CTX (r13=-0.55 and r17=-0.62) and 
RANKL (r13=-0.39 and r17=-0.29), and were therefore named “Fat-bone interaction”. The as-
sociation between scores in factors f1 and f3 was strong (r=0.80), but the variance of factor f3 
scores was 17% higher than that of factor f1 scores. Girls with higher scores in these “Fat-bone 
interaction” factors at 13 and at 17 years of age had earlier menarche, higher body weight and 
higher body fat percentage (Table 2). At 13 and at 17 years of age, there was a crude positive 
association between the “Fat-bone interaction” factors and forearm bone mineral density at 
the same age. Those associations lost significance after adjustment for menarche age, weight 
and height (Table 3).
Local bone turnover
Factors f2 and f4 at 13 and 17 years of age, respectively, was defined by a direct association 
with PINP (r13=0.60 and r17=0.38) and an inverse association with OPG (r13=-0.31 and r17=-
0.30). There was a strong association between scores in factors f2 and f4 (r=0.90), but the 
variance of factor f4 scores was under half (42%) of that of factor f2 scores. These factors 
were named “Local bone turnover” and were not significantly associated with menarche age, 
height, weight or body fat percentage at 13 or 17 years of age (Table 2). There were also no 
significant associations between factors f2 or f4 and bone mineral density at 13 or 17 years of 
age (Table 3).
The dynamics of adolescent bone: a cohort study in girls104
Discussion
By using an exploratory approach to population data in adolescent girls, we have identified 
an association of serum leptin with RANKL and CTX that remained consistent between early 
and late adolescence. This may represent the major pathway in the mediation of the fat-bone 
relationship in this life stage. Serum OPG and PINP were correlated together, but not with 
adipokines.
We identified one factor defined by a direct relation with leptin and an inverse relation with 
RANKL and CTX (a posteriori named “fat-bone interaction”). It has been documented that 
leptin modulates the OPG/RANKL ratio by inhibiting the expression of RANKL while having no 
effect on OPG expression in osteoblasts [23]. This is compatible with our findings of a statisti-
cal aggregation of leptin with RANKL and not OPG. An inverse association between leptin and 
RANKL had been previously observed, but restricted to children with prior fracture [24]. Our 
results add to previous knowledge by suggesting that increased leptin levels and decreased 
RANKL translate a relation between increased adiposity and decreased osteoclastogenesis re-
sulting in decreased bone resorption, as measured through their association with serum CTX, a 
marker of matrix degradation. The present study also improves previous knowledge by show-
ing the persistence of this association from early to late adolescence.
Regarding bone physical properties, we found a strong crude association between this “fat-
bone interaction” factor and forearm bone mineral density in early and late adolescence. There 
is evidence that the predominance of central (hypothalamic) or peripheral (osteoblastic) ac-
tions of leptin varies with the regions of the skeleton considered [4]. While at the axial skel-
eton an antiosteogenic action is expected, at the appendicular skeleton, as is the case in our 
study, anabolic effects should be expected - and indeed were suggested in our study. However, 
after adjustment for menarche age and body size, the magnitude of the associations decreased 
substantially, suggesting that those variables accounted for a considerable part of the crude 
association observed. This is consistent with the findings from previous studies, where no sig-
nificant associations of serum leptin and bone physical properties were found after fat mass 
adjustment in children [12] as well as in postmenopausal women [9, 25].
In the present study, serum adiponectin was not associated with osteoclast regulators or 
with markers of bone turnover. Adiponectin has well-known insulin-sensitizing effects [26, 
27], and this relation has recently gained importance in the context of bone health, since the 
discovery of a bone-pancreas endocrine loop that places bone as an organ actively involved in 
the systemic regulation of energy metabolism [28]. Osteoblasts secrete osteocalcin, which 
enters the systemic circulation in its undercarboxylated form and functions as a hormone that 
stimulates the secretion of insulin by the pancreas, as well as the expression of adiponectin 
by the adipose tissue, and increases insulin sensitivity at target organs, including bone [3]. 
Adiponectin is known to modulate bone mass directly, by stimulating osteoblast growth and 
inhibiting osteoclastogenesis, and indirectly, through modulating insulin sensitivity [28]. An 
in vivo study suggested that, even though the sum of these two factors had a negative effect 
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on bone, adiponectin-deficient mice had only slightly altered bone morphology [5]. This is in 
agreement with the absence of associations between adiponectin and bone turnover in our 
study, as well as with a previous study of children aged 5 to 16 years, which did not find associ-
ations between adiponectin and OPG, RANKL or bone turnover markers [24]. In a large cohort 
of children, a negative association between adiponectin and bone parameters was observed, 
but with lower magnitude in girls and in children with more advanced pubertal development, 
which also agrees with our results [11].
In a systematic review of studies assessing the relation between adipokines (leptin, adiponec-
tin, resistin, and visfatin) and ghrelin on bone mineral density and fracture risk in adults, adi-
ponectin was the adipokine most strongly and negatively associated with bone mineral density 
in both genders and independently of fat mass [29]. In the same study, leptin was positively 
associated with bone mineral density, particularly in postmenopausal women. However, as in 
the present investigation, important confounding by fat mass was found. A more recent longi-
tudinal study corroborated those results, by suggesting that adiponectin, but not leptin, was 
associated with BMD loss in older women [9]. Our finding that the leptin pathway had larger 
influence on bone turnover when compared to adiponectin is in contrast with the results of that 
review but is not contradictory with the previously-stated hypothesis of a possible heterogene-
ity of fat-bone relations in different life stages [19].
We identified “Local bone turnover” factors, characterized by inverse associations between 
OPG and bone formation (PINP) in early and late adolescence. Even though this factor was not 
clearly related to anthropometry or other bone turnover parameters in our study, increased 
OPG has also been found associated with decreased bone formation in middle-aged men [30]. 
Nevertheless, our observation that the variance of scores in this factor decreased substantially 
from 13 to 17 years of age suggests that importance of this factor within the population may 
decrease with increasing skeletal maturity.
The crude associations of the “Fat-bone interaction” factors with forearm bone mineral den-
sity at 13 and at 17 years of age were largely attenuated after adjustment for menarche age, 
height and weight. Additionally, there were no associations between scores in the “Local bone 
turnover” factors and bone density. This may be explained within the framework of the mecha-
nostat theory, by which bone physical properties would be changed mainly in response to a 
defined homeostatic set point determined by mechanical requirements [19]. According to this 
theory, bone homeostasis is regulated in order to ensure that its resistance to external stress 
is kept constant, even in the presence of altered levels of hormones or adipokines. Systemic in-
fluences would therefore be able to alter bone metabolism (a physiological dimension) without 
interfering with final bone mechanical properties (a physical dimension). Our findings reinforce 
that, when studying the etiology of fragility fractures, it is essential to distinguish systemic 
influences according to whether or not they may be expected to have relevant effects on me-
chanical properties. Indeed, in our study, although there were clear associations between sys-
temic factors and bone turnover, these were not reflected on areal bone mineral density.
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As a way of dealing with the great complexity of bone physiology, previous epidemiologic re-
search has focused on the potential effect of one single hormone or cytokine on bone proper-
ties. Whereas such a reductionist approach may be particularly valuable in basic research, 
observational epidemiologic studies can rarely, if ever, attain that level of simplicity success-
fully. Since bone physiology can be seen as a complex system that is not fully explained by the 
understanding of its component parts [31], it is essential to approach it more inclusively and to 
avoid excessive decomposing [18]. In the present work, we used exploratory factor analysis 
to describe and quantify the strongest statistical relations between variables in a dataset. It 
should be noted that this technique does not provide a causal interpretation to the observed 
statistical associations and, conversely, the absence of statistical correlations does not ex-
clude causal relations between the parameters examined at the physiological level, particular-
ly considering the great internal validity of previous experimental evidence. It does, however, 
suggest that there are a number of coexisting mechanisms that preclude the observation of 
each single pathway at the population level. While this may seem straightforward, it has rel-
evant implications for translational research, as previously observed with the unexpected lack 
of success of leptin as a mainstream therapy for obesity [32].
Due to its enormous complexity, we did not expect that the present study could clarify all 
the relevant pathways of the fat-bone relation. Our results are of course conditioned by the 
mediators that we chose to quantify. However, there is substantial evidence of the importance 
of these pathways at the physiological level. Our study was also limited by the fact that we 
used a single measure of bone mineral density derived by dual-energy X-ray absorptiometry 
which did not distinguish between bone compartments. This becomes relevant when consider-
ing that trabecular bone is more metabolically active than cortical bone and therefore should 
be more susceptible to circulating levels of hormones and cytokines [4]. Additionally, periph-
eral measures of bone properties are neither universally standardized nor completely accurate 
surrogates of whole-body measures [33]. However, our option to measure the forearm was 
essential for ensuring safety and portability necessary to attain high participation proportion 
and low participation bias in the original cohort.
Our approach has the advantage of using an exploratory technique to assess patterns in the ag-
gregation of components of the fat-bone relation in a prospectively followed population-based 
sample. We were able to quantify those associations in adolescence, which may contribute to 
understand their influences on peak bone mass attainment. Moreover, we observed great con-
sistency in the factors identified in early and late adolescence, as well as in their associations 
with bone mineral density. This prospective observation argues for the validity of our results, 
since it suggests low probability that findings could be attributable to intraindividual variability 
in serum parameters.
At the population level, we identified an important pattern linking fat and bone in adolescent 
girls, probably involving systemic mediation by leptin and local mediation by RANKL, and re-
flected on bone resorption. Our study also brings evidence that hormones and cytokines in-
volved in fat-bone communication may interfere mainly with bone turnover rather than with 
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bone mineral density. Such an effect on bone metabolism could have the purpose of regulating 
observed physical properties during growth.
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Table 1. Mean (standard-deviation) sample characteristics at 13 and at 17 years of age
13 years old 17 years old
Number (%) postmenarcheal 252 (84.0) 300 (100.0)
Bone mineral density (g/cm2) 0.366 (0.059) 0.441 (0.050)
Height (cm) 158.5 (6.1) 161.4 (5.7)
Weight (kg) 54.7 (10.6) 59.1 (10.0)
Body fat (%) 27.6 (7.8) 26.0 (7.0)
Leptin (pg/ml) 20.4 (19.3) 23.0 (19.8)
Adiponectin (pg/ml) 55.2 (32.0) 47.9 (27.8)
CTX (ng/ml) 1.48 (0.64) 1.15 (0.48)
PINP (ng/ml) 45.1 (34.1) 43.5 (32.7)
RANKL (pmol/l) 0.58 (0.48) 0.21 (0.28)
OPG (pmol/l) 0.56 (0.60) 0.64 (0.48)
Table 2. Pearson’s correlation coefficients between scores in the factors identified and menarche age and 
anthropometric variables at each age
Fat-bone interaction Local bone turnover
Factor f1
(13 years old)
Factor f3
(17 years old)
Factor f2
(13 years old)
Factor f4
(17 years old)
Menarche age (years) -0.39 
(p<0.001)
-0.24
(p<0.001)
0.00
(p=0.962)
0.02
(p=0.740)
Height (cm) 0.10
(p=0.070)
-0.05
(p=0.366)
0.06
(p=0.330)
0.01
(p=0.800)
Weight (kg) 0.52
(p<0.001)
0.40
(p<0.001)
-0.10
(p=0.092)
-0.04
(p=0.542)
Body fat (%) 0.56
(p<0.001)
0.43
(p<0.001)
-0.11
(p=0.063)
-0.03
(p=0.596)
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Table 3. Linear regression coefficients (95% confidence intervals) for the associations between scores in each factor 
and bone mineral density (in mg/cm2) at 13 and 17 years of age.
BMD 13 Annual BMD change BMD 17
Crude Adjusted* Crude Adjusted* Crude Adjusted*
Fat-bone interaction†
Factor f1: 13 years old 
Factor f3: 17 years old
25.1 
(18.8, 31.4)
---
5.3 
(-1.5, 12.1)
---
-3.5 
(-5.0, -2.0)
---
-1.0 
(-2.8, 0.8)
---
13.5 
(7.8, 19.1)
9.6
(3.8, 15.3)
3.8 
(-2.5, 10.1)
0.3 
(-5.9, 6.5)
Local bone turnover‡
Factor f2: 13 years old 
Factor f4: 17 years old
-2.9 
(-9.8, 3.9)
---
-0.3 
(-5.8, 5.2)
---
0.2 
(-1.4, 1.8)
---
-0.1 
(-1.6, 1.4)
---
-3.0 
(-8.9, 2.9)
-0.4
(-6.3, 5.4)
-1.7
(-7.2, 3.7)
0.6 
(-4.8, 6.0)
* adjusted for menarche age, weight and height
† Leptin+, CTX-, RANKL-
‡ PINP+, OPG-
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Figure 1. Path diagram of the relations between factors and parameters used for exploratory factor analysis at two 
time points with factor loading invariance and correlated residuals across time (predicted correlations are presented)
LEP ADIP RANKL OPG CTX PINP LEP ADIP RANKL OPG CTX PINP
13 years old 17 years old
0.38
0.04
-0.55 -0.02
-0.39
-0.01
-0.25
0.08
0.01 0.60
-0.02
-0.31
0.40
0.04
-0.62 -0.02
-0.29
-0.02
-0.16
0.05
0.01 0.38
-0.01
-0.30
0.17
0.80
0.19
0.07
0.90
0.13
0.43 0.55 0.46 0.45 0.38 0.08
LEP - leptin
ADIP - adiponectin
RANKL – receptor activator of nuclear factor kB ligand
OPG – osteoprotegerin
CTX – C-terminal telopeptide of type I collagen
PINP – procollagen type I N propeptide
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4.6. Early initiation of smoking and alcohol drinking as a 
predictor of lower forearm bone mineral density in late 
adolescence: a cohort study in girls
Raquel Lucas, Sílvia Fraga, Elisabete Ramos, Henrique Barros
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Abstract
Background: Adolescence is a critical stage for bone accrual. It is also decisive for the estab-
lishment of behaviors such as smoking and alcohol drinking.
Objective: To quantify the short- and long-term associations between smoking and drinking 
initiation and bone mineral density in adolescent girls.
Methods: We used prospective data from 731 girls identified in public and private schools 
in Porto, Portugal. Evaluations were conducted when participants were 13 and 17 years old. 
Bone mineral density (BMD) was measured at the forearm by dual-energy X-ray absorptiom-
etry and weight, height and fat-free mass were measured. Pubertal development status was 
estimated using menarche age. Self-administered questionnaires were used to collect data 
on smoking and alcohol drinking, physical exercise and calcium and vitamin D intakes. BMD in 
early and late adolescence was analyzed as a continuous or dichotomous (Z-score cutoff: -1.0) 
variable. Associations were calculated using linear or logistic regression.
Results: Over one quarter of these girls had tried smoking by 13, while 59% had drunk alco-
holic beverages and 20% had experienced both behaviors by that age. Lower mean BMD at 
17 years of age was observed in girls who had ever smoked by 13, as well as in those who 
reported drinking at that age. There were no significant cross-sectional associations between 
experience and frequency of smoking or drinking and BMD at 13 years of age. However, we ob-
served significant associations between BMD z-score<-1 in late adolescence and having ever 
smoked by 13, after adjustment for menarche age and sports practice, (OR=1.92; 95% CI: 1.21, 
3.05) and with ever smoking and drinking in the same period (OR=2.33; 95% CI: 1.36, 4.00). 
Conclusion: Our study adds prospective evidence to the role of early initiation of smoking and 
alcohol drinking as relevant markers of lower bone mineral density in late adolescence.
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Introduction
It is currently believed that bone quality is characterized by important tracking throughout 
the life course, in such a way that the probability of fragility fracture in old age may be part-
ly traced back to the bone properties attained during the first decades of life [1]. Peak bone 
strength, through its surrogate peak bone mass, was proposed as a potential determinant of 
fragility fractures in adulthood, with even larger influence than the rate of bone loss [2]. As 
a consequence, increasing interest has been devoted to the study of bone mineralization in 
childhood and adolescence and particularly to the factors that interfere with this process [3]. 
Family studies have shown that most variability in bone properties observed within populations 
is hereditary [4]. However, known genetic polymorphisms explain only a small fraction of this 
variation and complex biological interactions preclude a clear distinction of the phenotypic 
effects of common genetic makeup from those of shared environments [5]. Regardless of this 
intrinsic challenge, environmental factors are thought to act essentially by modulating the 
achievement of an individual’s full genetic potential for bone mass [6]. Therefore, in the pri-
mary prevention of fragility fractures in old age, modifiable determinants of bone properties 
early in life are of evident interest.
Causal roles for smoking and alcohol intake in the pathogenesis of fragility fractures during 
adulthood have long been suggested. Presently, substantial epidemiological evidence has ac-
cumulated of higher fracture rates among smokers [7] and heavy drinkers [8]. Although there 
are several possible biological mechanisms underlying such relations whose relative importance 
remains to be clarified, bone properties seem to be major mediators of such pathways [9-11].
Most research on the effects of smoking and alcohol on bone health has targeted adulthood, when 
the major concerns are rate of bone loss and trauma severity. In fact, even though childhood and 
adolescence are the periods of highest bone mineral accrual, critical for peak bone mass attain-
ment, there is comparative scarcity of research on the association between those behaviors and 
bone parameters in the first decades of life. Studies that examined those relations early in life 
yielded heterogeneous results, some proposing absent or weak effects and others describing in-
verse associations since young ages. However, most evidence was cross-sectional [12, 13], from 
small samples of specific populations [14-16] or targeting wide age ranges [17-20]. 
Adolescence is a critical stage not only for bone accrual but also for the establishment of 
potentially deleterious health-related behaviors [21]. Early uptake of smoking and drinking 
can be viewed simultaneously as a component as well as marker of a set of such unhealthy 
exposures. Thus, it is relevant to assess whether initiation of these behaviors in the general 
adolescent population may predict suboptimal bone properties in the short- and long-terms.
Therefore, by prospectively evaluating a population-based cohort of girls, we aimed at quan-
tifying the associations between early initiation of smoking and alcohol drinking and forearm 
bone mineral density in early and late adolescence.
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Methods
In the present study, we used prospective data collected from 731 adolescent girls recruited 
and followed up as part of the Epidemiological Health Investigation of Teenagers in Porto 
(EPITeen), a cohort of urban adolescents born in 1990.
Cohort recruitment (13 years old) and follow-up evaluation (17 years old)
During the 2003/2004 school year, the research team approached all public and private schools 
in Porto, Portugal, that provided teaching to children born in 1990. Forty-six out of 51 eligible 
schools agreed to participate by facilitating the contact between researchers and students 
and their families. The aims and procedures involved in the study were explained to parents, 
teachers, and children through meetings arranged in each school as well as through writ-
ten materials. In participant schools, we identified 2787 eligible boys and girls of whom 78% 
agreed to participate and provided information for at least part of the protocol. The recruitment 
process yielded a baseline sample of 1116 13-year-old girls. Recruitment procedures have 
been described in detail elsewhere [22].
The first follow-up evaluation of this cohort was conducted during the 2007/2008 school year. 
Re-evaluations were scheduled by contacting schools or participants directly, using contact 
details provided during the recruitment period. Of the 1116 girls initially recruited, 892 were 
successfully reevaluated at 17 years of age (attrition rate: 20.1%). 
Ethics Statement
Written informed consent was obtained from all participants and their legal guardians in each 
evaluation. The study protocol was defined according to the Declaration of Helsinki and was 
approved by the Ethics Committee of the University Hospital of São João in Porto, Portugal.
Physical examination
The same protocol for physical examination was used in baseline and follow-up evalu-
ations. Bone mineral density (BMD) was measured in g/cm2 at the distal radius of the non-
dominant forearm by dual-energy X-ray absorptiometry (DXA) using a GE Lunar® Peripheral 
Instantaneous X-ray Imager. In case of reported previous fracture of the non-dominant arm, 
the dominant arm was the one assessed. Anthropometry was obtained while the adolescent 
stood barefoot in light indoor clothing. Weight was measured to the nearest tenth of kilogram 
(Tanita®), and height was measured in centimeters, to the nearest tenth, using a portable 
stadiometer (Seca®). Fat-free mass was estimated to the nearest tenth of kilogram using 
bioelectrical impedance (Tanita® TBF-300). Pubertal development status was measured using 
menarche age in years, obtained through a self-administered questionnaire.
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Behavioral variables
Behavioral characteristics were collected at 13 and 17 years of age, using self-administered 
questionnaires. One of the questionnaires was completed at home with parental assistance 
and included issues such as dietary intake, vitamin or mineral supplements, physical activity, 
and parental education (measured as the number of schooling years completed by the parent 
with the highest formal education). Sensitive behavioral topics (smoking, alcohol drinking and 
oral contraceptive use) were inquired trough a questionnaire filled in at school without paren-
tal assistance and ensuring privacy. 
Smoking behavior was assessed at each age using the question “Have you ever smoked?”. 
Adolescents were classified as never smokers if they reported having never tried smoking 
in both evaluations, as ever smokers between 13 and 17 years of age if they reported having 
never smoked in the 13-year-old questionnaire but having smoked in the 17-year-old question-
naire and as ever smokers at 13 if they reported having ever tried smoking in the 13-year-old 
questionnaire. At each age, among ever smokers, the frequency of smoking was classified 
using the following categories: has tried but does not currently smoke, smokes but not every 
day, smokes at least once a day.
Drinking behavior was assessed through the question “Have you ever drunk an alcoholic bev-
erage?”. Adolescents were classified as never drinkers if they had never tried drinking in both 
evaluations, as ever drinkers between 13 and 17 years of age if they reported not drinking in 
the 13-year-old questionnaire but drinking in the 17-year-old questionnaire and as drinkers at 
13 if they reported drinking in the 13-year-old questionnaire. At each age ever drinkers were 
categorized in one of the following groups: has tried but does not currently drink, drinks less 
than once a week, drinks at least once a week but not every day, drinks every day.
Physical exercise practice was assessed at 13 and 17 years of age using the question “Besides 
school time, how frequently do you practice sports for at least 20 minutes?”. Participants were 
grouped into one of two categories: those practicing sports up to once weekly and those who 
practiced two or more times per week. 
In order to assess smoking and drinking as markers of a set of adverse health behaviors, we 
used previously-defined behavioral clusters as exposures. These groups were identified in this 
population using the natural structure of the following set of data: sports activities, fruit intake, 
sleeping hours and time spent in sedentary activities, as well as tobacco and alcohol use [23]. 
Adolescents were classified in one of three following groups according to behavioral aggrega-
tion: healthiest (cluster 1), intermediate (cluster 2) and least healthy (cluster 3).
Dietary habits in the 12 months preceding the evaluation were assessed at 13 years of age 
using a food frequency questionnaire that was designed by adapting to the adolescent popula-
tion a questionnaire previously validated in Portuguese adults [24]. The questionnaire com-
prised 92 food items, whose average frequency of consumption was asked to participants. 
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This information, together with a previously defined average portion size, was used to compute 
the average daily intake of each nutrient using Food Processor Plus®. Using this procedure, we 
estimated daily intakes of calcium (mg/day) and vitamin D (μg/day).
Adolescents were also asked about vitamin or mineral supplementation in the previous 12 
months, from which we extracted information about the use of specific calcium and/or vitamin 
D supplements (Anatomical Therapeutic Chemical code A12A). Additionally, current oral con-
traceptive use was obtained by combining information from reported medication in the previ-
ous month with a specific question inquiring about current use of the birth control pill.
Data analysis
The main outcome, bone mineral density, was used either as a continuous variable or as z-scores, 
obtained by calculating the difference between each BMD value and the sample mean, divided by 
the sample standard-deviation. The clinical cutoff for the diagnosis of low bone mass for chrono-
logic age is a Z-score under -2.0  [25]. Since this is a population based sample we found a low 
frequency of this pathological change (1.5% prevalence at 13 years of age). Nevertheless, we 
aimed to characterize those individuals that, within the normal range, had lower bone density. 
Since there are no agreed cutoffs for bone mineral density in the general pediatric population 
and z-score units are considered the measure with the clearest clinical significance, adolescents 
were classified as having high or low BMD at each age, according to whether their z-score was 
above or below -1.0 (this cutoff was 0.303 g/cm2 at 13 and 0.386 g/cm2 at 17 years of age). To 
assess possible confounders or mediators, menarche age, anthropometric parameters, nutrient 
and supplement intake, physical activity, oral contraceptives, parental education, and behavioral 
clusters were described according to classes of smoking and drinking behaviors, as well as ac-
cording to bone mineral density z-score classes (≥-1SD or <-1 SD) at 13 and 17 years of age. 
One-way ANOVA was used to compare means between groups. Proportions were compared 
using Chi-square of Fisher’s exact tests, as appropriate. We calculated adjusted mean BMD val-
ues and 95% confidence intervals (95% CI) using linear regression. Logistic regression was also 
used to estimate the magnitude of the adjusted associations (odds ratios and 95% CI) of smoking 
and drinking precocity with low bone mineral density in late adolescence.
From a total of 892 girls assessed both at 13 and 17 years of age, 731 had complete informa-
tion regarding smoking and drinking habits and forearm bone densitometry. Missing data are 
mostly due to the fact that the bone density equipment was not available during a short period 
of time. By comparing the 385 girls in the initial cohort who were not analyzed with the remain-
ing 731, there were no differences in the frequency of ever smoking at 13 (26.6% vs. 26.8%, 
respectively, p=0.933) or in the proportion post-menarcheal at recruitment (84.3% vs. 86.3%, 
respectively, p=0.404). However, girls who were not included in the present analysis reported 
less frequently having ever drunk an alcoholic beverage at 13 years of age (47.2% vs. 58.4%, 
p=0.001), and had higher mean baseline BMD (0.368 vs. 0.358 g/cm2, p=0.027).
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Results
Forearm bone mineral density
In this sample of 731 girls, mean (SD) forearm bone mineral density was 0.358 (0.057) at 13 
and 0.434 (0.052) g/cm2 at 17 years of age. Among the 125 girls who had low bone mineral 
density (<-1 SD below the mean) at 13 years of age, 56% remained in the low BMD group at 
17. Of the 606 without low BMD at 13, 90% remained in that category at 17 years of age. Low 
BMD in both ages was more frequent in girls with later menarche, lower body mass index and 
lower fat-free mass. Although non-significantly, the proportion of girls reporting regular sports 
practice at 17 years of age was lower among those with BMD z-score<-1 at the same age, but 
no clear association was found at 13 years of age. No association was found between BMD and 
calcium and vitamin D dietary intakes or supplements, use of oral contraceptives, period of 
schooling of the most educated parent, or behavioral cluster (Table 1).
Smoking and alcohol drinking
Of the 731 girls evaluated, 712 and 716 provided information regarding ever smoking and 
drinking alcohol, respectively, in both evaluations.
At 13 years of age, over one quarter of the girls reported having ever smoked. Among ever 
smokers at 13, 189 provided useful frequency data, of which 165 (85.9%) reported not smoking 
regularly, 15 (7.8%) smoked but not every day while 9 (4.7%) smoked every day. Also about one 
quarter of girls had first tried smoking between 13 and 17 years of age and half remained never 
smokers up to 17 years of age. Among 329 girls who had ever smoked by 17 years of age and 
provided frequency data, 224 (66.9%) did not smoke regularly, 33 (9.8%) smoked but not every 
day and 72 (21.5%) reported smoking at least once a day. 
Almost 60% of girls reported having ever drunk an alcoholic beverage by 13 years of age. 
Among the 414 ever drinkers at 13 who provided frequency information, 380 (91.8%) reported 
not drinking regularly, 26 (6.3%) drank under once a week and 8 (1.9%) reported drinking at 
least once a week. By 17 years of age, an additional 30% of girls had first tried drinking. Among 
593 ever drinkers at 17 that provided frequency information, 273 (46.0%) reported not drinking 
regularly, 266 (44.8%) drank less than once a week and 54 (9.1%) drank at least once a week. 
Regarding both behaviors combined, one fifth of the sample reported having tried smoking and 
drinking by 13 years of age.
The characteristics of adolescents according to smoking and drinking behaviors are summed 
up in Table 2. Early initiation of both behaviors was more frequent among girls with earlier men-
arche: 12.0 was the mean menarche age among ever smokers and drinkers vs. 12.4 in the re-
maining girls. No differences in mean body mass index (BMI) or fat-free mass at 13 years of age 
were found between classes of smoking and drinking experience. However, an overall decreasing 
trend in weight, BMI and fat-free mass at 17 years of age with increasing smoking and drinking 
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precocity was observed. Oral contraceptive use by 17 was more frequent in girls who tried smok-
ing and drinking earlier in life. Decreasing trends across classes of smoking were found for mean 
calcium (p-value for linear trend: 0.149) and vitamin D (p-value for linear trend: 0.036) intakes. 
The frequency of reported regular sports practice in both evaluations decreased non-significant-
ly with increasing smoking precocity but increased (significantly at 13 years of age) with drinking 
precocity. When compared to girls who had not tried smoking or drinking before 13 years of age 
and to those who reported one of those behaviors, an intermediate frequency of regular sports 
practice was found in girls who had tried both smoking and drinking by 13. Average parental 
formal education was highest among adolescents who reported drinking before 13 years of age, 
and lowest in those who had never tried drinking by 17 years of age.
Smoking and/or drinking and 13-year-old bone mineral density
Table 3 presents mean BMD values at 13 years of age, according to smoking and alcohol drink-
ing experience. Estimates are presented adjusted for menarche age and sports practice, and 
additionally adjusted for body mass index. Overall, we found no clear cross-sectional associa-
tions between BMD at 13 and smoking or drinking experience or frequency at the same age.
Smoking and/or drinking and 17-year-old bone mineral density
In Table 4, average BMD is presented according to experience and frequency of smoking and 
drinking in early and late adolescence. After adjustment for menarche age and sports practice, 
forearm BMD at 17 years of age was lower among girls who ever tried smoking before 13 years 
of age (0.426 vs. 0.437 g/cm2 among never smokers), as well as in those who had ever drunk an 
alcoholic beverage before 13 (0.431 vs. 0.447 g/cm2 among never drinkers). The significance 
of both associations was attenuated after adjustment for body mass index. No significant as-
sociations were found between smoking or drinking frequency and 17 year-old BMD, but there 
was a decreasing trend of BMD with increasing drinking frequency at 13 (adjusted BMD was 
0.439 in those who never drank vs. 0.414 g/cm2 in those who drank at least once a week) and 
at 17 years of age (adjusted BMD was 0.438 in those who never drank vs. 0.420 g/cm2 in those 
who drank daily). BMD in late adolescence was significantly lower in girls who had tried smok-
ing and drinking before 13 (0.422 vs. 0.438 g/cm2 in those who had tried none by that age).
Figure 1 presents crude and adjusted odds ratios and 95% confidence intervals for the as-
sociations between smoking and drinking precocity and BMD z-score category. When consid-
ered dichotomously, there were clear significant associations between low 17 years BMD (z-
score<-1) and having ever smoked by 13 years of age (OR=1.92; 95% CI: 1.21, 3.05, adjusted 
for menarche age and sports practice) as well as with ever smoking and drinking in the same 
period (adjusted OR=2.33; 95% CI: 1.36, 4.00). Associations remained significant after adjust-
ment for body size or for baseline BMD. Although with lower precision and no statistical signifi-
cance, an increasing trend of lower BMD z-score was found with increasing drinking precocity. 
Similarly to the results obtained with the linear model, there was an absence of dose-response 
relations between smoking and/or drinking frequency and BMD z-score categories.
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Discussion
In the present study, early initiation of smoking and alcohol drinking was inversely associated 
with late adolescence forearm bone mineral density in girls. This suggests a long-term as-
sociation of these behaviors with bone accrual. These relations were not apparent when we 
quantified associations between smoking and drinking and bone mineral density at the same 
age. In the age range of our study, comparatively short exposure periods and cumulative doses 
may explain the absence of short-term associations and they may also be accountable for the 
observed lack of any significant dose-response relations between the reported frequency of 
smoking or drinking and bone quality.
Mean BMD estimates were adjusted for menarche age and sports practice to overcome the 
confounding effect of these factors, since they are not only associated with smoking and drink-
ing but also determinants of bone quality. We also tested the possibility of confounding by 
several other factors (height, nutrient intake, supplement use, oral contraception, and parental 
education) which were not adjusted for in the final analysis, since they were not simultane-
ously associated with bone mineral density and smoking or drinking. We found lower average 
BMI as well as lower fat-free mass in late adolescence among girls who had experienced 
smoking and/or drinking by 13 years of age, suggesting that body size may be a relevant inter-
mediate step in possible effects of these behaviors on bone quality. In agreement, we observed 
an attenuation of the associations between smoking or drinking and BMD after body size ad-
justment. This is to be expected if BMI is a mediator, since adjustment for body size should 
substantially decrease the component of the total effect operating through that path, resulting 
in weaker overall associations.
Previous research pertaining to this life stage is scarce but results are overall consistent with 
our findings. In a small prospective study of 9th grade adolescents, smoking and drinking ex-
perience were negatively associated with 12th grade bone mineral density [15]. Additionally, a 
2-year follow-up study in a small sample of female University students showed an unfavorable 
development of bone mineral density in young women smokers who did not use oral contra-
ceptives [18]. In a trial of an oral contraceptive, a higher mean loss of BMD was found among 
female adolescents who used alcohol [16]. However, another larger cross-sectional study in 
young women failed to find associations between smoking or drinking and forearm bone min-
eral density [13]. Nevertheless, a study in young men found a negative association of smoking 
with bone mineral density and cortical thickness [12]. More recently, a cross-sectional study 
reinforced this hypothesis, since smoking was associated with higher frequency of previous 
fracture and with worse bone properties in young male siblings. These associations were stron-
ger in men whose smoking initiation occurred at an early age, suggesting possible impairment 
of optimal peak bone mass and geometry [26]. Our results are in agreement with this negative 
influence of smoking and drinking on bone health, particularly regarding the potential role of 
precocity, but extend it, by providing evidence of long-term associations between smoking and 
alcohol intake and bone quality in a large sample of girls selected from the general population.
Results 123
While there is little research before peak bone mass accrual, an association between smok-
ing and the amount of skeletal mass has long been described in adult twins, in whom it was 
estimated that smoking one pack of cigarettes daily throughout adulthood would lead to a 5 to 
10% deficit in bone density by menopause [27]. Smoking has been hypothesized to decrease 
bone mineral density by interfering with body weight and fat mass, respectively by decreasing 
mechanical loading on the skeleton and by diminishing estrogen synthesis and leptin secretion 
by the adipose tissue [9]. Smoking may also act on bone metabolism by promoting accelerated 
estrogen metabolism and elimination, decreasing serum levels of calciotropic hormones, and 
increasing the secretion of adrenocortical hormones [28]. 
A recent systematic literature review showed that adult men and women reporting moder-
ate alcohol intake had higher bone mineral density than abstainers [29]. Whereas direct and 
hormone-mediated mechanisms have been proposed to account for this protective effect of 
ethanol, inhibition of bone resorption seems to be the most likely mechanism involved in this 
relation [30, 31]. Despite a possible protective effect of moderate consumption, studies in clini-
cal samples of heavy drinkers suggested excessive alcohol intake as a risk factor for lower 
bone mass [32]. This is supported by animal models, where impairing formation through an 
action on osteoblast activity appears as the most relevant mechanism by which alcohol inter-
feres with bone health [10, 32]. This finding has particular importance during the first decades 
of life, since the balance between bone formation and resorption favors formation, resulting 
in a cumulative increase in bone mass, as well as in changes in microarchitecture and ge-
ometry, with consequent contribution to overall bone physical properties [1]. Therefore, the 
interference of ethanol on bone formation may be especially relevant during that life stage. 
An additional issue with growing public health relevance from young ages is the possible 
interference of binge drinking with bone accrual. Although evidence from studies in human 
populations remains scarce, a recent review has identified interesting results from animal 
models where binge drinking was found to have short- and long-term deleterious effects on 
the teenage rat skeleton, through increased resorption and decreased formation [33]. In our 
study adolescents were not specifically questioned about binge drinking, but we found weak, 
non-significant  associations between the history of excessive alcohol consumption at 17 years 
of age (ever having felt drunk, age at the first drunkenness episode, and cumulative number 
of drunkenness experiences throughout life) and bone mineral density (results not shown). 
However, the significance of this lack of association is unclear, since exposure assessment in 
our study was not designed to explore the effect of binge drinking.
It should be noted that although there is a number of plausible biological mechanisms by 
which smoking and alcohol may affect bone quality, epidemiological evidence of the associa-
tion between these exposures and bone mineral density remains inconsistent in adult women 
[34]. In fact, there is substantial indication that smoking and drinking tend to cluster with a 
number of other unhealthy behaviors which may themselves have a relevant effect on bone 
health [23]. One possible explanation for the associations found in the present study is indeed 
that these behaviors are not causal exposures but markers of other adverse influences, such 
as poor nutrition or sedentarism. Nevertheless, we observed that the associations between 
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bone density and behavioral clusters (which included smoking, drinking, physical activity, fruit 
intake and sleeping hours) were weaker than those estimated between bone density and smok-
ing or drinking alone. Although this does not exclude the possibility that smoking and drinking 
are risk markers instead of risk factors, it suggests that the other behaviors included in the 
cluster definition are not the main causal influences responsible for the observed associations.
Limitations
In all prospective studies, differential losses to follow-up and non-random missing data may 
be important threats to validity since they may yield biased estimates. In the present study, 
girls who were excluded from the analysis because of missing data or losses to follow-up 
reported lower frequency of alcohol drinking and simultaneously had higher bone mineral den-
sity at 13 years of age. This is in agreement with our findings of an inverse association between 
this behavior and bone properties among girls included in the present analysis. Although this 
consistency does not clarify the extent of possible bias, it suggests that the direction of our 
results was probably not affected by differential information losses. 
A limitation of the present work is that we used forearm BMD to summarize bone proper-
ties, and peripheral measures of areal bone mineral density obtained by dual-energy X-ray 
absorptiometry are not perfect substitutes for axial or total body measures, since they are 
affected by bone size [35]. Whole-body DXA would have provided a more accurate estimate of 
the systemic effects under study, as well as allowing for the estimation of bone mineral con-
tent variation, which may be a more informative parameter in studies conducted during growth 
[36]. However, the large sample size and community-based setting of evaluations required a 
practical and portable method for bone quality assessment. An additional aspect is that areal 
bone mineral density in children can fail to capture true volumetric density since it partly re-
flects bone size in addition to density and complementary data on other physical properties 
or geometry, such as bone area or mineral content, were not available. However, it should be 
noted that the mechanical resistance of bone to trauma is a function of several properties of 
bone tissue, including size [37]. Therefore, areal bone mineral density may be seen as a com-
bined result of two important bone properties that determine strength: density and size. Even 
though this view is arguable, its rationale is supported by prospective evidence that areal bone 
mineral density is a good marker of fracture risk, as observed in a systematic review of studies 
in children [38].
In our study, pubertal development status was ascertained using menarche age. We acknowl-
edge that menarche occurs relatively late in the pubertal development process and is not a 
perfect substitute for physical examination [39]. However, it becomes particularly useful in 
population studies of large samples where the feasibility of physical examination is limited. 
Nevertheless, menarche age is believed to be reproducible in the short term, as shown in a 
Canadian study of adolescent girls, where over three quarters of participants were able to 
recall menarche age within 1 month [40]. Regarding physical activity, even though the ques-
tionnaire applied is widely used by physical activity and exercise experts in Portugal, it did not 
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undergo a formal validation procedure against accelerometer measurements. Nevertheless, 
the questionnaire was previously found to have high reproducibility [22].
An additional limitation of our study pertains to the possibility that the self-report of adverse 
health behaviors such as smoking and drinking by adolescents may be subject to misreporting 
due to both cognitive factors, such as comprehension and recall, and to situational influences, 
namely social desirability and interviewing conditions [41]. Moreover, the relatively low fre-
quency of regular smoking and drinking decreased the statistical power for the analysis of 
potential dose-response relations between these behaviors and bone mineral density, which 
could reinforce the plausibility of our findings. Another limitation is the fact that we have no 
record about accumulated exposure to tobacco or alcohol between evaluations. In order to 
address this, we used precocity in the initiation of those behaviors as a proxy for the duration 
of exposure.
Despite the above-mentioned constraints, we were able to quantify the associations under 
study using a prospective design and during a period that spanned most of adolescence. 
Importantly, girls in this sample were born in the same year, which minimized confounding 
by cohort or period effects. We were also able to test a substantial number of other potential 
confounders of the effect under study.
In the present prospective study conducted in community adolescent girls, early initiation of 
smoking and alcohol drinking were associated with lower forearm bone mineral density in late 
adolescence. These behaviors may be relevant red-flags for impaired long-term bone mineral 
acquisition up to peak bone mass.
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Table 1. Distribution of anthropometric and behavioral characteristics at 13 and 17 years of age according to bone 
mineral density (BMD) z-scores at 13 and 17 years of age.
BMD at 13 years of age BMD at 17 years of age
z-score≥-1† z-score<-1 p z-score≥-1† z-score<-1 p
N (%) 606 (82.9) 125 (17.1) 599 (81.9) 132 (18.1)
Mean (SD) menarche age 
(years)
12.1 (1.3) 13.2 (1.1) <0.001 12.2 (1.3) 12.8 (1.3) <0.001
Mean (SD) height at 13 (cm) 168.6 (6.2) 155.2 (7.8) <0.001 158.4(6.4) 156.3 (7.0) <0.001
Mean (SD) height at 17 (cm) 161.1 (6.1) 160.6 (7.0) 0.392 161.1 (6.3) 160.6 (6.0) 0.440
Mean (SD) weight at 13 (kg) 54.0 (9.4) 44.5 (7.5) <0.001 53.5 (9.5) 47.0 (9.2) <0.001
Mean (SD) weight at 17 (kg) 58.0 (9.2) 51.7 (7.3) <0.001 58.1 (9.1) 51.9 (7.9) <0.001
Mean (SD) body mass index 
at 13 (kg/m2)
21.4 (3.3) 18.4 (2.4) <0.001 21.3 (3.3) 19.1 (3.1) <0.001
Mean (SD) body mass index 
at 17 (kg/m2)
22.2 (3.7) 20.0 (2.3) <0.001 22.2 (3.5) 19.9 (3.2) <0.001
Mean (SD) fat-free mass at 
13 (kg)
38.6 (3.9) 35.4 (3.9) <0.001 38.6 (3.9) 35.8 (4.1) <0.001
Mean (SD) fat-free mass at 
17 (kg)
42.8 (3.7) 40.4 (3.7) <0.001 42.9 (3.7) 40.3 (3.6) <0.001
Mean (SD) calcium intake at 
13 (mg/day)
1146.6 
(464.0)
1127.5 
(444.6)
0.707 1157.6 
(467.4)
1073.7 
(420.6)
0.095
Mean (SD) vitamin D intake at 
13 (g/day)
4.5 (2.6) 4.5 (2.4) 0.881 4.6 (2.6) 4.2 (2.4) 0.183
Number (%) using calcium/vit 
D supplements  at 13
3 (0.5) 1 (0.8) 0.528 4 (0.7) 0 (0.0) >0.999
Number (%) using calcium/vit 
D supplements  at 17
‡ ‡ ‡ 3 (0.5) 1 (0.8) 0.550
Number (%) reporting oral 
contraceptive at 17
‡ ‡ ‡ 241 (40.2) 47 (35.6) 0.376
Number (%) practicing sports 
≥2 times/week at 13 
265 (44.5) 56 (47.1) 0.603 269 (45.8) 52 (40.6) 0.284
Number (%) practicing sports 
≥2 times/week at 17 
‡ ‡ ‡ 252 (43.7) 45 (35.2) 0.077
Mean (SD) parental education 
(schooling years)
10.7 (4.4) 10.5 (5.0) 0.644 10.6 (4.4) 11.1 (4.9) 0.234
Number (%) in behavioral 
clusters*
0.797 0.651
Cluster 1 210 (39.9) 43 (43.5) 215 (41.5) 40 (36.6)
Cluster 2 301 (57.1) 53 (53.5) 288 (55.7) 66 (60.6)
Cluster 3 16 (3.0) 3 (3.0) 16 (3.1) 3 (2.8)
P-values were calculated using chi-square of Fisher’s exact tests, as appropriate (for the comparisons between 
proportions), or using Student’s t-test (for the comparisons of means).
* Behavioral clusters defined using the following variables: sports activities, fruit intake, sleeping hours, time spent 
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in sedentary activities, tobacco and alcohol use [23]. Adolescents were classified in one of three following groups 
according to behavioral aggregation: healthiest (cluster 1), intermediate (cluster 2) and least healthy (cluster 3).
† Z-score -1.0 cutoff corresponded to 0.303g/cm2 at 13 and 0.386 g/cm2 at 17 years of age.
‡ Estimates are not presented because exposures are behaviors which took place in late adolescence while the outcome 
(BMD) refers to early adolescence.
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P-values were calculated using chi-square of Fisher’s exact tests, as appropriate (for the comparisons between 
proportions), or using one-way ANOVA (for the comparisons of means).
* Behavioral clusters defined using the following variables: sports activities, fruit intake, sleeping hours, time spent in 
sedentary activities, tobacco and alcohol use [23]. Adolescents were classified in one of three following groups 
according to behavioral aggregation: healthiest (cluster 1), intermediate (cluster 2) and least healthy (cluster 3).
Table 3. Mean forearm bone mineral density (BMD) and 95% confidence intervals (95% CI) at 13 years of age according 
to smoking and drinking categories and adverse behaviors clusters.
Mean (95% CI) forearm BMD at 13 years of age
n
Adjusted for menarche 
age and regular sports
Adjusted for menarche 
age, regular sports and 
body mass index
Smoking frequency at 13
Never tried smoking 523 0.359 (0.355, 0.363) 0.357 (0.353, 0.362)
Tried but does not currently smoke 165 0.355 (0.347, 0.363) 0.361 (0.355, 0.368)
Smokes but not every day/ smokes at least once a day 24 0.347 (0.326, 0.367) 0.355 (0.349, 0.361)
p 0.366 0.410
Drinking frequency at 13
Never tried drinking 298 0.359 (0.353, 0.365) 0.358 (0.353, 0.363)
Tried but does not currently drink 380 0.359 (0.354, 0.364) 0.359 (0.354, 0.363)
Drinks less than once a week 26 0.345 (0.325, 0.365) 0.351 (0.333, 0.368)
Drinks at least once a week but not every day/Drinks 
every day
8 0.353 (0.318, 0.388) 0.354 (0.323, 0.384)
p 0.590 0.826
Ever smoking or drinking before 13
Tried none 248 0.358 (0.351, 0.364) 0.358 (0.352, 0.363)
Tried one 312 0.361 (0.356, 0.367) 0.361 (0.356, 0.366)
Tried both 140 0.351 (0.343, 0.360) 0.353 (0.346, 0.361)
p 0.146 0.248
Behavioral cluster* at 13 years of age
Cluster 1 253 0.359 (0.353, 0.365) 0.358 (0.353, 0.364)
Cluster 2 354 0.359 (0.354, 0.364) 0.359 (0.355, 0.364)
Cluster 3 19 0.346 (0.323, 0.368) 0.350 (0.331, 0.370)
p 0.528 0.697
P-values were calculated using one-way ANOVA.
* Behavioral clusters defined using the following variables: sports activities, fruit intake, sleeping hours, time spent 
in sedentary activities, tobacco and alcohol use [23]. Adolescents were classified in one of three following groups 
according to behavioral aggregation: healthiest (cluster 1), intermediate (cluster 2) and least healthy (cluster 3).
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Table 4. Mean forearm bone mineral density (BMD) and 95% confidence intervals (95% CI) at 17 years of age according 
to smoking and drinking categories and adverse behaviors clusters.
Mean (95% CI) forearm BMD at 17 years of age
n Adjusted for menarche age and regular sports
Adjusted for menarche age, 
regular sports and body mass 
index
Smoking frequency at 13
Never tried 523 0.437 (0.433, 0.442) 0.436 (0.432, 0.440)
Tried but does not currently smoke 165 0.425 (0.417, 0.433) 0.426 (0.419, 0.434)
Smokes but not every day/ smokes at least 
once a day 24 0.431 (0.410, 0.452) 0.433 (0.413, 0.452)
p 0.217 0.068
Smoking frequency at 17
Never tried 390 0.436 (0.431, 0.441) 0.435 (0.430, 0.440)
Tried but does not currently smoke 224 0.435 (0.428, 0.442) 0.436 (0.429, 0.442)
Smokes but not every day 33 0.418 (0.400, 0.436) 0.421 (0.404, 0.438)
Smokes at least once a day 72 0.429 (0.417, 0.441) 0.432 (0.420, 0.443)
p 0.257 0.438
Ever smoking in adolescence
Never smoked at 17 353 0.437 (0.432, 0.443) 0.436 (0.431, 0.441)
Tried smoking after 13 but before 17 167 0.438 (0.430, 0.445) 0.438 (0.431, 0.445)
Tried smoking before 13 years of age 192 0.426 (0.418, 0.433) 0.428 (0.421, 0.435)
p 0.030 0.103
Drinking frequency at 13
Never tried drinking 298 0.439 (0.434, 0.445) 0.438 (0.433, 0.444)
Tried but does not currently drink 380 0.433 (0.428, 0.438) 0.433 (0.428, 0.438)
Drinks less than once a week 26 0.420 (0.400, 0.439) 0.428 (0.410, 0.447)
Drinks at least once a week but not every 
day/Drinks every day 8 0.414 (0.378, 0.449) 0.417 (0.384, 0.449)
p 0.084 0.282
Drinking frequency at 17
Never tried drinking 120 0.438 (0.429, 0.448) 0.434 (0.425, 0.442)
Tried but does not currently drink 273 0.436 (0.430, 0.442) 0.436 (0.430, 0.442)
Drinks less than once a week 266 0.432 (0.426, 0.438) 0.434 (0.428, 0.439)
Drinks at least once a week but not every 
day/Drinks every day 54 0.420 (0.406, 0.434) 0.424 (0.411, 0.438)
p 0.157 0.471
Ever drinking in adolescence
Never drank at 17 84 0.447 (0.435, 0.458) 0.441 (0.430, 0.451)
Tried drinking after 13 but before 17 213 0.436 (0.430, 0.443) 0.437 (0.431, 0.444)
Tried drinking before 13 years of age 419 0.431 (0.426, 0.436) 0.432 (0.428, 0.437)
p 0.045 0.216
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Ever smoking or drinking before 13
Tried none 248 0.438 (0.431, 0.444) 0.438 (0.432, 0.444)
Tried one 312 0.437 (0.431, 0.443) 0.436 (0.431, 0.442)
Tried both 140 0.422 (0.413, 0.430) 0.424 (0.416, 0.433)
p 0.006 0.023
Behavioral cluster* at 13 years of age
Cluster 1 253 0.439 (0.433, 0.446) 0.438 (0.432, 0.444)
Cluster 2 354 0.432 (0.427, 0.438) 0.433 (0.428, 0.438)
Cluster 3 19 0.436 (0.412, 0.459) 0.439 (0.417, 0.461)
p 0.307 0.399
P-values were calculated using one-way ANOVA.
* Behavioral clusters defined using the following variables: sports activities, fruit intake, sleeping hours, time spent 
in sedentary activities, tobacco and alcohol use [23]. Adolescents were classified in one of three following groups 
according to behavioral aggregation: healthiest (cluster 1), intermediate (cluster 2) and least healthy (cluster 3).
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In the present work we have examined bone dynamics from early to late adolescence in a co-
hort of girls born 1990 and prospectively followed-up from 13 to 17 years of age. As presented 
in Figure 15, our specific approaches went from a focus on the whole adolescent population 
(Papers I and IV) to an emphasis on individuals at higher disease risk, such as those who were 
overweight at least once during adolescence (Paper II) or those who reported early smoking 
or drinking behaviors (Paper V). Our description of bone was directed not only to physical prop-
erties (Papers I, II and V) but also to bone turnover (Papers III, and IV). 
Figure 15. Conceptual dimensions representing specific approaches in Papers I-V
The epidemiologic approach to the study of disease etiology is founded on the premise that 
disease causation can be validly uncovered by observing differences between groups of sub-
jects in human populations. Specifically, epidemiologic studies of disease etiology are built 
on the assumption that it is possible to infer causation from statistical correlations between 
variables measured in a population [139]. For such an assumption to be true, individuals under 
study would have to be comparable between themselves, i.e. equal in all characteristics other 
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than the exposure being studied. In counterfactual terminology, this is equivalent to stating 
individuals need to be exchangeable with regard to the exposure [140]. Since individuals within 
a population are usually different in a number of characteristics beyond those being studied, 
epidemiologic research tries to identify and account for all the important factors that differ 
between them and can be an alternative explanation for observed statistical associations. 
Epidemiologic research becomes then particularly focused on ruling out bias and confounding 
in order to optimize study validity.
In the present work, we used data from a cohort of individuals evaluated twice (in early and 
late adolescence) to address the objectives. Selection bias at recruitment is possible, since 
only adolescent present at schools were invited to participate, thus excluding children not 
attending middle-school at 13 years of age, such as those severely ill or in very adverse so-
cial circumstances. However, we estimate this to be a small minority of subjects, who would 
likely have very low impact on measures obtained from a populational approach such as the 
present one. An additional issue is participation bias, since children who did not participate in 
the study are likely to be systematically different from those who accepted to take part in the 
evaluations. Since ethical issues precluded the collection of information on eligible individuals 
who refused to participate, we cannot estimate the scope of such differences. However, even 
though it is not directly relatable with participation bias, the high participation proportion at 
baseline (78%) may decrease the impact of that potential limitation [133].
Another important point in cohort studies is the extension of differential losses to follow-up. In 
the present study attrition was 20.5%, which is generally considered low [141].  Additionally, in 
each of the present studies, when we compared children who were and were not successfully 
reevaluated regarding characteristics collected at recruitment, although there were some sig-
nificant differences, the magnitude of those differences was generally small, namely regarding 
our main outcome, bone mineral density. Nevertheless, whenever possible, we adjusted our 
analyses to factors that were presumed to affect censoring and outcomes simultaneously, as 
previously described [141]. Furthermore, the trade-off between the impact of possible dif-
ferential losses to follow-up and the strengths of the cohort approach should be examined. In 
fact, with prospective studies such as the present one, we are generally able to understand 
the temporal sequence of events, to estimate effects in a comparatively long term (that in our 
case spanned most of adolescence), and to describe estimates of changes in bone parameters 
throughout adolescence unaffected by cohort or period effects. The cohort approach has also 
been shown to increase the validity of growth estimates when compared to cross-sectional 
data, since the latter underestimate the true steepness of growth curves as well as average 
peak growth velocity [59, 142].
Due to the fact that the sample studied was included in a large population-based cohort of 
adolescents who were evaluated in their own schools, several methodological options had 
to be made in order to optimize feasibility and participation. Since the evaluation setting did 
not guarantee enough privacy, the assessment of pubertal development status could not be 
conducted using Tanner staging and we used menarche age as an estimate of sexual maturity. 
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Our observation that there was a strong relation of bone mineral density with menarche age 
reinforced the validity of that option. 
Another option of the present work was to use dual-energy X-ray absorptiometry at the fore-
arm to estimate bone quality at each age as well as changes throughout adolescence. This 
method has the advantages of rapid scan times and low radiation, which are especially im-
portant features in studies conducted in children [143]. Additionally, the fact that dual-energy 
X-ray absorptiometry is the most widely used method for bone assessment allows for com-
parisons between settings and populations. However, it should be noted that dual-energy X-ray 
absorptiometry has relevant limitations, the most important of which is that it provides as 
output measure the ratio between the mass of mineral tissue and the projected bone area, 
in g/cm2. Therefore, the resulting estimate is not a true material volumetric density but an 
areal measure, which gives rise to an important bias due to bone size [144]. If no size correc-
tions are applied, given two bones of the same true volumetric density, the one of larger size 
will be assigned a higher value of areal bone mineral density than the smaller one. In fact, 
inadequate adjustment for size-related artifacts has been considered responsible for spurious 
associations between areal bone mineral density and potentially modifiable factors such as 
calcium intake, adiposity and physical activity [145]. Several solutions have been proposed 
for standardizing the analysis of bone densitometry data with regard to size effects, including 
height adjustment equations [57], as well as less restrictive procedures such as the use bone 
mineral content as the dependent variable and bone area, weight and height as independent 
variables in multiple regression modeling [47]. Two approaches seem interesting as strategies 
to deal with the dependence of areal bone mineral density on bone size. One of them is to ac-
count for body size using one of the above-described techniques. The other strategy, which was 
preferred throughout the present thesis, was to use areal bone mineral density without adjust-
ment. We recognize that areal bone mineral density is a mixed measure of true density and 
size and that it might not be an accurate measure of either of the two. However, overall bone 
strength should be viewed as a complex construct, composed of multiple dimensions, includ-
ing material density and size. Since bones of larger size have higher mechanical resistance, 
independently of volumetric density, we believe that crude measures of areal bone mineral 
density are more reflective of overall bone strength than adjusted ones. This option has the 
empirical support of a prospective study where areal bone mineral density was a predictor of 
fractures in childhood and adolescence [146]. Additionally, given that true volumetric density 
varies comparatively little throughout adolescence, interindividual and intraindividual changes 
in areal bone mineral density observed in the present work are mainly a function of changes in 
bone size and consequently in overall bone strength.
Another important issue is that, in contrast with quantitative computed tomography, dual-en-
ergy X-ray absorptiometry does not allow for the distinction between cortical and trabecular 
bone, which could help clarify the mechanisms underlying presumed systemic effects, since 
trabecular bone is more sensitive than cortical bone to metabolic influences. Quantitative 
computed tomography would also allow for the estimation of relevant parameters of bone 
geometry that are known to influence ultimate strength, namely periosteal and endosteal 
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circumferences, cortical area and cortical thickness.
An additional relevant aspect in our method of bone mineral density estimation was the choice 
of anatomical site, which had to be the result of a tradeoff between validity and feasibility. 
We chose the forearm as it implied a lower dose of radiation and consequently greater ac-
ceptability by participants, and a higher portability of the device, which needed to be trans-
ported between nearly 50 schools. However, peripheral dual-energy X-ray absorptiometry is 
not a perfect substitute for axial or whole-body measures because the composition of bone 
varies substantially throughout the skeleton as do basal loads exerted on bone tissue [147]. 
Nevertheless, there is evidence of an important bone mineral density correlation between ana-
tomical sites, supported by the predictive ability of peripheral bone mineral density regarding 
fracture risk [148, 149].
We cannot be certain that these girls had reached the peak forearm bone mineral density by 
17 years of age. However, it has been estimated that only an average increase of 0.006 g/cm2 
in total body bone mineral density (and 20 g of total body bone mineral content) happens in 
girls between 17 and 20 years old, as opposed to a 0.019 g/cm2 increase between 15 and 17 
years of age [150]. Another study estimated that 94% of peak bone mineral content and 98% 
of peak volumetric bone mineral density at the radius were attained by 16 years of age in girls 
[151]. Therefore, we believe that our late adolescence estimates were good surrogates for 
peak forearm bone mineral density. 
A key consideration that goes beyond specific methodological options pertains to the assump-
tion of the relevance of modifying peak bone mass attainment for fracture prevention during 
adulthood. Adolescence is undoubtedly an important period for the attainment of bone strength, 
particularly when considering that the amount of bone mineral acquired during that life stage 
is estimated to be twice that lost between 50 and 80 years of age [7]. As a consequence, it has 
been generally accepted that optimizing the genetic potential for peak bone mass is helpful 
in avoiding fragility fractures in adulthood [47]. However, one of the main limitations of the 
concept of optimizing peak bone mass or density is that it is unidimensional and may oversim-
plify the complex dynamics of bone development during growth [152]. More importantly, even 
though optimizing peak bone mass seems a sensible public health strategy, there is still no 
longitudinal evidence of a relevant benefit on fracture occurrence. Currently, it is not known 
which one of the models presented in Figure 16, if any, is a valid representation of the effect of 
interventions directed at optimizing peak bone mass. In fact, it has been argued that there are 
serious challenges to the premises that: 1) interventions in childhood are effective in increas-
ing peak bone mass; 2) increasing peak bone mass is effective in maintaining higher bone mass 
throughout adulthood [56, 65]. 
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Figure 16. Proposed models for the effect of interventions to increase peak bone mass 
(reproduced from Gafni & Baron [56])
Gafni and Baron observed in an animal model that iatrogenic osteoporosis was completely 
reversed after removal of the exposure through complete resorption of the osteoporotic bone 
and replacement with new healthy bone [56]. New bone was formed both through endocondral 
ossification at the growth plate and through periosteal formation, resulting in no differences 
from control animals regarding bone size, density or strength. These laboratory findings were 
consistent with those of clinical trials of calcium supplementation in children, where, at the 
longest point after supplementation, either non-significant or only small long-term effects on 
bone mineral density were seen [153]. There is also little evidence of a long-term effect of 
physical activity on bone mineral density [77]. 
However, even if optimizing bone mineral accrual by intervening on modifiable factors does not 
improve peak bone mass or if peak bone mass optimization by itself does not decrease fracture 
risk, it is very likely that modifiable determinants of bone properties, such as anthropometry, 
and lifestyles are similar in childhood and adulthood. It is also known that adolescence is a 
critical life stage for the experimentation and establishment of many health-related behav-
iors that will be replicated or maintained throughout the life course. As such, even if there 
are no direct long-term effects on adult bone of behavioral modification in adolescence, early 
intervention on life-long causes of bone fragility may have indirect persistent effects, if such 
exposures keep their relevance throughout the life course. For instance, it may be that physi-
cal activity in childhood does not influence fracture risk in late adulthood, but the maintenance 
of adequate levels of exercise throughout life starting from childhood (a life stage where that 
behavior is easier to implement) could be an important preventive strategy regarding fragility 
fractures. As a consequence, interventions on such modifiable determinants of bone quality 
before peak bone mass should probably be expected to have an effect, even if indirect, on 
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fracture probability in adulthood. Therefore, the search for the etiology of bone fragility from 
early life and the intervention upon its modifiable causes seems to retain relevance as a life 
course approach, which could result in an early initiation of sustained beneficial health related-
behaviors rather than a “one-time investment” in bone quality with long-term effects.
With its first two evaluations (at 13 and 17 years of age), the EPITeen cohort has allowed for 
the collection and analysis of a wide spectrum of data related to several dimensions of ado-
lescent health. Specifically in the area of skeletal health, the EPITeen study has provided the 
opportunity to measure and characterize physical and biochemical parameters of bone quality, 
and to frame those findings within a much wider context that includes other dimensions of 
health, both individual and contextual. The fact that all adolescents were born in 1990 and 
were evaluated at approximately the same age minimized possible confounding by age, cohort 
or period effects. In addition, this study has the advantage of being a population-based design, 
which optimizes the generalizability of findings, potentially extending their applicability within 
the public health framework.
6. Conclusions
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In the present study there was a small weight-independent effect of adiposity on bone min-
eral density in early adolescent girls, by which we estimate that fat mass does not have an 
important specific effect on bone mechanical properties in the adiposity range observed in 
the general population. However, overweight could modify the relative importance of the non-
mechanical effect of fat on bone physical properties, since we found that low-grade systemic 
inflammation associated with increased adiposity may have a harmful effect on forearm bone 
mineral density in late adolescence.
With regard to a more fundamental perspective of bone development, we found that dynamic 
markers of bone turnover, such as serum levels of osteoclastogenesis regulators and collag-
enous markers may be more sensitive indicators of bone status than bone mineral density 
throughout different stages of growth and sexual development in adolescence. Further evi-
dence of their usefulness as a dynamic measure of bone status in the general population was 
their association with leptin, a major mediator of the fat-bone relation, which was not observed 
regarding bone mineral density. These findings emphasize the importance of disentangling 
mechanical and biochemical dimensions of growing bone.
At a contextual level, more clearly interpretable in terms of behavioral modification directed at 
health promotion, we found that lifestyle factors such as early initiation of smoking and alcohol 
drinking may be useful red-flags to indicate suboptimal forearm bone mineral density accrual 
up to late adolescence.
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